id	sid	tid	token	lemma	pos
aiua-10305	1	1	stesura	stesura	PROPN
aiua-10305	1	2	seveso	seveso	PROPN
aiua-10305	1	3	475archivio	475archivio	PROPN
aiua-10305	1	4	italiano	italiano	NOUN
aiua-10305	1	5	di	di	X
aiua-10305	1	6	urologia	urologia	PROPN
aiua-10305	1	7	e	e	PROPN
aiua-10305	1	8	andrologia	andrologia	NOUN
aiua-10305	1	9	2021	2021	NUM
aiua-10305	1	10	;	;	PUNCT
aiua-10305	1	11	93	93	NUM
aiua-10305	1	12	,	,	PUNCT
aiua-10305	1	13	4	4	NUM
aiua-10305	1	14	original	original	ADJ
aiua-10305	1	15	paper	paper	NOUN
aiua-10305	1	16	no	no	DET
aiua-10305	1	17	conflict	conflict	NOUN
aiua-10305	1	18	of	of	ADP
aiua-10305	1	19	interest	interest	NOUN
aiua-10305	1	20	declared	declare	VERB
aiua-10305	1	21	.	.	PUNCT
aiua-10305	2	1	grows	grow	VERB
aiua-10305	2	2	in	in	ADP
aiua-10305	2	3	the	the	DET
aiua-10305	2	4	southern	southern	ADJ
aiua-10305	2	5	united	united	PROPN
aiua-10305	2	6	states	states	PROPN
aiua-10305	2	7	,	,	PUNCT
aiua-10305	2	8	particularly	particularly	ADV
aiua-10305	2	9	in	in	ADP
aiua-10305	2	10	florida	florida	PROPN
aiua-10305	2	11	and	and	CCONJ
aiua-10305	2	12	south	south	PROPN
aiua-10305	2	13	carolina	carolina	PROPN
aiua-10305	2	14	(	(	PUNCT
aiua-10305	2	15	2	2	NUM
aiua-10305	2	16	)	)	PUNCT
aiua-10305	2	17	.	.	PUNCT
aiua-10305	3	1	sr	sr	PROPN
aiua-10305	3	2	is	be	AUX
aiua-10305	3	3	commonly	commonly	ADV
aiua-10305	3	4	used	use	VERB
aiua-10305	3	5	throughout	throughout	ADP
aiua-10305	3	6	the	the	DET
aiua-10305	3	7	world	world	NOUN
aiua-10305	3	8	to	to	PART
aiua-10305	3	9	treat	treat	VERB
aiua-10305	3	10	benign	benign	ADJ
aiua-10305	3	11	prostatic	prostatic	ADJ
aiua-10305	3	12	hyperplasia	hyperplasia	NOUN
aiua-10305	3	13	(	(	PUNCT
aiua-10305	3	14	bph	bph	NOUN
aiua-10305	3	15	)	)	PUNCT
aiua-10305	3	16	and	and	CCONJ
aiua-10305	3	17	prostatitis	prostatitis	NOUN
aiua-10305	3	18	.	.	PUNCT
aiua-10305	4	1	although	although	SCONJ
aiua-10305	4	2	its	its	PRON
aiua-10305	4	3	mechanism	mechanism	NOUN
aiua-10305	4	4	of	of	ADP
aiua-10305	4	5	action	action	NOUN
aiua-10305	4	6	has	have	AUX
aiua-10305	4	7	not	not	PART
aiua-10305	4	8	fully	fully	ADV
aiua-10305	4	9	been	be	AUX
aiua-10305	4	10	demonstrated	demonstrate	VERB
aiua-10305	4	11	yet	yet	ADV
aiua-10305	4	12	,	,	PUNCT
aiua-10305	4	13	it	it	PRON
aiua-10305	4	14	is	be	AUX
aiua-10305	4	15	mainly	mainly	ADV
aiua-10305	4	16	used	use	VERB
aiua-10305	4	17	on	on	ADP
aiua-10305	4	18	the	the	DET
aiua-10305	4	19	assumption	assumption	NOUN
aiua-10305	4	20	that	that	SCONJ
aiua-10305	4	21	sr	sr	PROPN
aiua-10305	4	22	is	be	AUX
aiua-10305	4	23	a	a	DET
aiua-10305	4	24	5a	5a	NUM
aiua-10305	4	25	-	-	PUNCT
aiua-10305	4	26	reductase	reductase	NOUN
aiua-10305	4	27	inhibitor	inhibitor	NOUN
aiua-10305	4	28	,	,	PUNCT
aiua-10305	4	29	consequently	consequently	ADV
aiua-10305	4	30	blocking	block	VERB
aiua-10305	4	31	the	the	DET
aiua-10305	4	32	conversion	conversion	NOUN
aiua-10305	4	33	of	of	ADP
aiua-10305	4	34	testosterone	testosterone	NOUN
aiua-10305	4	35	to	to	ADP
aiua-10305	4	36	dihydrotestosterone	dihydrotestosterone	NOUN
aiua-10305	4	37	(	(	PUNCT
aiua-10305	4	38	dht	dht	PROPN
aiua-10305	4	39	)	)	PUNCT
aiua-10305	4	40	a	a	DET
aiua-10305	4	41	biologically	biologically	ADV
aiua-10305	4	42	more	more	ADV
aiua-10305	4	43	active	active	ADJ
aiua-10305	4	44	hormone	hormone	NOUN
aiua-10305	4	45	(	(	PUNCT
aiua-10305	4	46	2	2	NUM
aiua-10305	4	47	,	,	PUNCT
aiua-10305	4	48	3	3	NUM
aiua-10305	4	49	)	)	PUNCT
aiua-10305	4	50	.	.	PUNCT
aiua-10305	5	1	in	in	ADP
aiua-10305	5	2	the	the	DET
aiua-10305	5	3	literature	literature	NOUN
aiua-10305	5	4	,	,	PUNCT
aiua-10305	5	5	however	however	ADV
aiua-10305	5	6	,	,	PUNCT
aiua-10305	5	7	several	several	ADJ
aiua-10305	5	8	studies	study	NOUN
aiua-10305	5	9	have	have	AUX
aiua-10305	5	10	proved	prove	VERB
aiua-10305	5	11	that	that	SCONJ
aiua-10305	5	12	sr	sr	PROPN
aiua-10305	5	13	,	,	PUNCT
aiua-10305	5	14	besides	besides	SCONJ
aiua-10305	5	15	being	be	AUX
aiua-10305	5	16	very	very	ADV
aiua-10305	5	17	selective	selective	ADJ
aiua-10305	5	18	for	for	ADP
aiua-10305	5	19	the	the	DET
aiua-10305	5	20	prostate	prostate	NOUN
aiua-10305	5	21	gland	gland	NOUN
aiua-10305	5	22	,	,	PUNCT
aiua-10305	5	23	has	have	AUX
aiua-10305	5	24	,	,	PUNCT
aiua-10305	5	25	above	above	ADP
aiua-10305	5	26	all	all	PRON
aiua-10305	5	27	,	,	PUNCT
aiua-10305	5	28	pro	pro	ADJ
aiua-10305	5	29	-	-	ADJ
aiua-10305	5	30	apoptotic	apoptotic	ADJ
aiua-10305	5	31	,	,	PUNCT
aiua-10305	5	32	anti	anti	ADJ
aiua-10305	5	33	-	-	ADJ
aiua-10305	5	34	inflammatory	inflammatory	ADJ
aiua-10305	5	35	,	,	PUNCT
aiua-10305	5	36	and	and	CCONJ
aiua-10305	5	37	antioxidant	antioxidant	ADJ
aiua-10305	5	38	properties	property	NOUN
aiua-10305	5	39	(	(	PUNCT
aiua-10305	5	40	4	4	NUM
aiua-10305	5	41	-	-	SYM
aiua-10305	5	42	21	21	NUM
aiua-10305	5	43	)	)	PUNCT
aiua-10305	5	44	.	.	PUNCT
aiua-10305	6	1	normally	normally	ADV
aiua-10305	6	2	used	use	VERB
aiua-10305	6	3	sr	sr	PROPN
aiua-10305	6	4	doses	dose	NOUN
aiua-10305	6	5	vary	vary	VERB
aiua-10305	6	6	between	between	ADP
aiua-10305	6	7	320	320	NUM
aiua-10305	6	8	and	and	CCONJ
aiua-10305	6	9	450	450	NUM
aiua-10305	6	10	mg	mg	NUM
aiua-10305	6	11	/	/	SYM
aiua-10305	6	12	day	day	NOUN
aiua-10305	6	13	.	.	PUNCT
aiua-10305	7	1	the	the	DET
aiua-10305	7	2	aim	aim	NOUN
aiua-10305	7	3	of	of	ADP
aiua-10305	7	4	this	this	DET
aiua-10305	7	5	study	study	NOUN
aiua-10305	7	6	is	be	AUX
aiua-10305	7	7	to	to	PART
aiua-10305	7	8	clarify	clarify	VERB
aiua-10305	7	9	whether	whether	SCONJ
aiua-10305	7	10	sr	sr	PROPN
aiua-10305	7	11	is	be	AUX
aiua-10305	7	12	able	able	ADJ
aiua-10305	7	13	to	to	PART
aiua-10305	7	14	cause	cause	VERB
aiua-10305	7	15	negative	negative	ADJ
aiua-10305	7	16	effects	effect	NOUN
aiua-10305	7	17	on	on	ADP
aiua-10305	7	18	male	male	ADJ
aiua-10305	7	19	sexual	sexual	ADJ
aiua-10305	7	20	function	function	NOUN
aiua-10305	7	21	.	.	PUNCT
aiua-10305	8	1	such	such	ADJ
aiua-10305	8	2	belief	belief	NOUN
aiua-10305	8	3	is	be	AUX
aiua-10305	8	4	circulating	circulate	VERB
aiua-10305	8	5	in	in	ADP
aiua-10305	8	6	non	non	ADJ
aiua-10305	8	7	-	-	ADJ
aiua-10305	8	8	medical	medical	ADJ
aiua-10305	8	9	social	social	ADJ
aiua-10305	8	10	networks	network	NOUN
aiua-10305	8	11	and	and	CCONJ
aiua-10305	8	12	is	be	AUX
aiua-10305	8	13	maintained	maintain	VERB
aiua-10305	8	14	by	by	ADP
aiua-10305	8	15	patients	patient	NOUN
aiua-10305	8	16	as	as	ADP
aiua-10305	8	17	a	a	DET
aiua-10305	8	18	result	result	NOUN
aiua-10305	8	19	of	of	ADP
aiua-10305	8	20	web	web	NOUN
aiua-10305	8	21	surfing	surfing	NOUN
aiua-10305	8	22	.	.	PUNCT
aiua-10305	9	1	not	not	PART
aiua-10305	9	2	infrequently	infrequently	ADV
aiua-10305	9	3	,	,	PUNCT
aiua-10305	9	4	even	even	ADV
aiua-10305	9	5	in	in	ADP
aiua-10305	9	6	our	our	PRON
aiua-10305	9	7	clinics	clinic	NOUN
aiua-10305	9	8	,	,	PUNCT
aiua-10305	9	9	we	we	PRON
aiua-10305	9	10	encounter	encounter	VERB
aiua-10305	9	11	patients	patient	NOUN
aiua-10305	9	12	suffering	suffer	VERB
aiua-10305	9	13	from	from	ADP
aiua-10305	9	14	bph	bph	NOUN
aiua-10305	9	15	or	or	CCONJ
aiua-10305	9	16	prostatitis	prostatitis	NOUN
aiua-10305	9	17	who	who	PRON
aiua-10305	9	18	underwent	undergo	VERB
aiua-10305	9	19	treatment	treatment	NOUN
aiua-10305	9	20	of	of	ADP
aiua-10305	9	21	varying	vary	VERB
aiua-10305	9	22	length	length	NOUN
aiua-10305	9	23	with	with	ADP
aiua-10305	9	24	sr	sr	PROPN
aiua-10305	9	25	,	,	PUNCT
aiua-10305	9	26	who	who	PRON
aiua-10305	9	27	claim	claim	VERB
aiua-10305	9	28	to	to	PART
aiua-10305	9	29	have	have	AUX
aiua-10305	9	30	noticed	notice	VERB
aiua-10305	9	31	a	a	DET
aiua-10305	9	32	significant	significant	ADJ
aiua-10305	9	33	reduction	reduction	NOUN
aiua-10305	9	34	in	in	ADP
aiua-10305	9	35	their	their	PRON
aiua-10305	9	36	erectile	erectile	NOUN
aiua-10305	9	37	potency	potency	NOUN
aiua-10305	9	38	,	,	PUNCT
aiua-10305	9	39	and	and	CCONJ
aiua-10305	9	40	in	in	ADP
aiua-10305	9	41	some	some	DET
aiua-10305	9	42	cases	case	NOUN
aiua-10305	9	43	even	even	ADV
aiua-10305	9	44	in	in	ADP
aiua-10305	9	45	their	their	PRON
aiua-10305	9	46	libido	libido	NOUN
aiua-10305	9	47	.	.	PUNCT
aiua-10305	10	1	many	many	ADJ
aiua-10305	10	2	web	web	NOUN
aiua-10305	10	3	forums	forum	NOUN
aiua-10305	10	4	in	in	ADP
aiua-10305	10	5	the	the	DET
aiua-10305	10	6	world	world	NOUN
aiua-10305	10	7	discuss	discuss	VERB
aiua-10305	10	8	the	the	DET
aiua-10305	10	9	alleged	allege	VERB
aiua-10305	10	10	negative	negative	ADJ
aiua-10305	10	11	effects	effect	NOUN
aiua-10305	10	12	of	of	ADP
aiua-10305	10	13	sr	sr	PROPN
aiua-10305	10	14	,	,	PUNCT
aiua-10305	10	15	equating	equate	VERB
aiua-10305	10	16	them	they	PRON
aiua-10305	10	17	directly	directly	ADV
aiua-10305	10	18	to	to	ADP
aiua-10305	10	19	the	the	DET
aiua-10305	10	20	post	post	ADJ
aiua-10305	10	21	-	-	ADJ
aiua-10305	10	22	finasteride	finasteride	ADJ
aiua-10305	10	23	syndrome	syndrome	NOUN
aiua-10305	10	24	;	;	PUNCT
aiua-10305	10	25	unfortunately	unfortunately	ADV
aiua-10305	10	26	,	,	PUNCT
aiua-10305	10	27	once	once	ADV
aiua-10305	10	28	pseudo	pseudo	NOUN
aiua-10305	10	29	-	-	NOUN
aiua-10305	10	30	confirmation	confirmation	NOUN
aiua-10305	10	31	is	be	AUX
aiua-10305	10	32	found	find	VERB
aiua-10305	10	33	by	by	ADP
aiua-10305	10	34	surfing	surf	VERB
aiua-10305	10	35	the	the	DET
aiua-10305	10	36	net	net	NOUN
aiua-10305	10	37	,	,	PUNCT
aiua-10305	10	38	a	a	DET
aiua-10305	10	39	belief	belief	NOUN
aiua-10305	10	40	quickly	quickly	ADV
aiua-10305	10	41	and	and	CCONJ
aiua-10305	10	42	easily	easily	ADV
aiua-10305	10	43	goes	go	VERB
aiua-10305	10	44	viral	viral	ADJ
aiua-10305	10	45	.	.	PUNCT
aiua-10305	11	1	is	be	AUX
aiua-10305	11	2	it	it	PRON
aiua-10305	11	3	possible	possible	ADJ
aiua-10305	11	4	that	that	SCONJ
aiua-10305	11	5	sr	sr	PROPN
aiua-10305	11	6	may	may	AUX
aiua-10305	11	7	have	have	VERB
aiua-10305	11	8	a	a	DET
aiua-10305	11	9	nocebo	nocebo	NOUN
aiua-10305	11	10	effect	effect	NOUN
aiua-10305	11	11	and	and	CCONJ
aiua-10305	11	12	therefore	therefore	ADV
aiua-10305	11	13	negatively	negatively	ADV
aiua-10305	11	14	impact	impact	VERB
aiua-10305	11	15	the	the	DET
aiua-10305	11	16	health	health	NOUN
aiua-10305	11	17	of	of	ADP
aiua-10305	11	18	patients	patient	NOUN
aiua-10305	11	19	,	,	PUNCT
aiua-10305	11	20	regardless	regardless	ADV
aiua-10305	11	21	of	of	ADP
aiua-10305	11	22	any	any	DET
aiua-10305	11	23	real	real	ADJ
aiua-10305	11	24	pharmacological	pharmacological	ADJ
aiua-10305	11	25	adverse	adverse	ADJ
aiua-10305	11	26	effect	effect	NOUN
aiua-10305	11	27	(	(	PUNCT
aiua-10305	11	28	22	22	NUM
aiua-10305	11	29	)	)	PUNCT
aiua-10305	11	30	?	?	PUNCT
aiua-10305	12	1	the	the	DET
aiua-10305	12	2	aim	aim	NOUN
aiua-10305	12	3	of	of	ADP
aiua-10305	12	4	this	this	DET
aiua-10305	12	5	work	work	NOUN
aiua-10305	12	6	was	be	AUX
aiua-10305	12	7	to	to	PART
aiua-10305	12	8	assess	assess	VERB
aiua-10305	12	9	whether	whether	SCONJ
aiua-10305	12	10	sr	sr	PROPN
aiua-10305	12	11	can	can	AUX
aiua-10305	12	12	cause	cause	VERB
aiua-10305	12	13	negative	negative	ADJ
aiua-10305	12	14	effects	effect	NOUN
aiua-10305	12	15	on	on	ADP
aiua-10305	12	16	male	male	ADJ
aiua-10305	12	17	sexual	sexual	ADJ
aiua-10305	12	18	function	function	NOUN
aiua-10305	12	19	.	.	PUNCT
aiua-10305	13	1	we	we	PRON
aiua-10305	13	2	therefore	therefore	ADV
aiua-10305	13	3	carried	carry	VERB
aiua-10305	13	4	out	out	ADP
aiua-10305	13	5	an	an	DET
aiua-10305	13	6	in	in	ADP
aiua-10305	13	7	-	-	PUNCT
aiua-10305	13	8	depth	depth	NOUN
aiua-10305	13	9	systematic	systematic	ADJ
aiua-10305	13	10	review	review	NOUN
aiua-10305	13	11	and	and	CCONJ
aiua-10305	13	12	metaanalysis	metaanalysis	NOUN
aiua-10305	13	13	in	in	ADP
aiua-10305	13	14	accordance	accordance	NOUN
aiua-10305	13	15	with	with	ADP
aiua-10305	13	16	the	the	DET
aiua-10305	13	17	prisma	prisma	NOUN
aiua-10305	13	18	guidelines	guideline	NOUN
aiua-10305	13	19	(	(	PUNCT
aiua-10305	13	20	23	23	NUM
aiua-10305	13	21	)	)	PUNCT
aiua-10305	13	22	.	.	PUNCT
aiua-10305	14	1	materials	material	NOUN
aiua-10305	14	2	and	and	CCONJ
aiua-10305	14	3	methods	method	NOUN
aiua-10305	14	4	this	this	DET
aiua-10305	14	5	review	review	NOUN
aiua-10305	14	6	was	be	AUX
aiua-10305	14	7	conducted	conduct	VERB
aiua-10305	14	8	in	in	ADP
aiua-10305	14	9	accordance	accordance	NOUN
aiua-10305	14	10	with	with	ADP
aiua-10305	14	11	the	the	DET
aiua-10305	14	12	preferred	preferred	ADJ
aiua-10305	14	13	reporting	reporting	NOUN
aiua-10305	14	14	items	item	NOUN
aiua-10305	14	15	for	for	ADP
aiua-10305	14	16	systematic	systematic	ADJ
aiua-10305	14	17	reviews	review	NOUN
aiua-10305	14	18	and	and	CCONJ
aiua-10305	14	19	metaanalyses	metaanalyse	NOUN
aiua-10305	14	20	(	(	PUNCT
aiua-10305	14	21	prisma	prisma	NOUN
aiua-10305	14	22	)	)	PUNCT
aiua-10305	14	23	guidelines	guideline	NOUN
aiua-10305	14	24	(	(	PUNCT
aiua-10305	14	25	23	23	NUM
aiua-10305	14	26	)	)	PUNCT
aiua-10305	14	27	.	.	PUNCT
aiua-10305	15	1	the	the	DET
aiua-10305	15	2	review	review	NOUN
aiua-10305	15	3	protocol	protocol	NOUN
aiua-10305	15	4	was	be	AUX
aiua-10305	15	5	submitted	submit	VERB
aiua-10305	15	6	for	for	ADP
aiua-10305	15	7	registration	registration	NOUN
aiua-10305	15	8	on	on	ADP
aiua-10305	15	9	the	the	DET
aiua-10305	15	10	prospero	prospero	NOUN
aiua-10305	15	11	platform	platform	NOUN
aiua-10305	15	12	(	(	PUNCT
aiua-10305	15	13	i	i	NOUN
aiua-10305	15	14	d	d	PROPN
aiua-10305	15	15	287140	287140	NUM
aiua-10305	15	16	)	)	PUNCT
aiua-10305	15	17	.	.	PUNCT
aiua-10305	16	1	two	two	NUM
aiua-10305	16	2	electronic	electronic	ADJ
aiua-10305	16	3	databases	database	NOUN
aiua-10305	16	4	(	(	PUNCT
aiua-10305	16	5	pubmed	pubmed	NOUN
aiua-10305	16	6	and	and	CCONJ
aiua-10305	16	7	embase	embase	NOUN
aiua-10305	16	8	)	)	PUNCT
aiua-10305	16	9	were	be	AUX
aiua-10305	16	10	searched	search	VERB
aiua-10305	16	11	for	for	ADP
aiua-10305	16	12	articles	article	NOUN
aiua-10305	16	13	published	publish	VERB
aiua-10305	16	14	up	up	ADP
aiua-10305	16	15	to	to	PART
aiua-10305	16	16	30	30	NUM
aiua-10305	16	17	september	september	PROPN
aiua-10305	16	18	2021	2021	NUM
aiua-10305	16	19	.	.	PUNCT
aiua-10305	17	1	the	the	DET
aiua-10305	17	2	search	search	NOUN
aiua-10305	17	3	was	be	AUX
aiua-10305	17	4	performed	perform	VERB
aiua-10305	17	5	using	use	VERB
aiua-10305	17	6	the	the	DET
aiua-10305	17	7	following	following	ADJ
aiua-10305	17	8	terms	term	NOUN
aiua-10305	17	9	:	:	PUNCT
aiua-10305	17	10	(	(	PUNCT
aiua-10305	17	11	serenoa	serenoa	ADJ
aiua-10305	17	12	repens	repen	NOUN
aiua-10305	17	13	or	or	CCONJ
aiua-10305	17	14	saw	see	VERB
aiua-10305	17	15	palmetto	palmetto	NOUN
aiua-10305	17	16	or	or	CCONJ
aiua-10305	17	17	sabal	sabal	ADJ
aiua-10305	17	18	background	background	NOUN
aiua-10305	17	19	:	:	PUNCT
aiua-10305	17	20	serenoa	serenoa	ADJ
aiua-10305	17	21	repens	repen	NOUN
aiua-10305	17	22	(	(	PUNCT
aiua-10305	17	23	sr	sr	PROPN
aiua-10305	17	24	)	)	PUNCT
aiua-10305	17	25	is	be	AUX
aiua-10305	17	26	a	a	DET
aiua-10305	17	27	plant	plant	NOUN
aiua-10305	17	28	used	use	VERB
aiua-10305	17	29	to	to	PART
aiua-10305	17	30	treat	treat	VERB
aiua-10305	17	31	benign	benign	ADJ
aiua-10305	17	32	prostatic	prostatic	ADJ
aiua-10305	17	33	hyperplasia	hyperplasia	NOUN
aiua-10305	17	34	and	and	CCONJ
aiua-10305	17	35	prostatitis	prostatitis	NOUN
aiua-10305	17	36	.	.	PUNCT
aiua-10305	18	1	we	we	PRON
aiua-10305	18	2	know	know	VERB
aiua-10305	18	3	that	that	SCONJ
aiua-10305	18	4	sr	sr	PROPN
aiua-10305	18	5	act	act	VERB
aiua-10305	18	6	as	as	ADP
aiua-10305	18	7	a	a	DET
aiua-10305	18	8	5α	5α	ADJ
aiua-10305	18	9	-	-	PUNCT
aiua-10305	18	10	reductase	reductase	NOUN
aiua-10305	18	11	inhibitor	inhibitor	NOUN
aiua-10305	18	12	,	,	PUNCT
aiua-10305	18	13	moreover	moreover	ADV
aiua-10305	18	14	,	,	PUNCT
aiua-10305	18	15	several	several	ADJ
aiua-10305	18	16	studies	study	NOUN
aiua-10305	18	17	have	have	AUX
aiua-10305	18	18	proved	prove	VERB
aiua-10305	18	19	that	that	SCONJ
aiua-10305	18	20	sr	sr	PROPN
aiua-10305	18	21	has	have	VERB
aiua-10305	18	22	anti	anti	ADJ
aiua-10305	18	23	-	-	ADJ
aiua-10305	18	24	inflammatory	inflammatory	ADJ
aiua-10305	18	25	and	and	CCONJ
aiua-10305	18	26	antioxidant	antioxidant	ADJ
aiua-10305	18	27	properties	property	NOUN
aiua-10305	18	28	.	.	PUNCT
aiua-10305	19	1	there	there	PRON
aiua-10305	19	2	is	be	VERB
aiua-10305	19	3	some	some	DET
aiua-10305	19	4	belief	belief	NOUN
aiua-10305	19	5	among	among	ADP
aiua-10305	19	6	patients	patient	NOUN
aiua-10305	19	7	that	that	PRON
aiua-10305	19	8	sr	sr	PROPN
aiua-10305	19	9	may	may	AUX
aiua-10305	19	10	negatively	negatively	ADV
aiua-10305	19	11	impact	impact	VERB
aiua-10305	19	12	male	male	ADJ
aiua-10305	19	13	sexual	sexual	ADJ
aiua-10305	19	14	function	function	NOUN
aiua-10305	19	15	.	.	PUNCT
aiua-10305	20	1	such	such	ADJ
aiua-10305	20	2	belief	belief	NOUN
aiua-10305	20	3	is	be	AUX
aiua-10305	20	4	circulating	circulate	VERB
aiua-10305	20	5	in	in	ADP
aiua-10305	20	6	non	non	ADJ
aiua-10305	20	7	-	-	ADJ
aiua-10305	20	8	medical	medical	ADJ
aiua-10305	20	9	social	social	ADJ
aiua-10305	20	10	networks	network	NOUN
aiua-10305	20	11	and	and	CCONJ
aiua-10305	20	12	is	be	AUX
aiua-10305	20	13	perhaps	perhaps	ADV
aiua-10305	20	14	maintained	maintain	VERB
aiua-10305	20	15	by	by	ADP
aiua-10305	20	16	patients	patient	NOUN
aiua-10305	20	17	as	as	ADP
aiua-10305	20	18	a	a	DET
aiua-10305	20	19	result	result	NOUN
aiua-10305	20	20	of	of	ADP
aiua-10305	20	21	incorrect	incorrect	ADJ
aiua-10305	20	22	web	web	NOUN
aiua-10305	20	23	surfing	surfing	NOUN
aiua-10305	20	24	.	.	PUNCT
aiua-10305	21	1	however	however	ADV
aiua-10305	21	2	,	,	PUNCT
aiua-10305	21	3	it	it	PRON
aiua-10305	21	4	is	be	AUX
aiua-10305	21	5	also	also	ADV
aiua-10305	21	6	possible	possible	ADJ
aiua-10305	21	7	that	that	SCONJ
aiua-10305	21	8	sr	sr	PROPN
aiua-10305	21	9	may	may	AUX
aiua-10305	21	10	exert	exert	VERB
aiua-10305	21	11	a	a	DET
aiua-10305	21	12	“	"	PUNCT
aiua-10305	21	13	nocebo	nocebo	NOUN
aiua-10305	21	14	”	"	PUNCT
aiua-10305	21	15	effect	effect	NOUN
aiua-10305	21	16	thus	thus	ADV
aiua-10305	21	17	negatively	negatively	ADV
aiua-10305	21	18	impacting	impact	VERB
aiua-10305	21	19	on	on	ADP
aiua-10305	21	20	the	the	DET
aiua-10305	21	21	general	general	ADJ
aiua-10305	21	22	well	well	NOUN
aiua-10305	21	23	-	-	PUNCT
aiua-10305	21	24	being	being	NOUN
aiua-10305	21	25	of	of	ADP
aiua-10305	21	26	patients	patient	NOUN
aiua-10305	21	27	.	.	PUNCT
aiua-10305	22	1	objective	objective	NOUN
aiua-10305	22	2	:	:	PUNCT
aiua-10305	22	3	the	the	DET
aiua-10305	22	4	aim	aim	NOUN
aiua-10305	22	5	of	of	ADP
aiua-10305	22	6	this	this	DET
aiua-10305	22	7	study	study	NOUN
aiua-10305	22	8	is	be	AUX
aiua-10305	22	9	to	to	PART
aiua-10305	22	10	investigate	investigate	VERB
aiua-10305	22	11	whether	whether	SCONJ
aiua-10305	22	12	sr	sr	PROPN
aiua-10305	22	13	is	be	AUX
aiua-10305	22	14	causing	cause	VERB
aiua-10305	22	15	negative	negative	ADJ
aiua-10305	22	16	effects	effect	NOUN
aiua-10305	22	17	on	on	ADP
aiua-10305	22	18	male	male	ADJ
aiua-10305	22	19	sexual	sexual	ADJ
aiua-10305	22	20	function	function	NOUN
aiua-10305	22	21	.	.	PUNCT
aiua-10305	23	1	methods	method	NOUN
aiua-10305	23	2	:	:	PUNCT
aiua-10305	23	3	to	to	PART
aiua-10305	23	4	ascertain	ascertain	VERB
aiua-10305	23	5	the	the	DET
aiua-10305	23	6	effect	effect	NOUN
aiua-10305	23	7	of	of	ADP
aiua-10305	23	8	sr	sr	PROPN
aiua-10305	23	9	on	on	ADP
aiua-10305	23	10	male	male	ADJ
aiua-10305	23	11	sexual	sexual	ADJ
aiua-10305	23	12	function	function	NOUN
aiua-10305	23	13	,	,	PUNCT
aiua-10305	23	14	we	we	PRON
aiua-10305	23	15	conducted	conduct	VERB
aiua-10305	23	16	a	a	DET
aiua-10305	23	17	systematic	systematic	ADJ
aiua-10305	23	18	review	review	NOUN
aiua-10305	23	19	and	and	CCONJ
aiua-10305	23	20	meta	meta	ADJ
aiua-10305	23	21	-	-	PUNCT
aiua-10305	23	22	analysis	analysis	NOUN
aiua-10305	23	23	,	,	PUNCT
aiua-10305	23	24	by	by	ADP
aiua-10305	23	25	performing	perform	VERB
aiua-10305	23	26	an	an	DET
aiua-10305	23	27	electronic	electronic	ADJ
aiua-10305	23	28	database	database	NOUN
aiua-10305	23	29	search	search	NOUN
aiua-10305	23	30	in	in	ADP
aiua-10305	23	31	accordance	accordance	NOUN
aiua-10305	23	32	with	with	ADP
aiua-10305	23	33	the	the	DET
aiua-10305	23	34	prisma	prisma	PROPN
aiua-10305	23	35	guidelines	guideline	NOUN
aiua-10305	23	36	.	.	PUNCT
aiua-10305	24	1	results	result	NOUN
aiua-10305	24	2	:	:	PUNCT
aiua-10305	24	3	out	out	ADP
aiua-10305	24	4	of	of	ADP
aiua-10305	24	5	20	20	NUM
aiua-10305	24	6	included	include	VERB
aiua-10305	24	7	papers	paper	NOUN
aiua-10305	24	8	,	,	PUNCT
aiua-10305	24	9	8	8	NUM
aiua-10305	24	10	papers	paper	NOUN
aiua-10305	24	11	reported	report	VERB
aiua-10305	24	12	comparisons	comparison	NOUN
aiua-10305	24	13	of	of	ADP
aiua-10305	24	14	sr	sr	PROPN
aiua-10305	24	15	with	with	ADP
aiua-10305	24	16	placebo	placebo	NOUN
aiua-10305	24	17	,	,	PUNCT
aiua-10305	24	18	and	and	CCONJ
aiua-10305	24	19	7	7	NUM
aiua-10305	24	20	studies	study	NOUN
aiua-10305	24	21	reported	report	VERB
aiua-10305	24	22	comparisons	comparison	NOUN
aiua-10305	24	23	of	of	ADP
aiua-10305	24	24	sr	sr	PROPN
aiua-10305	24	25	with	with	ADP
aiua-10305	24	26	tamsulosin	tamsulosin	NOUN
aiua-10305	24	27	.	.	PUNCT
aiua-10305	25	1	the	the	DET
aiua-10305	25	2	standardized	standardized	ADJ
aiua-10305	25	3	mean	mean	ADJ
aiua-10305	25	4	difference	difference	NOUN
aiua-10305	25	5	of	of	ADP
aiua-10305	25	6	changes	change	NOUN
aiua-10305	25	7	from	from	ADP
aiua-10305	25	8	baseline	baseline	ADJ
aiua-10305	25	9	scores	score	NOUN
aiua-10305	25	10	of	of	ADP
aiua-10305	25	11	sexual	sexual	ADJ
aiua-10305	25	12	function	function	NOUN
aiua-10305	25	13	was	be	AUX
aiua-10305	25	14	not	not	PART
aiua-10305	25	15	significantly	significantly	ADV
aiua-10305	25	16	different	different	ADJ
aiua-10305	25	17	between	between	ADP
aiua-10305	25	18	sr	sr	PROPN
aiua-10305	25	19	and	and	CCONJ
aiua-10305	25	20	placebo	placebo	NOUN
aiua-10305	25	21	(	(	PUNCT
aiua-10305	25	22	smd	smd	NOUN
aiua-10305	25	23	:	:	PUNCT
aiua-10305	25	24	0.43	0.43	NUM
aiua-10305	25	25	,	,	PUNCT
aiua-10305	25	26	95	95	NUM
aiua-10305	25	27	%	%	NOUN
aiua-10305	25	28	ci	ci	NOUN
aiua-10305	25	29	:	:	PUNCT
aiua-10305	25	30	0.18	0.18	NUM
aiua-10305	25	31	to	to	ADP
aiua-10305	25	32	1.05	1.05	NUM
aiua-10305	25	33	;	;	PUNCT
aiua-10305	25	34	i^2	i^2	X
aiua-10305	25	35	=	=	SYM
aiua-10305	25	36	95	95	NUM
aiua-10305	25	37	%	%	NOUN
aiua-10305	25	38	)	)	PUNCT
aiua-10305	25	39	.	.	PUNCT
aiua-10305	26	1	similarly	similarly	ADV
aiua-10305	26	2	,	,	PUNCT
aiua-10305	26	3	no	no	DET
aiua-10305	26	4	significant	significant	ADJ
aiua-10305	26	5	mean	mean	ADJ
aiua-10305	26	6	differences	difference	NOUN
aiua-10305	26	7	in	in	ADP
aiua-10305	26	8	the	the	DET
aiua-10305	26	9	male	male	ADJ
aiua-10305	26	10	sexual	sexual	ADJ
aiua-10305	26	11	function-4	function-4	PROPN
aiua-10305	26	12	(	(	PUNCT
aiua-10305	26	13	msf-4	msf-4	NOUN
aiua-10305	26	14	)	)	PUNCT
aiua-10305	26	15	test	test	NOUN
aiua-10305	26	16	scores	score	NOUN
aiua-10305	26	17	were	be	AUX
aiua-10305	26	18	found	find	VERB
aiua-10305	26	19	between	between	ADP
aiua-10305	26	20	sr	sr	PROPN
aiua-10305	26	21	and	and	CCONJ
aiua-10305	26	22	tamsulosin	tamsulosin	PROPN
aiua-10305	26	23	(	(	PUNCT
aiua-10305	26	24	smd	smd	NOUN
aiua-10305	26	25	:	:	PUNCT
aiua-10305	26	26	-0.31	-0.31	NUM
aiua-10305	26	27	,	,	PUNCT
aiua-10305	26	28	95	95	NUM
aiua-10305	26	29	%	%	NOUN
aiua-10305	26	30	ci	ci	NOUN
aiua-10305	26	31	:	:	PUNCT
aiua-10305	26	32	-0.82	-0.82	PUNCT
aiua-10305	26	33	to	to	ADP
aiua-10305	26	34	0.19	0.19	NUM
aiua-10305	26	35	;	;	PUNCT
aiua-10305	26	36	i^2	i^2	X
aiua-10305	26	37	=	=	NUM
aiua-10305	26	38	90	90	NUM
aiua-10305	26	39	%	%	NOUN
aiua-10305	26	40	)	)	PUNCT
aiua-10305	26	41	.	.	PUNCT
aiua-10305	27	1	conclusions	conclusion	NOUN
aiua-10305	27	2	:	:	PUNCT
aiua-10305	27	3	we	we	PRON
aiua-10305	27	4	found	find	VERB
aiua-10305	27	5	no	no	DET
aiua-10305	27	6	statistically	statistically	ADV
aiua-10305	27	7	significant	significant	ADJ
aiua-10305	27	8	differences	difference	NOUN
aiua-10305	27	9	between	between	ADP
aiua-10305	27	10	negative	negative	ADJ
aiua-10305	27	11	effects	effect	NOUN
aiua-10305	27	12	on	on	ADP
aiua-10305	27	13	sexual	sexual	ADJ
aiua-10305	27	14	function	function	NOUN
aiua-10305	27	15	in	in	ADP
aiua-10305	27	16	patients	patient	NOUN
aiua-10305	27	17	treated	treat	VERB
aiua-10305	27	18	with	with	ADP
aiua-10305	27	19	sr	sr	PROPN
aiua-10305	27	20	compared	compare	VERB
aiua-10305	27	21	to	to	ADP
aiua-10305	27	22	patients	patient	NOUN
aiua-10305	27	23	who	who	PRON
aiua-10305	27	24	received	receive	VERB
aiua-10305	27	25	placebo	placebo	NOUN
aiua-10305	27	26	.	.	PUNCT
aiua-10305	28	1	the	the	DET
aiua-10305	28	2	results	result	NOUN
aiua-10305	28	3	of	of	ADP
aiua-10305	28	4	our	our	PRON
aiua-10305	28	5	meta	meta	ADJ
aiua-10305	28	6	-	-	PUNCT
aiua-10305	28	7	analysis	analysis	NOUN
aiua-10305	28	8	are	be	AUX
aiua-10305	28	9	similar	similar	ADJ
aiua-10305	28	10	to	to	ADP
aiua-10305	28	11	those	those	PRON
aiua-10305	28	12	of	of	ADP
aiua-10305	28	13	other	other	ADJ
aiua-10305	28	14	systematic	systematic	ADJ
aiua-10305	28	15	reviews	review	NOUN
aiua-10305	28	16	.	.	PUNCT
aiua-10305	29	1	studies	study	NOUN
aiua-10305	29	2	are	be	AUX
aiua-10305	29	3	warranted	warrant	VERB
aiua-10305	29	4	to	to	PART
aiua-10305	29	5	ascertain	ascertain	VERB
aiua-10305	29	6	whether	whether	SCONJ
aiua-10305	29	7	any	any	DET
aiua-10305	29	8	such	such	ADJ
aiua-10305	29	9	effects	effect	NOUN
aiua-10305	29	10	might	might	AUX
aiua-10305	29	11	occur	occur	VERB
aiua-10305	29	12	as	as	ADP
aiua-10305	29	13	a	a	DET
aiua-10305	29	14	result	result	NOUN
aiua-10305	29	15	of	of	ADP
aiua-10305	29	16	a	a	DET
aiua-10305	29	17	nocebo	nocebo	NOUN
aiua-10305	29	18	effect	effect	NOUN
aiua-10305	29	19	.	.	PUNCT
aiua-10305	30	1	key	key	ADJ
aiua-10305	30	2	words	word	NOUN
aiua-10305	30	3	:	:	PUNCT
aiua-10305	30	4	serenoa	serenoa	ADJ
aiua-10305	30	5	repens	repen	NOUN
aiua-10305	30	6	;	;	PUNCT
aiua-10305	30	7	adverse	adverse	ADJ
aiua-10305	30	8	effects	effect	NOUN
aiua-10305	30	9	;	;	PUNCT
aiua-10305	30	10	nocebo	nocebo	NOUN
aiua-10305	30	11	effect	effect	NOUN
aiua-10305	30	12	;	;	PUNCT
aiua-10305	30	13	male	male	ADJ
aiua-10305	30	14	sexual	sexual	ADJ
aiua-10305	30	15	health	health	NOUN
aiua-10305	30	16	.	.	PUNCT
aiua-10305	30	17	submitted	submit	VERB
aiua-10305	30	18	30	30	NUM
aiua-10305	30	19	november	november	NOUN
aiua-10305	30	20	2021	2021	NUM
aiua-10305	30	21	;	;	PUNCT
aiua-10305	30	22	accepted	accept	VERB
aiua-10305	30	23	3	3	NUM
aiua-10305	30	24	december	december	PROPN
aiua-10305	30	25	2021	2021	NUM
aiua-10305	30	26	introduction	introduction	NOUN
aiua-10305	30	27	serenoa	serenoa	ADJ
aiua-10305	30	28	repens	repen	NOUN
aiua-10305	30	29	(	(	PUNCT
aiua-10305	30	30	sr	sr	PROPN
aiua-10305	30	31	)	)	PUNCT
aiua-10305	30	32	,	,	PUNCT
aiua-10305	30	33	also	also	ADV
aiua-10305	30	34	known	know	VERB
aiua-10305	30	35	as	as	ADP
aiua-10305	30	36	saw	see	VERB
aiua-10305	30	37	palmetto	palmetto	NOUN
aiua-10305	30	38	,	,	PUNCT
aiua-10305	30	39	sabal	sabal	ADJ
aiua-10305	30	40	serrulata	serrulata	NOUN
aiua-10305	30	41	,	,	PUNCT
aiua-10305	30	42	and	and	CCONJ
aiua-10305	30	43	american	american	ADJ
aiua-10305	30	44	dwarf	dwarf	PROPN
aiua-10305	30	45	palm	palm	NOUN
aiua-10305	30	46	tree	tree	NOUN
aiua-10305	30	47	,	,	PUNCT
aiua-10305	30	48	is	be	AUX
aiua-10305	30	49	a	a	DET
aiua-10305	30	50	plant	plant	NOUN
aiua-10305	30	51	originally	originally	ADV
aiua-10305	30	52	used	use	VERB
aiua-10305	30	53	by	by	ADP
aiua-10305	30	54	native	native	ADJ
aiua-10305	30	55	americans	americans	PROPN
aiua-10305	30	56	(	(	PUNCT
aiua-10305	30	57	seminole	seminole	NOUN
aiua-10305	30	58	and	and	CCONJ
aiua-10305	30	59	miccosukee	miccosukee	PROPN
aiua-10305	30	60	tribes	tribe	NOUN
aiua-10305	30	61	)	)	PUNCT
aiua-10305	30	62	both	both	CCONJ
aiua-10305	30	63	as	as	ADP
aiua-10305	30	64	food	food	NOUN
aiua-10305	30	65	and	and	CCONJ
aiua-10305	30	66	to	to	PART
aiua-10305	30	67	cure	cure	VERB
aiua-10305	30	68	urogenital	urogenital	ADJ
aiua-10305	30	69	ailments	ailment	NOUN
aiua-10305	30	70	(	(	PUNCT
aiua-10305	30	71	1	1	NUM
aiua-10305	30	72	)	)	PUNCT
aiua-10305	30	73	.	.	PUNCT
aiua-10305	31	1	the	the	DET
aiua-10305	31	2	plant	plant	NOUN
aiua-10305	31	3	belongs	belong	VERB
aiua-10305	31	4	to	to	ADP
aiua-10305	31	5	the	the	DET
aiua-10305	31	6	arecaceae	arecaceae	PROPN
aiua-10305	31	7	family	family	NOUN
aiua-10305	31	8	and	and	CCONJ
aiua-10305	31	9	mainly	mainly	ADV
aiua-10305	31	10	serenoa	serenoa	ADJ
aiua-10305	31	11	repens	repen	NOUN
aiua-10305	31	12	and	and	CCONJ
aiua-10305	31	13	its	its	PRON
aiua-10305	31	14	effects	effect	NOUN
aiua-10305	31	15	on	on	ADP
aiua-10305	31	16	male	male	ADJ
aiua-10305	31	17	sexual	sexual	ADJ
aiua-10305	31	18	function	function	NOUN
aiua-10305	31	19	.	.	PUNCT
aiua-10305	32	1	a	a	DET
aiua-10305	32	2	systematic	systematic	ADJ
aiua-10305	32	3	review	review	NOUN
aiua-10305	32	4	and	and	CCONJ
aiua-10305	32	5	meta	meta	NOUN
aiua-10305	32	6	-	-	PUNCT
aiua-10305	32	7	analysis	analysis	NOUN
aiua-10305	32	8	of	of	ADP
aiua-10305	32	9	clinical	clinical	ADJ
aiua-10305	32	10	trials	trial	NOUN
aiua-10305	32	11	gianni	gianni	PROPN
aiua-10305	32	12	paulis	paulis	PROPN
aiua-10305	32	13	1	1	NUM
aiua-10305	32	14	,	,	PUNCT
aiua-10305	32	15	andrea	andrea	PROPN
aiua-10305	32	16	paulis	paulis	PROPN
aiua-10305	32	17	2	2	NUM
aiua-10305	32	18	,	,	PUNCT
aiua-10305	32	19	gianpaolo	gianpaolo	NOUN
aiua-10305	32	20	perletti	perletti	NOUN
aiua-10305	32	21	3	3	NUM
aiua-10305	32	22	,	,	PUNCT
aiua-10305	32	23	4	4	NUM
aiua-10305	32	24	1	1	NUM
aiua-10305	32	25	department	department	NOUN
aiua-10305	32	26	of	of	ADP
aiua-10305	32	27	uro	uro	PROPN
aiua-10305	32	28	-	-	PUNCT
aiua-10305	32	29	andrology	andrology	PROPN
aiua-10305	32	30	,	,	PUNCT
aiua-10305	32	31	castelfidardo	castelfidardo	PROPN
aiua-10305	32	32	medical	medical	ADJ
aiua-10305	32	33	team	team	PROPN
aiua-10305	32	34	,	,	PUNCT
aiua-10305	32	35	rome	rome	PROPN
aiua-10305	32	36	,	,	PUNCT
aiua-10305	32	37	italy	italy	PROPN
aiua-10305	32	38	;	;	PUNCT
aiua-10305	32	39	2	2	NUM
aiua-10305	32	40	neurosystem	neurosystem	NOUN
aiua-10305	32	41	center	center	NOUN
aiua-10305	32	42	for	for	ADP
aiua-10305	32	43	applied	applied	ADJ
aiua-10305	32	44	psychology	psychology	NOUN
aiua-10305	32	45	and	and	CCONJ
aiua-10305	32	46	neuroscience	neuroscience	NOUN
aiua-10305	32	47	,	,	PUNCT
aiua-10305	32	48	janet	janet	PROPN
aiua-10305	32	49	clinical	clinical	ADJ
aiua-10305	32	50	centre	centre	PROPN
aiua-10305	32	51	,	,	PUNCT
aiua-10305	32	52	rome	rome	PROPN
aiua-10305	32	53	,	,	PUNCT
aiua-10305	32	54	italy	italy	PROPN
aiua-10305	32	55	;	;	PUNCT
aiua-10305	32	56	3	3	NUM
aiua-10305	32	57	department	department	NOUN
aiua-10305	32	58	of	of	ADP
aiua-10305	32	59	biotechnology	biotechnology	NOUN
aiua-10305	32	60	and	and	CCONJ
aiua-10305	32	61	life	life	NOUN
aiua-10305	32	62	sciences	science	NOUN
aiua-10305	32	63	,	,	PUNCT
aiua-10305	32	64	section	section	NOUN
aiua-10305	32	65	of	of	ADP
aiua-10305	32	66	medical	medical	ADJ
aiua-10305	32	67	and	and	CCONJ
aiua-10305	32	68	surgical	surgical	ADJ
aiua-10305	32	69	sciences	science	NOUN
aiua-10305	32	70	,	,	PUNCT
aiua-10305	32	71	university	university	NOUN
aiua-10305	32	72	of	of	ADP
aiua-10305	32	73	insubria	insubria	PROPN
aiua-10305	32	74	,	,	PUNCT
aiua-10305	32	75	varese	varese	PROPN
aiua-10305	32	76	,	,	PUNCT
aiua-10305	32	77	italy	italy	PROPN
aiua-10305	32	78	;	;	PUNCT
aiua-10305	32	79	4	4	NUM
aiua-10305	32	80	faculty	faculty	NOUN
aiua-10305	32	81	of	of	ADP
aiua-10305	32	82	medicine	medicine	NOUN
aiua-10305	32	83	and	and	CCONJ
aiua-10305	32	84	medical	medical	ADJ
aiua-10305	32	85	sciences	sciences	PROPN
aiua-10305	32	86	,	,	PUNCT
aiua-10305	32	87	ghent	ghent	PROPN
aiua-10305	32	88	university	university	PROPN
aiua-10305	32	89	,	,	PUNCT
aiua-10305	32	90	belgium	belgium	PROPN
aiua-10305	32	91	.	.	PUNCT
aiua-10305	33	1	doi	doi	PROPN
aiua-10305	33	2	:	:	PUNCT
aiua-10305	33	3	10.4081	10.4081	NUM
aiua-10305	33	4	/	/	SYM
aiua-10305	33	5	aiua.2021.4.475	aiua.2021.4.475	NOUN
aiua-10305	33	6	summary	summary	VERB
aiua-10305	33	7	archivio	archivio	NOUN
aiua-10305	33	8	italiano	italiano	X
aiua-10305	33	9	di	di	X
aiua-10305	33	10	urologia	urologia	PROPN
aiua-10305	33	11	e	e	PROPN
aiua-10305	33	12	andrologia	andrologia	NOUN
aiua-10305	33	13	2021	2021	NUM
aiua-10305	33	14	;	;	PUNCT
aiua-10305	33	15	93	93	NUM
aiua-10305	33	16	,	,	PUNCT
aiua-10305	33	17	4	4	NUM
aiua-10305	33	18	g.	g.	NOUN
aiua-10305	33	19	paulis	paulis	PROPN
aiua-10305	33	20	,	,	PUNCT
aiua-10305	33	21	a.	a.	NOUN
aiua-10305	33	22	paulis	paulis	PROPN
aiua-10305	33	23	,	,	PUNCT
aiua-10305	33	24	g.	g.	PROPN
aiua-10305	33	25	perletti	perletti	VERB
aiua-10305	33	26	476	476	NUM
aiua-10305	33	27	serrulata	serrulata	NOUN
aiua-10305	33	28	)	)	PUNCT
aiua-10305	33	29	and	and	CCONJ
aiua-10305	33	30	(	(	PUNCT
aiua-10305	33	31	orgasm	orgasm	NOUN
aiua-10305	33	32	or	or	CCONJ
aiua-10305	33	33	ejaculation	ejaculation	NOUN
aiua-10305	33	34	or	or	CCONJ
aiua-10305	33	35	erectile	erectile	ADJ
aiua-10305	33	36	dysfunction	dysfunction	NOUN
aiua-10305	33	37	or	or	CCONJ
aiua-10305	33	38	sexual	sexual	ADJ
aiua-10305	33	39	dysfunction	dysfunction	NOUN
aiua-10305	33	40	,	,	PUNCT
aiua-10305	33	41	physiological	physiological	ADJ
aiua-10305	33	42	)	)	PUNCT
aiua-10305	33	43	.	.	PUNCT
aiua-10305	34	1	relevant	relevant	ADJ
aiua-10305	34	2	data	datum	NOUN
aiua-10305	34	3	were	be	AUX
aiua-10305	34	4	also	also	ADV
aiua-10305	34	5	hand	hand	NOUN
aiua-10305	34	6	-	-	PUNCT
aiua-10305	34	7	searched	search	VERB
aiua-10305	34	8	through	through	ADP
aiua-10305	34	9	other	other	ADJ
aiua-10305	34	10	sources	source	NOUN
aiua-10305	34	11	.	.	PUNCT
aiua-10305	35	1	we	we	PRON
aiua-10305	35	2	considered	consider	VERB
aiua-10305	35	3	randomized	randomized	ADJ
aiua-10305	35	4	controlled	control	VERB
aiua-10305	35	5	trials	trial	NOUN
aiua-10305	35	6	(	(	PUNCT
aiua-10305	35	7	rcts	rct	NOUN
aiua-10305	35	8	)	)	PUNCT
aiua-10305	35	9	with	with	ADP
aiua-10305	35	10	an	an	DET
aiua-10305	35	11	open	open	ADJ
aiua-10305	35	12	-	-	PUNCT
aiua-10305	35	13	label	label	NOUN
aiua-10305	35	14	or	or	CCONJ
aiua-10305	35	15	single	single	ADJ
aiua-10305	35	16	/	/	SYM
aiua-10305	35	17	double	double	ADJ
aiua-10305	35	18	blinded	blind	VERB
aiua-10305	35	19	design	design	NOUN
aiua-10305	35	20	published	publish	VERB
aiua-10305	35	21	in	in	ADP
aiua-10305	35	22	english	english	PROPN
aiua-10305	35	23	without	without	ADP
aiua-10305	35	24	time	time	NOUN
aiua-10305	35	25	constraints	constraint	NOUN
aiua-10305	35	26	.	.	PUNCT
aiua-10305	36	1	we	we	PRON
aiua-10305	36	2	included	include	VERB
aiua-10305	36	3	studies	study	NOUN
aiua-10305	36	4	involving	involve	VERB
aiua-10305	36	5	male	male	ADJ
aiua-10305	36	6	subjects	subject	NOUN
aiua-10305	36	7	taking	take	VERB
aiua-10305	36	8	serenoa	serenoa	ADJ
aiua-10305	36	9	repens	repen	NOUN
aiua-10305	36	10	extracts	extract	NOUN
aiua-10305	36	11	to	to	PART
aiua-10305	36	12	treat	treat	VERB
aiua-10305	36	13	a	a	DET
aiua-10305	36	14	prostatic	prostatic	ADJ
aiua-10305	36	15	condition	condition	NOUN
aiua-10305	36	16	,	,	PUNCT
aiua-10305	36	17	compared	compare	VERB
aiua-10305	36	18	with	with	ADP
aiua-10305	36	19	placebo	placebo	NOUN
aiua-10305	36	20	,	,	PUNCT
aiua-10305	36	21	or	or	CCONJ
aiua-10305	36	22	with	with	ADP
aiua-10305	36	23	various	various	ADJ
aiua-10305	36	24	drugs	drug	NOUN
aiua-10305	36	25	prescribed	prescribe	VERB
aiua-10305	36	26	for	for	ADP
aiua-10305	36	27	benign	benign	ADJ
aiua-10305	36	28	prostatic	prostatic	ADJ
aiua-10305	36	29	hyperplasia	hyperplasia	NOUN
aiua-10305	36	30	(	(	PUNCT
aiua-10305	36	31	bph	bph	NOUN
aiua-10305	36	32	)	)	PUNCT
aiua-10305	36	33	(	(	PUNCT
aiua-10305	36	34	e.g.	e.g.	ADV
aiua-10305	36	35	,	,	PUNCT
aiua-10305	36	36	alpha	alpha	NOUN
aiua-10305	36	37	adrenoceptor	adrenoceptor	NOUN
aiua-10305	36	38	blockers	blocker	NOUN
aiua-10305	36	39	,	,	PUNCT
aiua-10305	36	40	alpha	alpha	NOUN
aiua-10305	36	41	-	-	PUNCT
aiua-10305	36	42	reductase	reductase	NOUN
aiua-10305	36	43	inhibitors	inhibitor	NOUN
aiua-10305	36	44	)	)	PUNCT
aiua-10305	36	45	.	.	PUNCT
aiua-10305	37	1	the	the	DET
aiua-10305	37	2	following	follow	VERB
aiua-10305	37	3	outcomes	outcome	NOUN
aiua-10305	37	4	were	be	AUX
aiua-10305	37	5	considered	consider	VERB
aiua-10305	37	6	:	:	PUNCT
aiua-10305	37	7	(	(	PUNCT
aiua-10305	37	8	i	i	NOUN
aiua-10305	37	9	)	)	PUNCT
aiua-10305	37	10	the	the	DET
aiua-10305	37	11	rate	rate	NOUN
aiua-10305	37	12	of	of	ADP
aiua-10305	37	13	sexual	sexual	ADJ
aiua-10305	37	14	dysfunction	dysfunction	NOUN
aiua-10305	37	15	(	(	PUNCT
aiua-10305	37	16	erectile	erectile	ADJ
aiua-10305	37	17	dysfunction	dysfunction	NOUN
aiua-10305	37	18	,	,	PUNCT
aiua-10305	37	19	ejaculatory	ejaculatory	ADJ
aiua-10305	37	20	dysfunction	dysfunction	NOUN
aiua-10305	37	21	,	,	PUNCT
aiua-10305	37	22	dysorgasmia	dysorgasmia	NOUN
aiua-10305	37	23	,	,	PUNCT
aiua-10305	37	24	loss	loss	NOUN
aiua-10305	37	25	of	of	ADP
aiua-10305	37	26	libido	libido	NOUN
aiua-10305	37	27	)	)	PUNCT
aiua-10305	37	28	,	,	PUNCT
aiua-10305	37	29	and/or	and/or	CCONJ
aiua-10305	37	30	the	the	DET
aiua-10305	37	31	changes	change	NOUN
aiua-10305	37	32	of	of	ADP
aiua-10305	37	33	scores	score	NOUN
aiua-10305	37	34	of	of	ADP
aiua-10305	37	35	questionnaires	questionnaire	NOUN
aiua-10305	37	36	measuring	measure	VERB
aiua-10305	37	37	sexual	sexual	ADJ
aiua-10305	37	38	function	function	NOUN
aiua-10305	37	39	.	.	PUNCT
aiua-10305	38	1	the	the	DET
aiua-10305	38	2	brief	brief	ADJ
aiua-10305	38	3	male	male	ADJ
aiua-10305	38	4	sexual	sexual	ADJ
aiua-10305	38	5	function	function	NOUN
aiua-10305	38	6	inventory	inventory	NOUN
aiua-10305	38	7	(	(	PUNCT
aiua-10305	38	8	bmsfi	bmsfi	ADJ
aiua-10305	38	9	)	)	PUNCT
aiua-10305	38	10	is	be	AUX
aiua-10305	38	11	a	a	DET
aiua-10305	38	12	questionnaire	questionnaire	NOUN
aiua-10305	38	13	to	to	PART
aiua-10305	38	14	measure	measure	VERB
aiua-10305	38	15	male	male	ADJ
aiua-10305	38	16	sexual	sexual	ADJ
aiua-10305	38	17	function	function	NOUN
aiua-10305	38	18	covering	cover	VERB
aiua-10305	38	19	sexual	sexual	ADJ
aiua-10305	38	20	drive	drive	NOUN
aiua-10305	38	21	(	(	PUNCT
aiua-10305	38	22	two	two	NUM
aiua-10305	38	23	items	item	NOUN
aiua-10305	38	24	)	)	PUNCT
aiua-10305	38	25	,	,	PUNCT
aiua-10305	38	26	erection	erection	NOUN
aiua-10305	38	27	(	(	PUNCT
aiua-10305	38	28	three	three	NUM
aiua-10305	38	29	items	item	NOUN
aiua-10305	38	30	)	)	PUNCT
aiua-10305	38	31	,	,	PUNCT
aiua-10305	38	32	ejaculation	ejaculation	NOUN
aiua-10305	38	33	(	(	PUNCT
aiua-10305	38	34	two	two	NUM
aiua-10305	38	35	items	item	NOUN
aiua-10305	38	36	)	)	PUNCT
aiua-10305	38	37	,	,	PUNCT
aiua-10305	38	38	perceptions	perception	NOUN
aiua-10305	38	39	of	of	ADP
aiua-10305	38	40	problems	problem	NOUN
aiua-10305	38	41	in	in	ADP
aiua-10305	38	42	each	each	DET
aiua-10305	38	43	area	area	NOUN
aiua-10305	38	44	(	(	PUNCT
aiua-10305	38	45	three	three	NUM
aiua-10305	38	46	items	item	NOUN
aiua-10305	38	47	)	)	PUNCT
aiua-10305	38	48	,	,	PUNCT
aiua-10305	38	49	and	and	CCONJ
aiua-10305	38	50	overall	overall	ADJ
aiua-10305	38	51	satisfaction	satisfaction	NOUN
aiua-10305	38	52	(	(	PUNCT
aiua-10305	38	53	one	one	NUM
aiua-10305	38	54	item	item	NOUN
aiua-10305	38	55	)	)	PUNCT
aiua-10305	38	56	(	(	PUNCT
aiua-10305	38	57	24	24	NUM
aiua-10305	38	58	)	)	PUNCT
aiua-10305	38	59	.	.	PUNCT
aiua-10305	39	1	the	the	DET
aiua-10305	39	2	international	international	ADJ
aiua-10305	39	3	index	index	NOUN
aiua-10305	39	4	of	of	ADP
aiua-10305	39	5	erectile	erectile	NOUN
aiua-10305	39	6	function	function	NOUN
aiua-10305	39	7	(	(	PUNCT
aiua-10305	39	8	iief	iief	NOUN
aiua-10305	39	9	)	)	PUNCT
aiua-10305	39	10	is	be	AUX
aiua-10305	39	11	a	a	DET
aiua-10305	39	12	15item	15item	PROPN
aiua-10305	39	13	questionnaire	questionnaire	NOUN
aiua-10305	39	14	addressing	address	VERB
aiua-10305	39	15	five	five	NUM
aiua-10305	39	16	relevant	relevant	ADJ
aiua-10305	39	17	domains	domain	NOUN
aiua-10305	39	18	of	of	ADP
aiua-10305	39	19	male	male	ADJ
aiua-10305	39	20	sexual	sexual	ADJ
aiua-10305	39	21	function	function	NOUN
aiua-10305	39	22	(	(	PUNCT
aiua-10305	39	23	erectile	erectile	NOUN
aiua-10305	39	24	function	function	NOUN
aiua-10305	39	25	,	,	PUNCT
aiua-10305	39	26	orgasmic	orgasmic	ADJ
aiua-10305	39	27	function	function	NOUN
aiua-10305	39	28	,	,	PUNCT
aiua-10305	39	29	sexual	sexual	ADJ
aiua-10305	39	30	desire	desire	NOUN
aiua-10305	39	31	,	,	PUNCT
aiua-10305	39	32	intercourse	intercourse	NOUN
aiua-10305	39	33	satisfaction	satisfaction	NOUN
aiua-10305	39	34	,	,	PUNCT
aiua-10305	39	35	and	and	CCONJ
aiua-10305	39	36	overall	overall	ADJ
aiua-10305	39	37	satisfaction	satisfaction	NOUN
aiua-10305	39	38	)	)	PUNCT
aiua-10305	39	39	(	(	PUNCT
aiua-10305	39	40	25	25	NUM
aiua-10305	39	41	)	)	PUNCT
aiua-10305	39	42	.	.	PUNCT
aiua-10305	40	1	an	an	DET
aiua-10305	40	2	abridged	abridge	VERB
aiua-10305	40	3	,	,	PUNCT
aiua-10305	40	4	five	five	NUM
aiua-10305	40	5	-	-	PUNCT
aiua-10305	40	6	item	item	NOUN
aiua-10305	40	7	version	version	NOUN
aiua-10305	40	8	of	of	ADP
aiua-10305	40	9	the	the	DET
aiua-10305	40	10	iief-5	iief-5	NUM
aiua-10305	40	11	can	can	AUX
aiua-10305	40	12	also	also	ADV
aiua-10305	40	13	be	be	AUX
aiua-10305	40	14	administered	administer	VERB
aiua-10305	40	15	for	for	ADP
aiua-10305	40	16	the	the	DET
aiua-10305	40	17	evaluation	evaluation	NOUN
aiua-10305	40	18	of	of	ADP
aiua-10305	40	19	erectile	erectile	ADJ
aiua-10305	40	20	dysfunction	dysfunction	NOUN
aiua-10305	40	21	(	(	PUNCT
aiua-10305	40	22	26	26	NUM
aiua-10305	40	23	)	)	PUNCT
aiua-10305	40	24	.	.	PUNCT
aiua-10305	41	1	increasing	increase	VERB
aiua-10305	41	2	severity	severity	NOUN
aiua-10305	41	3	of	of	ADP
aiua-10305	41	4	sexual	sexual	ADJ
aiua-10305	41	5	function	function	NOUN
aiua-10305	41	6	is	be	AUX
aiua-10305	41	7	associated	associate	VERB
aiua-10305	41	8	with	with	ADP
aiua-10305	41	9	lower	low	ADJ
aiua-10305	41	10	scores	score	NOUN
aiua-10305	41	11	of	of	ADP
aiua-10305	41	12	bmsfi	bmsfi	ADJ
aiua-10305	41	13	and	and	CCONJ
aiua-10305	41	14	iief	iief	ADJ
aiua-10305	41	15	.	.	PUNCT
aiua-10305	42	1	the	the	DET
aiua-10305	42	2	male	male	ADJ
aiua-10305	42	3	sexual	sexual	ADJ
aiua-10305	42	4	function4	function4	NOUN
aiua-10305	42	5	item	item	NOUN
aiua-10305	42	6	(	(	PUNCT
aiua-10305	42	7	msf-4	msf-4	NOUN
aiua-10305	42	8	)	)	PUNCT
aiua-10305	42	9	questionnaire	questionnaire	NOUN
aiua-10305	42	10	is	be	AUX
aiua-10305	42	11	a	a	DET
aiua-10305	42	12	concise	concise	ADJ
aiua-10305	42	13	survey	survey	NOUN
aiua-10305	42	14	evaluating	evaluate	VERB
aiua-10305	42	15	four	four	NUM
aiua-10305	42	16	items	item	NOUN
aiua-10305	42	17	(	(	PUNCT
aiua-10305	42	18	interest	interest	NOUN
aiua-10305	42	19	in	in	ADP
aiua-10305	42	20	sex	sex	NOUN
aiua-10305	42	21	,	,	PUNCT
aiua-10305	42	22	quality	quality	NOUN
aiua-10305	42	23	of	of	ADP
aiua-10305	42	24	erection	erection	NOUN
aiua-10305	42	25	,	,	PUNCT
aiua-10305	42	26	achievement	achievement	NOUN
aiua-10305	42	27	of	of	ADP
aiua-10305	42	28	ejaculation	ejaculation	NOUN
aiua-10305	42	29	,	,	PUNCT
aiua-10305	42	30	and	and	CCONJ
aiua-10305	42	31	achievement	achievement	NOUN
aiua-10305	42	32	of	of	ADP
aiua-10305	42	33	orgasm	orgasm	NOUN
aiua-10305	42	34	)	)	PUNCT
aiua-10305	42	35	.	.	PUNCT
aiua-10305	43	1	lower	low	ADJ
aiua-10305	43	2	scores	score	NOUN
aiua-10305	43	3	of	of	ADP
aiua-10305	43	4	this	this	DET
aiua-10305	43	5	instrument	instrument	NOUN
aiua-10305	43	6	are	be	AUX
aiua-10305	43	7	associated	associate	VERB
aiua-10305	43	8	with	with	ADP
aiua-10305	43	9	better	well	ADJ
aiua-10305	43	10	preserved	preserve	VERB
aiua-10305	43	11	sexual	sexual	ADJ
aiua-10305	43	12	function	function	NOUN
aiua-10305	43	13	(	(	PUNCT
aiua-10305	43	14	27	27	NUM
aiua-10305	43	15	)	)	PUNCT
aiua-10305	43	16	.	.	PUNCT
aiua-10305	44	1	two	two	NUM
aiua-10305	44	2	independent	independent	ADJ
aiua-10305	44	3	authors	author	NOUN
aiua-10305	44	4	performed	perform	VERB
aiua-10305	44	5	title	title	NOUN
aiua-10305	44	6	and	and	CCONJ
aiua-10305	44	7	abstract	abstract	ADJ
aiua-10305	44	8	screening	screening	NOUN
aiua-10305	44	9	of	of	ADP
aiua-10305	44	10	all	all	DET
aiua-10305	44	11	retrieved	retrieve	VERB
aiua-10305	44	12	records	record	NOUN
aiua-10305	44	13	to	to	ADP
aiua-10305	44	14	delete	delete	ADJ
aiua-10305	44	15	duplicates	duplicate	NOUN
aiua-10305	44	16	and	and	CCONJ
aiua-10305	44	17	to	to	PART
aiua-10305	44	18	exclude	exclude	VERB
aiua-10305	44	19	reports	report	NOUN
aiua-10305	44	20	that	that	PRON
aiua-10305	44	21	did	do	AUX
aiua-10305	44	22	not	not	PART
aiua-10305	44	23	meet	meet	VERB
aiua-10305	44	24	the	the	DET
aiua-10305	44	25	inclusion	inclusion	NOUN
aiua-10305	44	26	criteria	criterion	NOUN
aiua-10305	44	27	.	.	PUNCT
aiua-10305	45	1	a	a	DET
aiua-10305	45	2	second	second	ADJ
aiua-10305	45	3	round	round	NOUN
aiua-10305	45	4	of	of	ADP
aiua-10305	45	5	full	full	ADJ
aiua-10305	45	6	-	-	PUNCT
aiua-10305	45	7	text	text	NOUN
aiua-10305	45	8	screening	screening	NOUN
aiua-10305	45	9	to	to	PART
aiua-10305	45	10	confirm	confirm	VERB
aiua-10305	45	11	/	/	SYM
aiua-10305	45	12	exclude	exclude	VERB
aiua-10305	45	13	the	the	DET
aiua-10305	45	14	inclusion	inclusion	NOUN
aiua-10305	45	15	of	of	ADP
aiua-10305	45	16	retrieved	retrieve	VERB
aiua-10305	45	17	studies	study	NOUN
aiua-10305	45	18	and	and	CCONJ
aiua-10305	45	19	to	to	PART
aiua-10305	45	20	extract	extract	VERB
aiua-10305	45	21	relevant	relevant	ADJ
aiua-10305	45	22	information	information	NOUN
aiua-10305	45	23	was	be	AUX
aiua-10305	45	24	performed	perform	VERB
aiua-10305	45	25	by	by	ADP
aiua-10305	45	26	2	2	NUM
aiua-10305	45	27	authors	author	NOUN
aiua-10305	45	28	using	use	VERB
aiua-10305	45	29	a	a	DET
aiua-10305	45	30	standardized	standardized	ADJ
aiua-10305	45	31	form	form	NOUN
aiua-10305	45	32	.	.	PUNCT
aiua-10305	46	1	the	the	DET
aiua-10305	46	2	publication	publication	NOUN
aiua-10305	46	3	bias	bias	NOUN
aiua-10305	46	4	was	be	AUX
aiua-10305	46	5	assessed	assess	VERB
aiua-10305	46	6	in	in	ADP
aiua-10305	46	7	the	the	DET
aiua-10305	46	8	presence	presence	NOUN
aiua-10305	46	9	of	of	ADP
aiua-10305	46	10	at	at	ADV
aiua-10305	46	11	least	least	ADV
aiua-10305	46	12	5	5	NUM
aiua-10305	46	13	trials	trial	NOUN
aiua-10305	46	14	.	.	PUNCT
aiua-10305	47	1	it	it	PRON
aiua-10305	47	2	was	be	AUX
aiua-10305	47	3	analyzed	analyze	VERB
aiua-10305	47	4	by	by	ADP
aiua-10305	47	5	visually	visually	ADV
aiua-10305	47	6	inspecting	inspect	VERB
aiua-10305	47	7	funnel	funnel	NOUN
aiua-10305	47	8	plots	plot	NOUN
aiua-10305	47	9	and	and	CCONJ
aiua-10305	47	10	by	by	ADP
aiua-10305	47	11	performing	perform	VERB
aiua-10305	47	12	the	the	DET
aiua-10305	47	13	egger	egger	NOUN
aiua-10305	47	14	’s	’s	NOUN
aiua-10305	47	15	and	and	CCONJ
aiua-10305	47	16	begg	begg	PROPN
aiua-10305	47	17	’s	’s	PART
aiua-10305	47	18	tests	test	NOUN
aiua-10305	47	19	using	use	VERB
aiua-10305	47	20	the	the	DET
aiua-10305	47	21	metaessentials	metaessential	NOUN
aiua-10305	47	22	1	1	NUM
aiua-10305	47	23	software	software	NOUN
aiua-10305	47	24	(	(	PUNCT
aiua-10305	47	25	rotterdam	rotterdam	PROPN
aiua-10305	47	26	school	school	NOUN
aiua-10305	47	27	of	of	ADP
aiua-10305	47	28	management	management	NOUN
aiua-10305	47	29	,	,	PUNCT
aiua-10305	47	30	erasmus	erasmus	PROPN
aiua-10305	47	31	university	university	PROPN
aiua-10305	47	32	,	,	PUNCT
aiua-10305	47	33	the	the	DET
aiua-10305	47	34	netherlands	netherlands	PROPN
aiua-10305	47	35	)	)	PUNCT
aiua-10305	47	36	.	.	PUNCT
aiua-10305	48	1	statistical	statistical	ADJ
aiua-10305	48	2	analysis	analysis	NOUN
aiua-10305	48	3	was	be	AUX
aiua-10305	48	4	performed	perform	VERB
aiua-10305	48	5	using	use	VERB
aiua-10305	48	6	the	the	DET
aiua-10305	48	7	revman5	revman5	PROPN
aiua-10305	48	8	software	software	NOUN
aiua-10305	48	9	.	.	PUNCT
aiua-10305	49	1	meta	meta	ADJ
aiua-10305	49	2	-	-	PUNCT
aiua-10305	49	3	analysis	analysis	NOUN
aiua-10305	49	4	was	be	AUX
aiua-10305	49	5	performed	perform	VERB
aiua-10305	49	6	using	use	VERB
aiua-10305	49	7	a	a	DET
aiua-10305	49	8	random	random	ADJ
aiua-10305	49	9	effects	effect	NOUN
aiua-10305	49	10	model	model	NOUN
aiua-10305	49	11	.	.	PUNCT
aiua-10305	50	1	dichotomous	dichotomous	ADJ
aiua-10305	50	2	data	datum	NOUN
aiua-10305	50	3	(	(	PUNCT
aiua-10305	50	4	presence	presence	NOUN
aiua-10305	50	5	/	/	SYM
aiua-10305	50	6	absence	absence	NOUN
aiua-10305	50	7	of	of	ADP
aiua-10305	50	8	sexual	sexual	ADJ
aiua-10305	50	9	dysfunction	dysfunction	NOUN
aiua-10305	50	10	)	)	PUNCT
aiua-10305	50	11	or	or	CCONJ
aiua-10305	50	12	continuous	continuous	ADJ
aiua-10305	50	13	data	datum	NOUN
aiua-10305	50	14	reporting	reporting	NOUN
aiua-10305	50	15	changes	change	NOUN
aiua-10305	50	16	of	of	ADP
aiua-10305	50	17	mean	mean	ADJ
aiua-10305	50	18	values	value	NOUN
aiua-10305	50	19	of	of	ADP
aiua-10305	50	20	sexual	sexual	ADJ
aiua-10305	50	21	function	function	NOUN
aiua-10305	50	22	scores	score	NOUN
aiua-10305	50	23	and	and	CCONJ
aiua-10305	50	24	number	number	NOUN
aiua-10305	50	25	of	of	ADP
aiua-10305	50	26	per	per	ADP
aiua-10305	50	27	-	-	PUNCT
aiua-10305	50	28	protocol	protocol	NOUN
aiua-10305	50	29	or	or	CCONJ
aiua-10305	50	30	intent	intent	NOUN
aiua-10305	50	31	-	-	PUNCT
aiua-10305	50	32	to	to	ADP
aiua-10305	50	33	-	-	PUNCT
aiua-10305	50	34	treat	treat	NOUN
aiua-10305	50	35	patients	patient	NOUN
aiua-10305	50	36	were	be	AUX
aiua-10305	50	37	extracted	extract	VERB
aiua-10305	50	38	.	.	PUNCT
aiua-10305	51	1	for	for	ADP
aiua-10305	51	2	dichotomous	dichotomous	ADJ
aiua-10305	51	3	data	datum	NOUN
aiua-10305	51	4	we	we	PRON
aiua-10305	51	5	calculated	calculate	VERB
aiua-10305	51	6	odds	odd	NOUN
aiua-10305	51	7	ratios	ratio	NOUN
aiua-10305	51	8	(	(	PUNCT
aiua-10305	51	9	or	or	CCONJ
aiua-10305	51	10	)	)	PUNCT
aiua-10305	51	11	,	,	PUNCT
aiua-10305	51	12	for	for	ADP
aiua-10305	51	13	continuous	continuous	ADJ
aiua-10305	51	14	data	datum	NOUN
aiua-10305	51	15	presented	present	VERB
aiua-10305	51	16	as	as	ADP
aiua-10305	51	17	pre	pre	ADJ
aiua-10305	51	18	-	-	ADJ
aiua-10305	51	19	vs.	vs.	CCONJ
aiua-10305	51	20	post	post	ADJ
aiua-10305	51	21	-	-	NOUN
aiua-10305	51	22	therapy	therapy	NOUN
aiua-10305	51	23	mean	mean	NOUN
aiua-10305	51	24	differences	difference	NOUN
aiua-10305	51	25	,	,	PUNCT
aiua-10305	51	26	we	we	PRON
aiua-10305	51	27	calculated	calculate	VERB
aiua-10305	51	28	inverse	inverse	NOUN
aiua-10305	51	29	variance	variance	NOUN
aiua-10305	51	30	weighted	weight	VERB
aiua-10305	51	31	standardized	standardized	ADJ
aiua-10305	51	32	mean	mean	NOUN
aiua-10305	51	33	differences	difference	NOUN
aiua-10305	51	34	.	.	PUNCT
aiua-10305	52	1	for	for	ADP
aiua-10305	52	2	all	all	DET
aiua-10305	52	3	analyses	analysis	NOUN
aiua-10305	52	4	we	we	PRON
aiua-10305	52	5	calculated	calculate	VERB
aiua-10305	52	6	95	95	NUM
aiua-10305	52	7	%	%	NOUN
aiua-10305	52	8	confidence	confidence	NOUN
aiua-10305	52	9	intervals	interval	NOUN
aiua-10305	52	10	(	(	PUNCT
aiua-10305	52	11	ci	ci	NOUN
aiua-10305	52	12	)	)	PUNCT
aiua-10305	52	13	.	.	PUNCT
aiua-10305	53	1	heterogeneity	heterogeneity	NOUN
aiua-10305	53	2	was	be	AUX
aiua-10305	53	3	assessed	assess	VERB
aiua-10305	53	4	by	by	ADP
aiua-10305	53	5	calculating	calculate	VERB
aiua-10305	53	6	the	the	DET
aiua-10305	53	7	i^2	i^2	PROPN
aiua-10305	53	8	value	value	NOUN
aiua-10305	53	9	with	with	ADP
aiua-10305	53	10	95	95	NUM
aiua-10305	53	11	%	%	NOUN
aiua-10305	53	12	cis	cis	NOUN
aiua-10305	53	13	,	,	PUNCT
aiua-10305	53	14	and	and	CCONJ
aiua-10305	53	15	interpreted	interpret	VERB
aiua-10305	53	16	as	as	ADP
aiua-10305	53	17	follows	follow	VERB
aiua-10305	53	18	:	:	PUNCT
aiua-10305	53	19	0	0	NUM
aiua-10305	53	20	%	%	NOUN
aiua-10305	53	21	to	to	PART
aiua-10305	53	22	40	40	NUM
aiua-10305	53	23	%	%	NOUN
aiua-10305	53	24	:	:	PUNCT
aiua-10305	53	25	might	might	AUX
aiua-10305	53	26	not	not	PART
aiua-10305	53	27	be	be	AUX
aiua-10305	53	28	important	important	ADJ
aiua-10305	53	29	;	;	PUNCT
aiua-10305	53	30	30	30	NUM
aiua-10305	53	31	%	%	NOUN
aiua-10305	53	32	to	to	PART
aiua-10305	53	33	60	60	NUM
aiua-10305	53	34	%	%	NOUN
aiua-10305	53	35	:	:	PUNCT
aiua-10305	53	36	may	may	AUX
aiua-10305	53	37	represent	represent	VERB
aiua-10305	53	38	moderate	moderate	ADJ
aiua-10305	53	39	heterogeneity	heterogeneity	NOUN
aiua-10305	53	40	;	;	PUNCT
aiua-10305	53	41	50	50	NUM
aiua-10305	53	42	%	%	NOUN
aiua-10305	53	43	to	to	PART
aiua-10305	53	44	90	90	NUM
aiua-10305	53	45	%	%	NOUN
aiua-10305	53	46	:	:	PUNCT
aiua-10305	53	47	may	may	AUX
aiua-10305	53	48	represent	represent	VERB
aiua-10305	53	49	substantial	substantial	ADJ
aiua-10305	53	50	heterogeneity	heterogeneity	NOUN
aiua-10305	53	51	;	;	PUNCT
aiua-10305	53	52	75	75	NUM
aiua-10305	53	53	%	%	NOUN
aiua-10305	53	54	to	to	PART
aiua-10305	53	55	100	100	NUM
aiua-10305	53	56	%	%	NOUN
aiua-10305	53	57	:	:	PUNCT
aiua-10305	53	58	considerable	considerable	ADJ
aiua-10305	53	59	heterogeneity	heterogeneity	NOUN
aiua-10305	53	60	.	.	PUNCT
aiua-10305	54	1	a	a	DET
aiua-10305	54	2	summary	summary	NOUN
aiua-10305	54	3	of	of	ADP
aiua-10305	54	4	findings	finding	NOUN
aiua-10305	54	5	table	table	NOUN
aiua-10305	54	6	was	be	AUX
aiua-10305	54	7	generated	generate	VERB
aiua-10305	54	8	,	,	PUNCT
aiua-10305	54	9	and	and	CCONJ
aiua-10305	54	10	the	the	DET
aiua-10305	54	11	quality	quality	NOUN
aiua-10305	54	12	of	of	ADP
aiua-10305	54	13	the	the	DET
aiua-10305	54	14	evidence	evidence	NOUN
aiua-10305	54	15	emerging	emerge	VERB
aiua-10305	54	16	from	from	ADP
aiua-10305	54	17	meta	meta	NOUN
aiua-10305	54	18	-	-	PUNCT
aiua-10305	54	19	analyses	analysis	NOUN
aiua-10305	54	20	including	include	VERB
aiua-10305	54	21	at	at	ADV
aiua-10305	54	22	least	least	ADV
aiua-10305	54	23	3	3	NUM
aiua-10305	54	24	studies	study	NOUN
aiua-10305	54	25	was	be	AUX
aiua-10305	54	26	rated	rate	VERB
aiua-10305	54	27	according	accord	VERB
aiua-10305	54	28	to	to	ADP
aiua-10305	54	29	grade	grade	NOUN
aiua-10305	54	30	criteria	criterion	NOUN
aiua-10305	54	31	.	.	PUNCT
aiua-10305	55	1	results	result	VERB
aiua-10305	55	2	a	a	DET
aiua-10305	55	3	prisma	prisma	NOUN
aiua-10305	55	4	flow	flow	NOUN
aiua-10305	55	5	diagram	diagram	NOUN
aiua-10305	55	6	illustrates	illustrate	VERB
aiua-10305	55	7	the	the	DET
aiua-10305	55	8	results	result	NOUN
aiua-10305	55	9	of	of	ADP
aiua-10305	55	10	the	the	DET
aiua-10305	55	11	study	study	NOUN
aiua-10305	55	12	selection	selection	NOUN
aiua-10305	55	13	process	process	NOUN
aiua-10305	55	14	(	(	PUNCT
aiua-10305	55	15	see	see	VERB
aiua-10305	55	16	figure	figure	NOUN
aiua-10305	55	17	1	1	NUM
aiua-10305	55	18	)	)	PUNCT
aiua-10305	55	19	.	.	PUNCT
aiua-10305	56	1	we	we	PRON
aiua-10305	56	2	retrieved	retrieve	VERB
aiua-10305	56	3	29	29	NUM
aiua-10305	56	4	papers	paper	NOUN
aiua-10305	56	5	:	:	PUNCT
aiua-10305	56	6	7	7	NUM
aiua-10305	56	7	papers	paper	NOUN
aiua-10305	56	8	from	from	ADP
aiua-10305	56	9	pubmed	pubmed	PROPN
aiua-10305	56	10	,	,	PUNCT
aiua-10305	56	11	17	17	NUM
aiua-10305	56	12	papers	paper	NOUN
aiua-10305	56	13	from	from	ADP
aiua-10305	56	14	embase	embase	NOUN
aiua-10305	56	15	and	and	CCONJ
aiua-10305	56	16	5	5	NUM
aiua-10305	56	17	from	from	ADP
aiua-10305	56	18	other	other	ADJ
aiua-10305	56	19	sources	source	NOUN
aiua-10305	56	20	(	(	PUNCT
aiua-10305	56	21	handsearching	handsearche	VERB
aiua-10305	56	22	)	)	PUNCT
aiua-10305	56	23	.	.	PUNCT
aiua-10305	57	1	four	four	NUM
aiua-10305	57	2	duplicate	duplicate	ADJ
aiua-10305	57	3	papers	paper	NOUN
aiua-10305	57	4	were	be	AUX
aiua-10305	57	5	removed	remove	VERB
aiua-10305	57	6	,	,	PUNCT
aiua-10305	57	7	and	and	CCONJ
aiua-10305	57	8	5	5	NUM
aiua-10305	57	9	papers	paper	NOUN
aiua-10305	57	10	were	be	AUX
aiua-10305	57	11	excluded	exclude	VERB
aiua-10305	57	12	as	as	SCONJ
aiua-10305	57	13	they	they	PRON
aiua-10305	57	14	were	be	AUX
aiua-10305	57	15	found	find	VERB
aiua-10305	57	16	to	to	PART
aiua-10305	57	17	be	be	AUX
aiua-10305	57	18	not	not	PART
aiua-10305	57	19	related	relate	VERB
aiua-10305	57	20	to	to	ADP
aiua-10305	57	21	this	this	DET
aiua-10305	57	22	review	review	NOUN
aiua-10305	57	23	.	.	PUNCT
aiua-10305	58	1	figure	figure	NOUN
aiua-10305	58	2	1	1	NUM
aiua-10305	58	3	.	.	PUNCT
aiua-10305	59	1	a	a	DET
aiua-10305	59	2	prisma	prisma	NOUN
aiua-10305	59	3	flow	flow	NOUN
aiua-10305	59	4	diagram	diagram	NOUN
aiua-10305	59	5	.	.	PUNCT
aiua-10305	60	1	477archivio	477archivio	PROPN
aiua-10305	60	2	italiano	italiano	NOUN
aiua-10305	60	3	di	di	X
aiua-10305	60	4	urologia	urologia	PROPN
aiua-10305	60	5	e	e	PROPN
aiua-10305	60	6	andrologia	andrologia	NOUN
aiua-10305	60	7	2021	2021	NUM
aiua-10305	60	8	;	;	PUNCT
aiua-10305	60	9	93	93	NUM
aiua-10305	60	10	,	,	PUNCT
aiua-10305	60	11	4	4	NUM
aiua-10305	60	12	serenoa	serenoa	ADJ
aiua-10305	60	13	repens	repen	NOUN
aiua-10305	60	14	and	and	CCONJ
aiua-10305	60	15	sexual	sexual	ADJ
aiua-10305	60	16	function	function	NOUN
aiua-10305	60	17	out	out	ADP
aiua-10305	60	18	of	of	ADP
aiua-10305	60	19	the	the	DET
aiua-10305	60	20	20	20	NUM
aiua-10305	60	21	remaining	remain	VERB
aiua-10305	60	22	papers	paper	NOUN
aiua-10305	60	23	,	,	PUNCT
aiua-10305	60	24	we	we	PRON
aiua-10305	60	25	selected	select	VERB
aiua-10305	60	26	8	8	NUM
aiua-10305	60	27	papers	paper	NOUN
aiua-10305	60	28	reporting	report	VERB
aiua-10305	60	29	comparisons	comparison	NOUN
aiua-10305	60	30	of	of	ADP
aiua-10305	60	31	sr	sr	PROPN
aiua-10305	60	32	with	with	ADP
aiua-10305	60	33	placebo	placebo	NOUN
aiua-10305	60	34	.	.	PUNCT
aiua-10305	61	1	three	three	NUM
aiua-10305	61	2	records	record	NOUN
aiua-10305	61	3	were	be	AUX
aiua-10305	61	4	discarded	discard	VERB
aiua-10305	61	5	after	after	ADP
aiua-10305	61	6	full	full	ADJ
aiua-10305	61	7	-	-	PUNCT
aiua-10305	61	8	text	text	NOUN
aiua-10305	61	9	reading	reading	NOUN
aiua-10305	61	10	(	(	PUNCT
aiua-10305	61	11	two	two	NUM
aiua-10305	61	12	were	be	AUX
aiua-10305	61	13	lacking	lack	VERB
aiua-10305	61	14	information	information	NOUN
aiua-10305	61	15	on	on	ADP
aiua-10305	61	16	sexual	sexual	ADJ
aiua-10305	61	17	outcomes	outcome	NOUN
aiua-10305	61	18	and	and	CCONJ
aiua-10305	61	19	one	one	NUM
aiua-10305	61	20	reported	report	VERB
aiua-10305	61	21	only	only	ADJ
aiua-10305	61	22	information	information	NOUN
aiua-10305	61	23	on	on	ADP
aiua-10305	61	24	sexual	sexual	ADJ
aiua-10305	61	25	hormones	hormone	NOUN
aiua-10305	61	26	)	)	PUNCT
aiua-10305	61	27	.	.	PUNCT
aiua-10305	62	1	other	other	ADJ
aiua-10305	62	2	7	7	NUM
aiua-10305	62	3	studies	study	NOUN
aiua-10305	62	4	reported	report	VERB
aiua-10305	62	5	comparisons	comparison	NOUN
aiua-10305	62	6	of	of	ADP
aiua-10305	62	7	sr	sr	PROPN
aiua-10305	62	8	with	with	ADP
aiua-10305	62	9	tamsulosin	tamsulosin	NOUN
aiua-10305	62	10	.	.	PUNCT
aiua-10305	63	1	two	two	NUM
aiua-10305	63	2	studies	study	NOUN
aiua-10305	63	3	were	be	AUX
aiua-10305	63	4	excluded	exclude	VERB
aiua-10305	63	5	because	because	SCONJ
aiua-10305	63	6	serenoa	serenoa	ADJ
aiua-10305	63	7	repens	repen	NOUN
aiua-10305	63	8	was	be	AUX
aiua-10305	63	9	administered	administer	VERB
aiua-10305	63	10	in	in	ADP
aiua-10305	63	11	association	association	NOUN
aiua-10305	63	12	with	with	ADP
aiua-10305	63	13	other	other	ADJ
aiua-10305	63	14	herbal	herbal	ADJ
aiua-10305	63	15	products	product	NOUN
aiua-10305	63	16	and	and	CCONJ
aiua-10305	63	17	one	one	NUM
aiua-10305	63	18	because	because	SCONJ
aiua-10305	63	19	sr	sr	PROPN
aiua-10305	63	20	was	be	AUX
aiua-10305	63	21	administered	administer	VERB
aiua-10305	63	22	in	in	ADP
aiua-10305	63	23	combination	combination	NOUN
aiua-10305	63	24	with	with	ADP
aiua-10305	63	25	tamsulosin	tamsulosin	NOUN
aiua-10305	63	26	versus	versus	ADP
aiua-10305	63	27	tamsulosin	tamsulosin	NOUN
aiua-10305	63	28	alone	alone	ADV
aiua-10305	63	29	.	.	PUNCT
aiua-10305	64	1	two	two	NUM
aiua-10305	64	2	studies	study	NOUN
aiua-10305	64	3	compared	compare	VERB
aiua-10305	64	4	sr	sr	PROPN
aiua-10305	64	5	with	with	ADP
aiua-10305	64	6	finasteride	finasteride	ADV
aiua-10305	64	7	;	;	PUNCT
aiua-10305	64	8	one	one	NUM
aiua-10305	64	9	was	be	AUX
aiua-10305	64	10	excluded	exclude	VERB
aiua-10305	64	11	because	because	SCONJ
aiua-10305	64	12	sr	sr	PROPN
aiua-10305	64	13	was	be	AUX
aiua-10305	64	14	administered	administer	VERB
aiua-10305	64	15	in	in	ADP
aiua-10305	64	16	combination	combination	NOUN
aiua-10305	64	17	with	with	ADP
aiua-10305	64	18	other	other	ADJ
aiua-10305	64	19	herbal	herbal	ADJ
aiua-10305	64	20	products	product	NOUN
aiua-10305	64	21	.	.	PUNCT
aiua-10305	65	1	three	three	NUM
aiua-10305	65	2	studies	study	NOUN
aiua-10305	65	3	compared	compare	VERB
aiua-10305	65	4	a	a	DET
aiua-10305	65	5	sr	sr	PROPN
aiua-10305	65	6	extract	extract	NOUN
aiua-10305	65	7	with	with	ADP
aiua-10305	65	8	other	other	ADJ
aiua-10305	65	9	herbal	herbal	ADJ
aiua-10305	65	10	products	product	NOUN
aiua-10305	65	11	.	.	PUNCT
aiua-10305	66	1	two	two	NUM
aiua-10305	66	2	were	be	AUX
aiua-10305	66	3	discarded	discard	VERB
aiua-10305	66	4	because	because	SCONJ
aiua-10305	66	5	of	of	ADP
aiua-10305	66	6	lack	lack	NOUN
aiua-10305	66	7	of	of	ADP
aiua-10305	66	8	information	information	NOUN
aiua-10305	66	9	on	on	ADP
aiua-10305	66	10	sexual	sexual	ADJ
aiua-10305	66	11	function	function	NOUN
aiua-10305	66	12	and	and	CCONJ
aiua-10305	66	13	one	one	NUM
aiua-10305	66	14	because	because	SCONJ
aiua-10305	66	15	sr	sr	PROPN
aiua-10305	66	16	was	be	AUX
aiua-10305	66	17	administered	administer	VERB
aiua-10305	66	18	in	in	ADP
aiua-10305	66	19	a	a	DET
aiua-10305	66	20	formulation	formulation	NOUN
aiua-10305	66	21	containing	contain	VERB
aiua-10305	66	22	other	other	ADJ
aiua-10305	66	23	herbal	herbal	ADJ
aiua-10305	66	24	products	product	NOUN
aiua-10305	66	25	.	.	PUNCT
aiua-10305	67	1	the	the	DET
aiua-10305	67	2	characteristics	characteristic	NOUN
aiua-10305	67	3	of	of	ADP
aiua-10305	67	4	the	the	DET
aiua-10305	67	5	10	10	NUM
aiua-10305	67	6	studies	study	NOUN
aiua-10305	67	7	finally	finally	ADV
aiua-10305	67	8	included	include	VERB
aiua-10305	67	9	in	in	ADP
aiua-10305	67	10	this	this	DET
aiua-10305	67	11	systematic	systematic	ADJ
aiua-10305	67	12	review	review	NOUN
aiua-10305	67	13	,	,	PUNCT
aiua-10305	67	14	and	and	CCONJ
aiua-10305	67	15	the	the	DET
aiua-10305	67	16	evaluation	evaluation	NOUN
aiua-10305	67	17	of	of	ADP
aiua-10305	67	18	risk	risk	NOUN
aiua-10305	67	19	of	of	ADP
aiua-10305	67	20	bias	bias	NOUN
aiua-10305	67	21	are	be	AUX
aiua-10305	67	22	presented	present	VERB
aiua-10305	67	23	in	in	ADP
aiua-10305	67	24	the	the	DET
aiua-10305	67	25	“	"	PUNCT
aiua-10305	67	26	supplementary	supplementary	ADJ
aiua-10305	67	27	materials	material	NOUN
aiua-10305	67	28	”	"	PUNCT
aiua-10305	67	29	.	.	PUNCT
aiua-10305	68	1	quantitative	quantitative	ADJ
aiua-10305	68	2	analysis	analysis	NOUN
aiua-10305	68	3	was	be	AUX
aiua-10305	68	4	limited	limit	VERB
aiua-10305	68	5	to	to	ADP
aiua-10305	68	6	five	five	NUM
aiua-10305	68	7	studies	study	NOUN
aiua-10305	68	8	comparing	compare	VERB
aiua-10305	68	9	therapy	therapy	NOUN
aiua-10305	68	10	with	with	ADP
aiua-10305	68	11	a	a	DET
aiua-10305	68	12	sr	sr	PROPN
aiua-10305	68	13	extract	extract	NOUN
aiua-10305	68	14	with	with	ADP
aiua-10305	68	15	placebo	placebo	NOUN
aiua-10305	68	16	,	,	PUNCT
aiua-10305	68	17	and	and	CCONJ
aiua-10305	68	18	to	to	ADP
aiua-10305	68	19	four	four	NUM
aiua-10305	68	20	studies	study	NOUN
aiua-10305	68	21	comparing	compare	VERB
aiua-10305	68	22	a	a	DET
aiua-10305	68	23	sr	sr	PROPN
aiua-10305	68	24	extract	extract	NOUN
aiua-10305	68	25	with	with	ADP
aiua-10305	68	26	tamsulosin	tamsulosin	NOUN
aiua-10305	68	27	(	(	PUNCT
aiua-10305	68	28	28	28	NUM
aiua-10305	68	29	-	-	SYM
aiua-10305	68	30	36	36	NUM
aiua-10305	68	31	)	)	PUNCT
aiua-10305	68	32	.	.	PUNCT
aiua-10305	69	1	a	a	DET
aiua-10305	69	2	study	study	NOUN
aiua-10305	69	3	comparing	compare	VERB
aiua-10305	69	4	a	a	DET
aiua-10305	69	5	sr	sr	PROPN
aiua-10305	69	6	extract	extract	NOUN
aiua-10305	69	7	with	with	ADP
aiua-10305	69	8	finasteride	finasteride	NOUN
aiua-10305	69	9	was	be	AUX
aiua-10305	69	10	only	only	ADV
aiua-10305	69	11	qualitatively	qualitatively	ADV
aiua-10305	69	12	evaluated	evaluate	VERB
aiua-10305	69	13	(	(	PUNCT
aiua-10305	69	14	37	37	NUM
aiua-10305	69	15	)	)	PUNCT
aiua-10305	69	16	.	.	PUNCT
aiua-10305	70	1	to	to	PART
aiua-10305	70	2	evaluate	evaluate	VERB
aiua-10305	70	3	differences	difference	NOUN
aiua-10305	70	4	in	in	ADP
aiua-10305	70	5	sexual	sexual	ADJ
aiua-10305	70	6	dysfunction	dysfunction	NOUN
aiua-10305	70	7	between	between	ADP
aiua-10305	70	8	treatment	treatment	NOUN
aiua-10305	70	9	arms	arm	NOUN
aiua-10305	70	10	we	we	PRON
aiua-10305	70	11	calculated	calculate	VERB
aiua-10305	70	12	standardized	standardized	ADJ
aiua-10305	70	13	mean	mean	NOUN
aiua-10305	70	14	differences	difference	NOUN
aiua-10305	70	15	,	,	PUNCT
aiua-10305	70	16	as	as	SCONJ
aiua-10305	70	17	included	include	VERB
aiua-10305	70	18	trials	trial	NOUN
aiua-10305	70	19	used	use	VERB
aiua-10305	70	20	different	different	ADJ
aiua-10305	70	21	sexual	sexual	ADJ
aiua-10305	70	22	function	function	NOUN
aiua-10305	70	23	scales	scale	NOUN
aiua-10305	70	24	.	.	PUNCT
aiua-10305	71	1	the	the	DET
aiua-10305	71	2	standardized	standardized	ADJ
aiua-10305	71	3	mean	mean	ADJ
aiua-10305	71	4	difference	difference	NOUN
aiua-10305	71	5	of	of	ADP
aiua-10305	71	6	changes	change	NOUN
aiua-10305	71	7	from	from	ADP
aiua-10305	71	8	baseline	baseline	ADJ
aiua-10305	71	9	scores	score	NOUN
aiua-10305	71	10	was	be	AUX
aiua-10305	71	11	not	not	PART
aiua-10305	71	12	significantly	significantly	ADV
aiua-10305	71	13	different	different	ADJ
aiua-10305	71	14	between	between	ADP
aiua-10305	71	15	sr	sr	PROPN
aiua-10305	71	16	and	and	CCONJ
aiua-10305	71	17	placebo	placebo	NOUN
aiua-10305	71	18	(	(	PUNCT
aiua-10305	71	19	smd	smd	NOUN
aiua-10305	71	20	:	:	PUNCT
aiua-10305	71	21	0.43	0.43	NUM
aiua-10305	71	22	,	,	PUNCT
aiua-10305	71	23	95	95	NUM
aiua-10305	71	24	%	%	NOUN
aiua-10305	71	25	ci	ci	NOUN
aiua-10305	71	26	:	:	PUNCT
aiua-10305	71	27	-0.18	-0.18	NUM
aiua-10305	71	28	to	to	ADP
aiua-10305	71	29	1.05	1.05	NUM
aiua-10305	71	30	;	;	PUNCT
aiua-10305	71	31	5	5	NUM
aiua-10305	71	32	trials	trial	NOUN
aiua-10305	71	33	,	,	PUNCT
aiua-10305	71	34	922	922	NUM
aiua-10305	71	35	patients	patient	NOUN
aiua-10305	71	36	;	;	PUNCT
aiua-10305	71	37	z	z	NOUN
aiua-10305	71	38	=	=	SYM
aiua-10305	71	39	1.37	1.37	NUM
aiua-10305	71	40	,	,	PUNCT
aiua-10305	71	41	p	p	X
aiua-10305	71	42	=	=	NOUN
aiua-10305	71	43	0.17	0.17	NUM
aiua-10305	71	44	;	;	PUNCT
aiua-10305	71	45	egger	egger	NOUN
aiua-10305	71	46	’s	’s	NOUN
aiua-10305	71	47	p	p	NOUN
aiua-10305	71	48	=	=	PROPN
aiua-10305	71	49	0.16	0.16	NUM
aiua-10305	71	50	;	;	PUNCT
aiua-10305	71	51	begg	begg	PROPN
aiua-10305	71	52	’s	’s	PART
aiua-10305	71	53	p	p	NOUN
aiua-10305	71	54	=	=	PROPN
aiua-10305	71	55	0.32	0.32	NUM
aiua-10305	71	56	)	)	PUNCT
aiua-10305	71	57	.	.	PUNCT
aiua-10305	72	1	this	this	DET
aiua-10305	72	2	analysis	analysis	NOUN
aiua-10305	72	3	was	be	AUX
aiua-10305	72	4	characterized	characterize	VERB
aiua-10305	72	5	by	by	ADP
aiua-10305	72	6	considerable	considerable	ADJ
aiua-10305	72	7	heterogeneity	heterogeneity	NOUN
aiua-10305	72	8	(	(	PUNCT
aiua-10305	72	9	i^2	i^2	X
aiua-10305	72	10	=	=	SYM
aiua-10305	72	11	95	95	NUM
aiua-10305	72	12	%	%	NOUN
aiua-10305	72	13	)	)	PUNCT
aiua-10305	72	14	(	(	PUNCT
aiua-10305	72	15	figure	figure	NOUN
aiua-10305	72	16	2	2	NUM
aiua-10305	72	17	)	)	PUNCT
aiua-10305	72	18	.	.	PUNCT
aiua-10305	73	1	no	no	DET
aiua-10305	73	2	significant	significant	ADJ
aiua-10305	73	3	mean	mean	ADJ
aiua-10305	73	4	differences	difference	NOUN
aiua-10305	73	5	in	in	ADP
aiua-10305	73	6	the	the	DET
aiua-10305	73	7	msf-4	msf-4	ADJ
aiua-10305	73	8	test	test	NOUN
aiua-10305	73	9	scores	score	NOUN
aiua-10305	73	10	were	be	AUX
aiua-10305	73	11	found	find	VERB
aiua-10305	73	12	between	between	ADP
aiua-10305	73	13	sr	sr	PROPN
aiua-10305	73	14	and	and	CCONJ
aiua-10305	73	15	tamsulosin	tamsulosin	PROPN
aiua-10305	73	16	(	(	PUNCT
aiua-10305	73	17	smd	smd	NOUN
aiua-10305	73	18	:	:	PUNCT
aiua-10305	73	19	-0.31	-0.31	NUM
aiua-10305	73	20	,	,	PUNCT
aiua-10305	73	21	95	95	NUM
aiua-10305	73	22	%	%	NOUN
aiua-10305	73	23	ci	ci	NOUN
aiua-10305	73	24	:	:	PUNCT
aiua-10305	73	25	-0.82	-0.82	PUNCT
aiua-10305	73	26	to	to	ADP
aiua-10305	73	27	0.19	0.19	NUM
aiua-10305	73	28	;	;	PUNCT
aiua-10305	73	29	3	3	NUM
aiua-10305	73	30	trials	trial	NOUN
aiua-10305	73	31	,	,	PUNCT
aiua-10305	73	32	826	826	NUM
aiua-10305	73	33	patients	patient	NOUN
aiua-10305	73	34	;	;	PUNCT
aiua-10305	73	35	z	z	NOUN
aiua-10305	73	36	=	=	SYM
aiua-10305	73	37	1.21	1.21	NUM
aiua-10305	73	38	,	,	PUNCT
aiua-10305	73	39	p	p	NOUN
aiua-10305	73	40	=	=	NOUN
aiua-10305	73	41	0.22	0.22	NUM
aiua-10305	73	42	;	;	PUNCT
aiua-10305	73	43	i^2	i^2	X
aiua-10305	73	44	=	=	SYM
aiua-10305	73	45	90	90	NUM
aiua-10305	73	46	%	%	NOUN
aiua-10305	73	47	)	)	PUNCT
aiua-10305	73	48	(	(	PUNCT
aiua-10305	73	49	figure	figure	NOUN
aiua-10305	73	50	3	3	NUM
aiua-10305	73	51	)	)	PUNCT
aiua-10305	73	52	.	.	PUNCT
aiua-10305	74	1	however	however	ADV
aiua-10305	74	2	,	,	PUNCT
aiua-10305	74	3	random	random	ADJ
aiua-10305	74	4	-	-	PUNCT
aiua-10305	74	5	effects	effect	NOUN
aiua-10305	74	6	meta	meta	ADJ
aiua-10305	74	7	-	-	PUNCT
aiua-10305	74	8	analysis	analysis	NOUN
aiua-10305	74	9	revealed	reveal	VERB
aiua-10305	74	10	that	that	SCONJ
aiua-10305	74	11	treatment	treatment	NOUN
aiua-10305	74	12	with	with	ADP
aiua-10305	74	13	sr	sr	PROPN
aiua-10305	74	14	is	be	AUX
aiua-10305	74	15	associated	associate	VERB
aiua-10305	74	16	with	with	ADP
aiua-10305	74	17	significantly	significantly	ADV
aiua-10305	74	18	lower	low	ADJ
aiua-10305	74	19	odds	odd	NOUN
aiua-10305	74	20	of	of	ADP
aiua-10305	74	21	ejaculatory	ejaculatory	ADJ
aiua-10305	74	22	disorders	disorder	NOUN
aiua-10305	74	23	compared	compare	VERB
aiua-10305	74	24	to	to	ADP
aiua-10305	74	25	tamsulosin	tamsulosin	NOUN
aiua-10305	74	26	(	(	PUNCT
aiua-10305	74	27	odds	odd	NOUN
aiua-10305	74	28	ratio	ratio	NOUN
aiua-10305	74	29	=	=	NOUN
aiua-10305	74	30	0.10	0.10	NUM
aiua-10305	74	31	,	,	PUNCT
aiua-10305	74	32	95	95	NUM
aiua-10305	74	33	%	%	NOUN
aiua-10305	74	34	ci	ci	NOUN
aiua-10305	74	35	:	:	PUNCT
aiua-10305	74	36	0.01	0.01	NUM
aiua-10305	74	37	to	to	ADP
aiua-10305	74	38	0.92	0.92	NUM
aiua-10305	74	39	;	;	PUNCT
aiua-10305	74	40	2	2	NUM
aiua-10305	74	41	trials	trial	NOUN
aiua-10305	74	42	,	,	PUNCT
aiua-10305	74	43	164	164	NUM
aiua-10305	74	44	participants	participant	NOUN
aiua-10305	74	45	,	,	PUNCT
aiua-10305	74	46	z	z	NOUN
aiua-10305	74	47	=	=	NUM
aiua-10305	74	48	2.03	2.03	NUM
aiua-10305	74	49	,	,	PUNCT
aiua-10305	74	50	p	p	NOUN
aiua-10305	74	51	=	=	NOUN
aiua-10305	74	52	0.04	0.04	NUM
aiua-10305	74	53	,	,	PUNCT
aiua-10305	74	54	i^2	i^2	X
aiua-10305	74	55	=	=	SYM
aiua-10305	74	56	0	0	NUM
aiua-10305	74	57	%	%	NOUN
aiua-10305	74	58	)	)	PUNCT
aiua-10305	74	59	,	,	PUNCT
aiua-10305	74	60	compared	compare	VERB
aiua-10305	74	61	to	to	ADP
aiua-10305	74	62	placebo	placebo	NOUN
aiua-10305	74	63	(	(	PUNCT
aiua-10305	74	64	see	see	VERB
aiua-10305	74	65	figure	figure	NOUN
aiua-10305	74	66	4	4	NUM
aiua-10305	74	67	)	)	PUNCT
aiua-10305	74	68	(	(	PUNCT
aiua-10305	74	69	34,35	34,35	NOUN
aiua-10305	74	70	)	)	PUNCT
aiua-10305	74	71	.	.	PUNCT
aiua-10305	75	1	final	final	ADJ
aiua-10305	75	2	results	result	NOUN
aiua-10305	75	3	are	be	AUX
aiua-10305	75	4	reported	report	VERB
aiua-10305	75	5	in	in	ADP
aiua-10305	75	6	table	table	NOUN
aiua-10305	75	7	1	1	NUM
aiua-10305	75	8	.	.	PUNCT
aiua-10305	75	9	discussion	discussion	NOUN
aiua-10305	75	10	although	although	SCONJ
aiua-10305	75	11	the	the	DET
aiua-10305	75	12	quality	quality	NOUN
aiua-10305	75	13	of	of	ADP
aiua-10305	75	14	evidence	evidence	NOUN
aiua-10305	75	15	grade	grade	NOUN
aiua-10305	75	16	of	of	ADP
aiua-10305	75	17	our	our	PRON
aiua-10305	75	18	meta	meta	ADJ
aiua-10305	75	19	-	-	PUNCT
aiua-10305	75	20	analysis	analysis	NOUN
aiua-10305	75	21	is	be	AUX
aiua-10305	75	22	low	low	ADJ
aiua-10305	75	23	(	(	PUNCT
aiua-10305	75	24	see	see	VERB
aiua-10305	75	25	table	table	NOUN
aiua-10305	75	26	1	1	NUM
aiua-10305	75	27	)	)	PUNCT
aiua-10305	75	28	,	,	PUNCT
aiua-10305	75	29	we	we	PRON
aiua-10305	75	30	found	find	VERB
aiua-10305	75	31	no	no	DET
aiua-10305	75	32	statistically	statistically	ADV
aiua-10305	75	33	significant	significant	ADJ
aiua-10305	75	34	differences	difference	NOUN
aiua-10305	75	35	between	between	ADP
aiua-10305	75	36	negative	negative	ADJ
aiua-10305	75	37	effects	effect	NOUN
aiua-10305	75	38	on	on	ADP
aiua-10305	75	39	sexual	sexual	ADJ
aiua-10305	75	40	function	function	NOUN
aiua-10305	75	41	in	in	ADP
aiua-10305	75	42	patients	patient	NOUN
aiua-10305	75	43	treated	treat	VERB
aiua-10305	75	44	with	with	ADP
aiua-10305	75	45	sr	sr	PROPN
aiua-10305	75	46	compared	compare	VERB
aiua-10305	75	47	to	to	ADP
aiua-10305	75	48	patients	patient	NOUN
aiua-10305	75	49	who	who	PRON
aiua-10305	75	50	received	receive	VERB
aiua-10305	75	51	placebo	placebo	NOUN
aiua-10305	75	52	or	or	CCONJ
aiua-10305	75	53	tamsulosin	tamsulosin	NOUN
aiua-10305	75	54	.	.	PUNCT
aiua-10305	76	1	this	this	PRON
aiua-10305	76	2	suggests	suggest	VERB
aiua-10305	76	3	that	that	SCONJ
aiua-10305	76	4	sr	sr	PROPN
aiua-10305	76	5	does	do	AUX
aiua-10305	76	6	not	not	PART
aiua-10305	76	7	appear	appear	VERB
aiua-10305	76	8	produce	produce	VERB
aiua-10305	76	9	negative	negative	ADJ
aiua-10305	76	10	figure	figure	NOUN
aiua-10305	76	11	2	2	NUM
aiua-10305	76	12	.	.	PUNCT
aiua-10305	76	13	statistical	statistical	ADJ
aiua-10305	76	14	analysis	analysis	NOUN
aiua-10305	76	15	:	:	PUNCT
aiua-10305	76	16	differences	difference	NOUN
aiua-10305	76	17	in	in	ADP
aiua-10305	76	18	sexual	sexual	ADJ
aiua-10305	76	19	dysfunction	dysfunction	NOUN
aiua-10305	76	20	between	between	ADP
aiua-10305	76	21	treatment	treatment	NOUN
aiua-10305	76	22	with	with	ADP
aiua-10305	76	23	serenoa	serenoa	ADJ
aiua-10305	76	24	repens	repen	NOUN
aiua-10305	76	25	and	and	CCONJ
aiua-10305	76	26	placebo	placebo	NOUN
aiua-10305	76	27	.	.	PUNCT
aiua-10305	77	1	figure	figure	NOUN
aiua-10305	77	2	3	3	NUM
aiua-10305	77	3	.	.	PUNCT
aiua-10305	78	1	statistical	statistical	ADJ
aiua-10305	78	2	analysis	analysis	NOUN
aiua-10305	78	3	:	:	PUNCT
aiua-10305	78	4	differences	difference	NOUN
aiua-10305	78	5	in	in	ADP
aiua-10305	78	6	the	the	DET
aiua-10305	78	7	msf-4	msf-4	ADJ
aiua-10305	78	8	test	test	NOUN
aiua-10305	78	9	scores	score	NOUN
aiua-10305	78	10	between	between	ADP
aiua-10305	78	11	treatment	treatment	NOUN
aiua-10305	78	12	with	with	ADP
aiua-10305	78	13	serenoa	serenoa	ADJ
aiua-10305	78	14	repens	repen	NOUN
aiua-10305	78	15	and	and	CCONJ
aiua-10305	78	16	tamsulosin	tamsulosin	NOUN
aiua-10305	78	17	.	.	PUNCT
aiua-10305	79	1	figure	figure	NOUN
aiua-10305	79	2	4	4	NUM
aiua-10305	79	3	.	.	PUNCT
aiua-10305	80	1	statistical	statistical	ADJ
aiua-10305	80	2	analysis	analysis	NOUN
aiua-10305	80	3	:	:	PUNCT
aiua-10305	80	4	ejaculatory	ejaculatory	ADJ
aiua-10305	80	5	disorders	disorder	NOUN
aiua-10305	80	6	after	after	ADP
aiua-10305	80	7	treatment	treatment	NOUN
aiua-10305	80	8	with	with	ADP
aiua-10305	80	9	serenoa	serenoa	ADJ
aiua-10305	80	10	repens	repen	NOUN
aiua-10305	80	11	and	and	CCONJ
aiua-10305	80	12	tamsulosin	tamsulosin	NOUN
aiua-10305	80	13	.	.	PUNCT
aiua-10305	81	1	archivio	archivio	NOUN
aiua-10305	81	2	italiano	italiano	PROPN
aiua-10305	81	3	di	di	X
aiua-10305	81	4	urologia	urologia	PROPN
aiua-10305	81	5	e	e	PROPN
aiua-10305	81	6	andrologia	andrologia	NOUN
aiua-10305	81	7	2021	2021	NUM
aiua-10305	81	8	;	;	PUNCT
aiua-10305	81	9	93	93	NUM
aiua-10305	81	10	,	,	PUNCT
aiua-10305	81	11	4	4	NUM
aiua-10305	81	12	g.	g.	NOUN
aiua-10305	81	13	paulis	paulis	PROPN
aiua-10305	81	14	,	,	PUNCT
aiua-10305	81	15	a.	a.	NOUN
aiua-10305	81	16	paulis	paulis	PROPN
aiua-10305	81	17	,	,	PUNCT
aiua-10305	81	18	g.	g.	PROPN
aiua-10305	81	19	perletti	perletti	PROPN
aiua-10305	81	20	478	478	NUM
aiua-10305	81	21	effects	effect	NOUN
aiua-10305	81	22	on	on	ADP
aiua-10305	81	23	male	male	ADJ
aiua-10305	81	24	sexual	sexual	ADJ
aiua-10305	81	25	function	function	NOUN
aiua-10305	81	26	.	.	PUNCT
aiua-10305	82	1	such	such	ADJ
aiua-10305	82	2	view	view	NOUN
aiua-10305	82	3	is	be	AUX
aiua-10305	82	4	supported	support	VERB
aiua-10305	82	5	by	by	ADP
aiua-10305	82	6	two	two	NUM
aiua-10305	82	7	studies	study	NOUN
aiua-10305	82	8	(	(	PUNCT
aiua-10305	82	9	marks	mark	NOUN
aiua-10305	82	10	et	et	NOUN
aiua-10305	82	11	al	al	PROPN
aiua-10305	82	12	.	.	PROPN
aiua-10305	82	13	,	,	PUNCT
aiua-10305	82	14	2000	2000	NUM
aiua-10305	82	15	;	;	PUNCT
aiua-10305	82	16	pytel	pytel	NOUN
aiua-10305	82	17	et	et	PROPN
aiua-10305	82	18	al	al	PROPN
aiua-10305	82	19	.	.	PROPN
aiua-10305	82	20	,	,	PUNCT
aiua-10305	82	21	2002	2002	NUM
aiua-10305	82	22	)	)	PUNCT
aiua-10305	82	23	which	which	PRON
aiua-10305	82	24	did	do	AUX
aiua-10305	82	25	not	not	PART
aiua-10305	82	26	detect	detect	VERB
aiua-10305	82	27	a	a	DET
aiua-10305	82	28	reduction	reduction	NOUN
aiua-10305	82	29	in	in	ADP
aiua-10305	82	30	the	the	DET
aiua-10305	82	31	serum	serum	NOUN
aiua-10305	82	32	levels	level	NOUN
aiua-10305	82	33	of	of	ADP
aiua-10305	82	34	male	male	ADJ
aiua-10305	82	35	sex	sex	NOUN
aiua-10305	82	36	hormones	hormone	NOUN
aiua-10305	82	37	(	(	PUNCT
aiua-10305	82	38	testosterone	testosterone	NOUN
aiua-10305	82	39	,	,	PUNCT
aiua-10305	82	40	dihydrotestosterone	dihydrotestosterone	NOUN
aiua-10305	82	41	)	)	PUNCT
aiua-10305	82	42	after	after	ADP
aiua-10305	82	43	treatment	treatment	NOUN
aiua-10305	82	44	with	with	ADP
aiua-10305	82	45	sr	sr	PROPN
aiua-10305	82	46	(	(	PUNCT
aiua-10305	82	47	38	38	NUM
aiua-10305	82	48	,	,	PUNCT
aiua-10305	82	49	39	39	NUM
aiua-10305	82	50	)	)	PUNCT
aiua-10305	82	51	.	.	PUNCT
aiua-10305	83	1	the	the	DET
aiua-10305	83	2	results	result	NOUN
aiua-10305	83	3	of	of	ADP
aiua-10305	83	4	our	our	PRON
aiua-10305	83	5	meta	meta	ADJ
aiua-10305	83	6	-	-	PUNCT
aiua-10305	83	7	analysis	analysis	NOUN
aiua-10305	83	8	are	be	AUX
aiua-10305	83	9	similar	similar	ADJ
aiua-10305	83	10	to	to	ADP
aiua-10305	83	11	those	those	PRON
aiua-10305	83	12	of	of	ADP
aiua-10305	83	13	other	other	ADJ
aiua-10305	83	14	authoritative	authoritative	ADJ
aiua-10305	83	15	systematic	systematic	ADJ
aiua-10305	83	16	reviews	review	NOUN
aiua-10305	83	17	,	,	PUNCT
aiua-10305	83	18	where	where	SCONJ
aiua-10305	83	19	sr	sr	PROPN
aiua-10305	83	20	was	be	AUX
aiua-10305	83	21	proved	prove	VERB
aiua-10305	83	22	to	to	PART
aiua-10305	83	23	have	have	VERB
aiua-10305	83	24	no	no	DET
aiua-10305	83	25	negative	negative	ADJ
aiua-10305	83	26	impact	impact	NOUN
aiua-10305	83	27	on	on	ADP
aiua-10305	83	28	male	male	ADJ
aiua-10305	83	29	sexual	sexual	ADJ
aiua-10305	83	30	function	function	NOUN
aiua-10305	83	31	(	(	PUNCT
aiua-10305	83	32	40	40	NUM
aiua-10305	83	33	-	-	SYM
aiua-10305	83	34	42	42	NUM
aiua-10305	83	35	)	)	PUNCT
aiua-10305	83	36	.	.	PUNCT
aiua-10305	84	1	it	it	PRON
aiua-10305	84	2	should	should	AUX
aiua-10305	84	3	furthermore	furthermore	ADV
aiua-10305	84	4	be	be	AUX
aiua-10305	84	5	evaluated	evaluate	VERB
aiua-10305	84	6	whether	whether	SCONJ
aiua-10305	84	7	the	the	DET
aiua-10305	84	8	negative	negative	ADJ
aiua-10305	84	9	effect	effect	NOUN
aiua-10305	84	10	of	of	ADP
aiua-10305	84	11	sr	sr	PROPN
aiua-10305	84	12	on	on	ADP
aiua-10305	84	13	male	male	ADJ
aiua-10305	84	14	sexuality	sexuality	NOUN
aiua-10305	84	15	reported	report	VERB
aiua-10305	84	16	by	by	ADP
aiua-10305	84	17	a	a	DET
aiua-10305	84	18	number	number	NOUN
aiua-10305	84	19	of	of	ADP
aiua-10305	84	20	patients	patient	NOUN
aiua-10305	84	21	both	both	CCONJ
aiua-10305	84	22	in	in	ADP
aiua-10305	84	23	our	our	PRON
aiua-10305	84	24	clinics	clinic	NOUN
aiua-10305	84	25	and	and	CCONJ
aiua-10305	84	26	on	on	ADP
aiua-10305	84	27	internet	internet	NOUN
aiua-10305	84	28	forums	forum	NOUN
aiua-10305	84	29	may	may	AUX
aiua-10305	84	30	be	be	AUX
aiua-10305	84	31	generated	generate	VERB
aiua-10305	84	32	by	by	ADP
aiua-10305	84	33	neuropsychological	neuropsychological	ADJ
aiua-10305	84	34	mechanisms	mechanism	NOUN
aiua-10305	84	35	.	.	PUNCT
aiua-10305	85	1	this	this	PRON
aiua-10305	85	2	is	be	AUX
aiua-10305	85	3	where	where	SCONJ
aiua-10305	85	4	the	the	DET
aiua-10305	85	5	concept	concept	NOUN
aiua-10305	85	6	of	of	ADP
aiua-10305	85	7	nocebo	nocebo	NOUN
aiua-10305	85	8	comes	come	VERB
aiua-10305	85	9	in	in	ADP
aiua-10305	85	10	.	.	PUNCT
aiua-10305	86	1	a	a	DET
aiua-10305	86	2	nocebo	nocebo	NOUN
aiua-10305	86	3	effect	effect	NOUN
aiua-10305	86	4	is	be	AUX
aiua-10305	86	5	generated	generate	VERB
aiua-10305	86	6	when	when	SCONJ
aiua-10305	86	7	a	a	DET
aiua-10305	86	8	patient	patient	NOUN
aiua-10305	86	9	’s	’s	PART
aiua-10305	86	10	beliefs	belief	NOUN
aiua-10305	86	11	and	and	CCONJ
aiua-10305	86	12	negative	negative	ADJ
aiua-10305	86	13	expectations	expectation	NOUN
aiua-10305	86	14	cause	cause	VERB
aiua-10305	86	15	a	a	DET
aiua-10305	86	16	worsening	worsening	NOUN
aiua-10305	86	17	of	of	ADP
aiua-10305	86	18	the	the	DET
aiua-10305	86	19	individual	individual	NOUN
aiua-10305	86	20	’s	’s	PART
aiua-10305	86	21	health	health	NOUN
aiua-10305	86	22	status	status	NOUN
aiua-10305	86	23	(	(	PUNCT
aiua-10305	86	24	22	22	NUM
aiua-10305	86	25	)	)	PUNCT
aiua-10305	86	26	.	.	PUNCT
aiua-10305	87	1	the	the	DET
aiua-10305	87	2	psychological	psychological	ADJ
aiua-10305	87	3	mechanisms	mechanism	NOUN
aiua-10305	87	4	underlying	underlie	VERB
aiua-10305	87	5	this	this	DET
aiua-10305	87	6	pesky	pesky	ADJ
aiua-10305	87	7	effect	effect	NOUN
aiua-10305	87	8	seem	seem	VERB
aiua-10305	87	9	to	to	PART
aiua-10305	87	10	include	include	VERB
aiua-10305	87	11	negative	negative	ADJ
aiua-10305	87	12	expectations	expectation	NOUN
aiua-10305	87	13	concerning	concern	VERB
aiua-10305	87	14	treatment	treatment	NOUN
aiua-10305	87	15	,	,	PUNCT
aiua-10305	87	16	high	high	ADJ
aiua-10305	87	17	levels	level	NOUN
aiua-10305	87	18	of	of	ADP
aiua-10305	87	19	anxiety	anxiety	NOUN
aiua-10305	87	20	,	,	PUNCT
aiua-10305	87	21	and	and	CCONJ
aiua-10305	87	22	classic	classic	ADJ
aiua-10305	87	23	conditioning	conditioning	NOUN
aiua-10305	87	24	(	(	PUNCT
aiua-10305	87	25	43	43	NUM
aiua-10305	87	26	)	)	PUNCT
aiua-10305	87	27	.	.	PUNCT
aiua-10305	88	1	a	a	DET
aiua-10305	88	2	study	study	NOUN
aiua-10305	88	3	by	by	ADP
aiua-10305	88	4	mondaini	mondaini	PROPN
aiua-10305	88	5	et	et	PROPN
aiua-10305	88	6	al	al	PROPN
aiua-10305	88	7	.	.	PUNCT
aiua-10305	88	8	(	(	PUNCT
aiua-10305	88	9	2007	2007	NUM
aiua-10305	88	10	)	)	PUNCT
aiua-10305	88	11	provides	provide	VERB
aiua-10305	88	12	a	a	DET
aiua-10305	88	13	very	very	ADV
aiua-10305	88	14	interesting	interesting	ADJ
aiua-10305	88	15	analysis	analysis	NOUN
aiua-10305	88	16	of	of	ADP
aiua-10305	88	17	the	the	DET
aiua-10305	88	18	causal	causal	ADJ
aiua-10305	88	19	role	role	NOUN
aiua-10305	88	20	of	of	ADP
aiua-10305	88	21	“	"	PUNCT
aiua-10305	88	22	negative	negative	ADJ
aiua-10305	88	23	expectations	expectation	NOUN
aiua-10305	88	24	”	"	PUNCT
aiua-10305	88	25	on	on	ADP
aiua-10305	88	26	the	the	DET
aiua-10305	88	27	nocebo	nocebo	NOUN
aiua-10305	88	28	effect	effect	NOUN
aiua-10305	88	29	,	,	PUNCT
aiua-10305	88	30	after	after	SCONJ
aiua-10305	88	31	patient	patient	NOUN
aiua-10305	88	32	have	have	AUX
aiua-10305	88	33	been	be	AUX
aiua-10305	88	34	informed	inform	VERB
aiua-10305	88	35	of	of	ADP
aiua-10305	88	36	the	the	DET
aiua-10305	88	37	possible	possible	ADJ
aiua-10305	88	38	side	side	NOUN
aiua-10305	88	39	effects	effect	NOUN
aiua-10305	88	40	of	of	ADP
aiua-10305	88	41	a	a	DET
aiua-10305	88	42	therapeutic	therapeutic	ADJ
aiua-10305	88	43	substance	substance	NOUN
aiua-10305	88	44	(	(	PUNCT
aiua-10305	88	45	44	44	NUM
aiua-10305	88	46	)	)	PUNCT
aiua-10305	88	47	.	.	PUNCT
aiua-10305	89	1	in	in	ADP
aiua-10305	89	2	this	this	DET
aiua-10305	89	3	study	study	NOUN
aiua-10305	89	4	,	,	PUNCT
aiua-10305	89	5	which	which	PRON
aiua-10305	89	6	included	include	VERB
aiua-10305	89	7	107	107	NUM
aiua-10305	89	8	patients	patient	NOUN
aiua-10305	89	9	suffering	suffer	VERB
aiua-10305	89	10	from	from	ADP
aiua-10305	89	11	bph	bph	NOUN
aiua-10305	89	12	,	,	PUNCT
aiua-10305	89	13	two	two	NUM
aiua-10305	89	14	treatment	treatment	NOUN
aiua-10305	89	15	groups	group	NOUN
aiua-10305	89	16	were	be	AUX
aiua-10305	89	17	created	create	VERB
aiua-10305	89	18	,	,	PUNCT
aiua-10305	89	19	with	with	ADP
aiua-10305	89	20	finasteride	finasteride	ADJ
aiua-10305	89	21	5	5	NUM
aiua-10305	89	22	mg	mg	NUM
aiua-10305	89	23	/	/	SYM
aiua-10305	89	24	day	day	NOUN
aiua-10305	89	25	and	and	CCONJ
aiua-10305	89	26	a	a	DET
aiua-10305	89	27	treatment	treatment	NOUN
aiua-10305	89	28	length	length	NOUN
aiua-10305	89	29	of	of	ADP
aiua-10305	89	30	12	12	NUM
aiua-10305	89	31	months	month	NOUN
aiua-10305	89	32	.	.	PUNCT
aiua-10305	90	1	patients	patient	NOUN
aiua-10305	90	2	of	of	ADP
aiua-10305	90	3	group	group	NOUN
aiua-10305	90	4	1	1	NUM
aiua-10305	90	5	(	(	PUNCT
aiua-10305	90	6	52	52	NUM
aiua-10305	90	7	patients	patient	NOUN
aiua-10305	90	8	)	)	PUNCT
aiua-10305	90	9	were	be	AUX
aiua-10305	90	10	also	also	ADV
aiua-10305	90	11	not	not	PART
aiua-10305	90	12	informed	inform	VERB
aiua-10305	90	13	of	of	ADP
aiua-10305	90	14	the	the	DET
aiua-10305	90	15	risk	risk	NOUN
aiua-10305	90	16	of	of	ADP
aiua-10305	90	17	side	side	NOUN
aiua-10305	90	18	effects	effect	NOUN
aiua-10305	90	19	on	on	ADP
aiua-10305	90	20	their	their	PRON
aiua-10305	90	21	sexuality	sexuality	NOUN
aiua-10305	90	22	;	;	PUNCT
aiua-10305	90	23	patients	patient	NOUN
aiua-10305	90	24	of	of	ADP
aiua-10305	90	25	group	group	NOUN
aiua-10305	90	26	2	2	NUM
aiua-10305	90	27	,	,	PUNCT
aiua-10305	90	28	instead	instead	ADV
aiua-10305	90	29	,	,	PUNCT
aiua-10305	90	30	were	be	AUX
aiua-10305	90	31	told	tell	VERB
aiua-10305	90	32	of	of	ADP
aiua-10305	90	33	the	the	DET
aiua-10305	90	34	possible	possible	ADJ
aiua-10305	90	35	–	–	PUNCT
aiua-10305	90	36	albeit	albeit	SCONJ
aiua-10305	90	37	rare	rare	ADJ
aiua-10305	90	38	–	–	PUNCT
aiua-10305	90	39	onset	onset	NOUN
aiua-10305	90	40	of	of	ADP
aiua-10305	90	41	sexual	sexual	ADJ
aiua-10305	90	42	problems	problem	NOUN
aiua-10305	90	43	such	such	ADJ
aiua-10305	90	44	as	as	ADP
aiua-10305	90	45	erectile	erectile	ADJ
aiua-10305	90	46	dysfunction	dysfunction	NOUN
aiua-10305	90	47	(	(	PUNCT
aiua-10305	90	48	ed	ed	NOUN
aiua-10305	90	49	)	)	PUNCT
aiua-10305	90	50	,	,	PUNCT
aiua-10305	90	51	decreased	decrease	VERB
aiua-10305	90	52	libido	libido	NOUN
aiua-10305	90	53	,	,	PUNCT
aiua-10305	90	54	and	and	CCONJ
aiua-10305	90	55	ejaculation	ejaculation	NOUN
aiua-10305	90	56	disorders	disorder	NOUN
aiua-10305	90	57	.	.	PUNCT
aiua-10305	91	1	the	the	DET
aiua-10305	91	2	results	result	NOUN
aiua-10305	91	3	,	,	PUNCT
aiua-10305	91	4	after	after	ADP
aiua-10305	91	5	treatment	treatment	NOUN
aiua-10305	91	6	with	with	ADP
aiua-10305	91	7	finasteride	finasteride	ADJ
aiua-10305	91	8	5	5	NUM
aiua-10305	91	9	mg	mg	NUM
aiua-10305	91	10	/	/	SYM
aiua-10305	91	11	day	day	NOUN
aiua-10305	91	12	for	for	ADP
aiua-10305	91	13	12	12	NUM
aiua-10305	91	14	months	month	NOUN
aiua-10305	91	15	,	,	PUNCT
aiua-10305	91	16	were	be	AUX
aiua-10305	91	17	the	the	DET
aiua-10305	91	18	following	following	NOUN
aiua-10305	91	19	:	:	PUNCT
aiua-10305	91	20	group	group	NOUN
aiua-10305	91	21	1	1	NUM
aiua-10305	91	22	,	,	PUNCT
aiua-10305	91	23	adverse	adverse	ADJ
aiua-10305	91	24	sexual	sexual	ADJ
aiua-10305	91	25	side	side	NOUN
aiua-10305	91	26	effects	effect	NOUN
aiua-10305	91	27	15.3	15.3	NUM
aiua-10305	91	28	%	%	NOUN
aiua-10305	91	29	(	(	PUNCT
aiua-10305	91	30	ed	ed	NOUN
aiua-10305	91	31	9.6	9.6	NUM
aiua-10305	91	32	%	%	NOUN
aiua-10305	91	33	,	,	PUNCT
aiua-10305	91	34	decreased	decrease	VERB
aiua-10305	91	35	libido	libido	ADJ
aiua-10305	91	36	7.7	7.7	NUM
aiua-10305	91	37	%	%	NOUN
aiua-10305	91	38	,	,	PUNCT
aiua-10305	91	39	ejaculation	ejaculation	NOUN
aiua-10305	91	40	disorders	disorder	NOUN
aiua-10305	91	41	5.7	5.7	NUM
aiua-10305	91	42	%	%	NOUN
aiua-10305	91	43	)	)	PUNCT
aiua-10305	91	44	;	;	PUNCT
aiua-10305	91	45	group	group	NOUN
aiua-10305	91	46	2	2	NUM
aiua-10305	91	47	,	,	PUNCT
aiua-10305	91	48	adverse	adverse	ADJ
aiua-10305	91	49	sexual	sexual	ADJ
aiua-10305	91	50	side	side	NOUN
aiua-10305	91	51	effects	effect	NOUN
aiua-10305	91	52	43.6	43.6	NUM
aiua-10305	91	53	%	%	NOUN
aiua-10305	91	54	(	(	PUNCT
aiua-10305	91	55	ed	ed	NOUN
aiua-10305	91	56	30.9	30.9	NUM
aiua-10305	91	57	%	%	NOUN
aiua-10305	91	58	,	,	PUNCT
aiua-10305	91	59	decreased	decrease	VERB
aiua-10305	91	60	libido	libido	ADJ
aiua-10305	91	61	23.6	23.6	NUM
aiua-10305	91	62	%	%	NOUN
aiua-10305	91	63	,	,	PUNCT
aiua-10305	91	64	ejaculation	ejaculation	NOUN
aiua-10305	91	65	disorders	disorder	NOUN
aiua-10305	91	66	16.3	16.3	NUM
aiua-10305	91	67	%	%	NOUN
aiua-10305	91	68	)	)	PUNCT
aiua-10305	91	69	.	.	PUNCT
aiua-10305	92	1	the	the	DET
aiua-10305	92	2	significantly	significantly	ADV
aiua-10305	92	3	higher	high	ADJ
aiua-10305	92	4	rate	rate	NOUN
aiua-10305	92	5	of	of	ADP
aiua-10305	92	6	sexual	sexual	ADJ
aiua-10305	92	7	dysfunctions	dysfunction	NOUN
aiua-10305	92	8	in	in	ADP
aiua-10305	92	9	group	group	NOUN
aiua-10305	92	10	2	2	NUM
aiua-10305	92	11	compared	compare	VERB
aiua-10305	92	12	to	to	ADP
aiua-10305	92	13	group	group	NOUN
aiua-10305	92	14	1	1	NUM
aiua-10305	92	15	clearly	clearly	ADV
aiua-10305	92	16	proves	prove	VERB
aiua-10305	92	17	that	that	SCONJ
aiua-10305	92	18	the	the	DET
aiua-10305	92	19	nocebo	nocebo	NOUN
aiua-10305	92	20	effect	effect	NOUN
aiua-10305	92	21	had	have	VERB
aiua-10305	92	22	a	a	DET
aiua-10305	92	23	significant	significant	ADJ
aiua-10305	92	24	impact	impact	NOUN
aiua-10305	92	25	on	on	ADP
aiua-10305	92	26	the	the	DET
aiua-10305	92	27	greater	great	ADJ
aiua-10305	92	28	number	number	NOUN
aiua-10305	92	29	of	of	ADP
aiua-10305	92	30	occurrences	occurrence	NOUN
aiua-10305	92	31	of	of	ADP
aiua-10305	92	32	sexual	sexual	ADJ
aiua-10305	92	33	problems	problem	NOUN
aiua-10305	92	34	in	in	ADP
aiua-10305	92	35	the	the	DET
aiua-10305	92	36	patients	patient	NOUN
aiua-10305	92	37	of	of	ADP
aiua-10305	92	38	group	group	NOUN
aiua-10305	92	39	2	2	NUM
aiua-10305	92	40	(	(	PUNCT
aiua-10305	92	41	44	44	NUM
aiua-10305	92	42	)	)	PUNCT
aiua-10305	92	43	.	.	PUNCT
aiua-10305	93	1	it	it	PRON
aiua-10305	93	2	is	be	AUX
aiua-10305	93	3	possible	possible	ADJ
aiua-10305	93	4	that	that	SCONJ
aiua-10305	93	5	sr	sr	PROPN
aiua-10305	93	6	may	may	AUX
aiua-10305	93	7	also	also	ADV
aiua-10305	93	8	have	have	VERB
aiua-10305	93	9	a	a	DET
aiua-10305	93	10	"	"	PUNCT
aiua-10305	93	11	nocebo	nocebo	NOUN
aiua-10305	93	12	"	"	PUNCT
aiua-10305	93	13	effect	effect	NOUN
aiua-10305	93	14	and	and	CCONJ
aiua-10305	93	15	therefore	therefore	ADV
aiua-10305	93	16	negatively	negatively	ADV
aiua-10305	93	17	impact	impact	VERB
aiua-10305	93	18	the	the	DET
aiua-10305	93	19	health	health	NOUN
aiua-10305	93	20	of	of	ADP
aiua-10305	93	21	patients	patient	NOUN
aiua-10305	93	22	.	.	PUNCT
aiua-10305	94	1	conclusions	conclusion	NOUN
aiua-10305	94	2	based	base	VERB
aiua-10305	94	3	on	on	ADP
aiua-10305	94	4	the	the	DET
aiua-10305	94	5	results	result	NOUN
aiua-10305	94	6	of	of	ADP
aiua-10305	94	7	our	our	PRON
aiua-10305	94	8	review	review	NOUN
aiua-10305	94	9	,	,	PUNCT
aiua-10305	94	10	sr	sr	PROPN
aiua-10305	94	11	does	do	AUX
aiua-10305	94	12	not	not	PART
aiua-10305	94	13	appear	appear	VERB
aiua-10305	94	14	to	to	PART
aiua-10305	94	15	cause	cause	VERB
aiua-10305	94	16	negative	negative	ADJ
aiua-10305	94	17	effects	effect	NOUN
aiua-10305	94	18	on	on	ADP
aiua-10305	94	19	male	male	ADJ
aiua-10305	94	20	sexuality	sexuality	NOUN
aiua-10305	94	21	;	;	PUNCT
aiua-10305	94	22	should	should	AUX
aiua-10305	94	23	any	any	DET
aiua-10305	94	24	such	such	ADJ
aiua-10305	94	25	effects	effect	NOUN
aiua-10305	94	26	occur	occur	VERB
aiua-10305	94	27	,	,	PUNCT
aiua-10305	94	28	they	they	PRON
aiua-10305	94	29	may	may	AUX
aiua-10305	94	30	be	be	AUX
aiua-10305	94	31	ascribed	ascribe	VERB
aiua-10305	94	32	to	to	ADP
aiua-10305	94	33	a	a	DET
aiua-10305	94	34	nocebo	nocebo	NOUN
aiua-10305	94	35	effect	effect	NOUN
aiua-10305	94	36	.	.	PUNCT
aiua-10305	95	1	adequately	adequately	ADV
aiua-10305	95	2	powered	power	VERB
aiua-10305	95	3	studies	study	NOUN
aiua-10305	95	4	are	be	AUX
aiua-10305	95	5	needed	need	VERB
aiua-10305	95	6	to	to	PART
aiua-10305	95	7	confirm	confirm	VERB
aiua-10305	95	8	this	this	DET
aiua-10305	95	9	hypothesis	hypothesis	NOUN
aiua-10305	95	10	.	.	PUNCT
aiua-10305	96	1	in	in	ADP
aiua-10305	96	2	such	such	DET
aiua-10305	96	3	a	a	DET
aiua-10305	96	4	case	case	NOUN
aiua-10305	96	5	to	to	PART
aiua-10305	96	6	reduce	reduce	VERB
aiua-10305	96	7	the	the	DET
aiua-10305	96	8	likelihood	likelihood	NOUN
aiua-10305	96	9	of	of	ADP
aiua-10305	96	10	a	a	DET
aiua-10305	96	11	nocebo	nocebo	NOUN
aiua-10305	96	12	effect	effect	NOUN
aiua-10305	96	13	,	,	PUNCT
aiua-10305	96	14	when	when	SCONJ
aiua-10305	96	15	mentioning	mention	VERB
aiua-10305	96	16	possible	possible	ADJ
aiua-10305	96	17	side	side	NOUN
aiua-10305	96	18	effects	effect	NOUN
aiua-10305	96	19	during	during	ADP
aiua-10305	96	20	the	the	DET
aiua-10305	96	21	informed	informed	ADJ
aiua-10305	96	22	consent	consent	NOUN
aiua-10305	96	23	process	process	NOUN
aiua-10305	96	24	prior	prior	ADV
aiua-10305	96	25	to	to	ADP
aiua-10305	96	26	treatment	treatment	NOUN
aiua-10305	96	27	,	,	PUNCT
aiua-10305	96	28	it	it	PRON
aiua-10305	96	29	may	may	AUX
aiua-10305	96	30	be	be	AUX
aiua-10305	96	31	necessary	necessary	ADJ
aiua-10305	96	32	to	to	PART
aiua-10305	96	33	structure	structure	VERB
aiua-10305	96	34	the	the	DET
aiua-10305	96	35	information	information	NOUN
aiua-10305	96	36	to	to	ADP
aiua-10305	96	37	patients	patient	NOUN
aiua-10305	96	38	by	by	ADP
aiua-10305	96	39	avoiding	avoid	VERB
aiua-10305	96	40	the	the	DET
aiua-10305	96	41	classic	classic	ADJ
aiua-10305	96	42	“	"	PUNCT
aiua-10305	96	43	negative	negative	ADJ
aiua-10305	96	44	”	"	PUNCT
aiua-10305	96	45	narrative	narrative	NOUN
aiua-10305	96	46	frame	frame	NOUN
aiua-10305	96	47	(	(	PUNCT
aiua-10305	96	48	percentage	percentage	NOUN
aiua-10305	96	49	of	of	ADP
aiua-10305	96	50	possibility	possibility	NOUN
aiua-10305	96	51	of	of	ADP
aiua-10305	96	52	having	have	VERB
aiua-10305	96	53	a	a	DET
aiua-10305	96	54	specific	specific	ADJ
aiua-10305	96	55	side	side	NOUN
aiua-10305	96	56	effect	effect	NOUN
aiua-10305	96	57	)	)	PUNCT
aiua-10305	96	58	,	,	PUNCT
aiua-10305	96	59	employing	employ	VERB
aiua-10305	96	60	instead	instead	ADV
aiua-10305	96	61	a	a	DET
aiua-10305	96	62	“	"	PUNCT
aiua-10305	96	63	positive	positive	ADJ
aiua-10305	96	64	”	"	PUNCT
aiua-10305	96	65	approach	approach	NOUN
aiua-10305	96	66	,	,	PUNCT
aiua-10305	96	67	providing	provide	VERB
aiua-10305	96	68	information	information	NOUN
aiua-10305	96	69	about	about	ADP
aiua-10305	96	70	the	the	DET
aiua-10305	96	71	percentage	percentage	NOUN
aiua-10305	96	72	of	of	ADP
aiua-10305	96	73	patients	patient	NOUN
aiua-10305	96	74	who	who	PRON
aiua-10305	96	75	are	be	AUX
aiua-10305	96	76	likely	likely	ADJ
aiua-10305	96	77	not	not	PART
aiua-10305	96	78	to	to	PART
aiua-10305	96	79	experience	experience	VERB
aiua-10305	96	80	any	any	DET
aiua-10305	96	81	side	side	NOUN
aiua-10305	96	82	effects	effect	NOUN
aiua-10305	96	83	.	.	PUNCT
aiua-10305	97	1	a	a	DET
aiua-10305	97	2	more	more	ADV
aiua-10305	97	3	in	in	ADP
aiua-10305	97	4	-	-	PUNCT
aiua-10305	97	5	depth	depth	NOUN
aiua-10305	97	6	knowledge	knowledge	NOUN
aiua-10305	97	7	of	of	ADP
aiua-10305	97	8	the	the	DET
aiua-10305	97	9	mechanisms	mechanism	NOUN
aiua-10305	97	10	that	that	PRON
aiua-10305	97	11	cause	cause	VERB
aiua-10305	97	12	the	the	DET
aiua-10305	97	13	nocebo	nocebo	NOUN
aiua-10305	97	14	effect	effect	NOUN
aiua-10305	97	15	,	,	PUNCT
aiua-10305	97	16	will	will	AUX
aiua-10305	97	17	help	help	VERB
aiua-10305	97	18	to	to	PART
aiua-10305	97	19	minimize	minimize	VERB
aiua-10305	97	20	its	its	PRON
aiua-10305	97	21	impact	impact	NOUN
aiua-10305	97	22	in	in	ADP
aiua-10305	97	23	the	the	DET
aiua-10305	97	24	clinical	clinical	ADJ
aiua-10305	97	25	activity	activity	NOUN
aiua-10305	97	26	of	of	ADP
aiua-10305	97	27	general	general	ADJ
aiua-10305	97	28	practitioners	practitioner	NOUN
aiua-10305	97	29	and	and	CCONJ
aiua-10305	97	30	specialists	specialist	NOUN
aiua-10305	97	31	alike	alike	ADV
aiua-10305	97	32	.	.	PUNCT
aiua-10305	98	1	acknowledgments	acknowledgment	NOUN
aiua-10305	98	2	we	we	PRON
aiua-10305	98	3	thank	thank	VERB
aiua-10305	98	4	dr	dr	PROPN
aiua-10305	98	5	.	.	PROPN
aiua-10305	98	6	pasquale	pasquale	PROPN
aiua-10305	98	7	del	del	PROPN
aiua-10305	98	8	vecchio	vecchio	PROPN
aiua-10305	98	9	for	for	ADP
aiua-10305	98	10	bibliometric	bibliometric	ADJ
aiua-10305	98	11	and	and	CCONJ
aiua-10305	98	12	data	datum	NOUN
aiua-10305	98	13	management	management	NOUN
aiua-10305	98	14	analysis	analysis	NOUN
aiua-10305	98	15	.	.	PUNCT
aiua-10305	99	1	references	reference	NOUN
aiua-10305	99	2	1	1	NUM
aiua-10305	99	3	.	.	PUNCT
aiua-10305	99	4	bennet	bennet	PROPN
aiua-10305	99	5	bc	bc	PROPN
aiua-10305	99	6	,	,	PUNCT
aiua-10305	99	7	hicklin	hicklin	PROPN
aiua-10305	99	8	jr	jr	PROPN
aiua-10305	99	9	.	.	PROPN
aiua-10305	99	10	uses	use	NOUN
aiua-10305	99	11	of	of	ADP
aiua-10305	99	12	saw	see	VERB
aiua-10305	99	13	palmetto	palmetto	NOUN
aiua-10305	99	14	(	(	PUNCT
aiua-10305	99	15	serenoa	serenoa	PROPN
aiua-10305	99	16	repens	repen	NOUN
aiua-10305	99	17	,	,	PUNCT
aiua-10305	99	18	arecaceae	arecaceae	PROPN
aiua-10305	99	19	)	)	PUNCT
aiua-10305	99	20	in	in	ADP
aiua-10305	99	21	florida	florida	PROPN
aiua-10305	99	22	.	.	PUNCT
aiua-10305	100	1	economic	economic	ADJ
aiua-10305	100	2	botany	botany	NOUN
aiua-10305	100	3	.	.	PUNCT
aiua-10305	101	1	1998	1998	NUM
aiua-10305	101	2	;	;	PUNCT
aiua-10305	101	3	52:381	52:381	NUM
aiua-10305	101	4	-	-	SYM
aiua-10305	101	5	393	393	NUM
aiua-10305	101	6	.	.	PUNCT
aiua-10305	102	1	2	2	NUM
aiua-10305	102	2	.	.	X
aiua-10305	102	3	duborija	duborija	NOUN
aiua-10305	102	4	-	-	PUNCT
aiua-10305	102	5	kovacevic	kovacevic	PROPN
aiua-10305	102	6	n	n	CCONJ
aiua-10305	102	7	,	,	PUNCT
aiua-10305	102	8	jakovljevic	jakovljevic	ADJ
aiua-10305	102	9	v	v	NOUN
aiua-10305	102	10	,	,	PUNCT
aiua-10305	102	11	sabo	sabo	NOUN
aiua-10305	102	12	a	a	PRON
aiua-10305	102	13	,	,	PUNCT
aiua-10305	102	14	et	et	PROPN
aiua-10305	102	15	al	al	PROPN
aiua-10305	102	16	.	.	PUNCT
aiua-10305	102	17	tolerability	tolerability	NOUN
aiua-10305	102	18	table	table	NOUN
aiua-10305	102	19	1	1	NUM
aiua-10305	102	20	.	.	PUNCT
aiua-10305	103	1	summary	summary	NOUN
aiua-10305	103	2	of	of	ADP
aiua-10305	103	3	findings	finding	NOUN
aiua-10305	103	4	.	.	PUNCT
aiua-10305	104	1	serenoa	serenoa	ADJ
aiua-10305	104	2	repens	repen	NOUN
aiua-10305	104	3	compared	compare	VERB
aiua-10305	104	4	with	with	ADP
aiua-10305	104	5	placebo	placebo	NOUN
aiua-10305	104	6	or	or	CCONJ
aiua-10305	104	7	active	active	ADJ
aiua-10305	104	8	drug	drug	NOUN
aiua-10305	104	9	(	(	PUNCT
aiua-10305	104	10	tamsulosin	tamsulosin	NOUN
aiua-10305	104	11	)	)	PUNCT
aiua-10305	104	12	patient	patient	NOUN
aiua-10305	104	13	or	or	CCONJ
aiua-10305	104	14	population	population	NOUN
aiua-10305	104	15	:	:	PUNCT
aiua-10305	104	16	patients	patient	NOUN
aiua-10305	104	17	with	with	ADP
aiua-10305	104	18	benign	benign	ADJ
aiua-10305	104	19	prostatic	prostatic	ADJ
aiua-10305	104	20	hyperplasia	hyperplasia	NOUN
aiua-10305	104	21	settings	setting	NOUN
aiua-10305	104	22	:	:	PUNCT
aiua-10305	104	23	outpatient	outpatient	NOUN
aiua-10305	104	24	intervention	intervention	NOUN
aiua-10305	104	25	:	:	PUNCT
aiua-10305	104	26	serenoa	serenoa	ADJ
aiua-10305	104	27	repens	repen	NOUN
aiua-10305	104	28	extract	extract	VERB
aiua-10305	104	29	comparators	comparator	NOUN
aiua-10305	104	30	:	:	PUNCT
aiua-10305	104	31	placebo	placebo	NOUN
aiua-10305	104	32	or	or	CCONJ
aiua-10305	104	33	active	active	ADJ
aiua-10305	104	34	comparator	comparator	NOUN
aiua-10305	104	35	(	(	PUNCT
aiua-10305	104	36	alpha	alpha	NOUN
aiua-10305	104	37	adrenoceptor	adrenoceptor	PROPN
aiua-10305	104	38	blocker	blocker	NOUN
aiua-10305	104	39	)	)	PUNCT
aiua-10305	104	40	outcomes	outcome	VERB
aiua-10305	104	41	intervention	intervention	NOUN
aiua-10305	104	42	vs.	vs.	ADP
aiua-10305	104	43	number	number	NOUN
aiua-10305	104	44	of	of	ADP
aiua-10305	104	45	participants	participant	NOUN
aiua-10305	104	46	quality	quality	NOUN
aiua-10305	104	47	of	of	ADP
aiua-10305	104	48	the	the	DET
aiua-10305	104	49	evidence	evidence	NOUN
aiua-10305	104	50	comparator	comparator	NOUN
aiua-10305	104	51	results	result	NOUN
aiua-10305	104	52	(	(	PUNCT
aiua-10305	104	53	studies	study	NOUN
aiua-10305	104	54	)	)	PUNCT
aiua-10305	104	55	(	(	PUNCT
aiua-10305	104	56	grade	grade	NOUN
aiua-10305	104	57	)	)	PUNCT
aiua-10305	104	58	sexual	sexual	NOUN
aiua-10305	104	59	(	(	PUNCT
aiua-10305	104	60	dys)function	dys)function	PROPN
aiua-10305	104	61	,	,	PUNCT
aiua-10305	104	62	sd	sd	ADP
aiua-10305	104	63	units	unit	NOUN
aiua-10305	104	64	the	the	DET
aiua-10305	104	65	sexual	sexual	ADJ
aiua-10305	104	66	function	function	NOUN
aiua-10305	104	67	score	score	NOUN
aiua-10305	104	68	in	in	ADP
aiua-10305	104	69	the	the	DET
aiua-10305	104	70	serenoa	serenoa	PROPN
aiua-10305	104	71	repens	repen	NOUN
aiua-10305	104	72	922	922	NUM
aiua-10305	104	73	⊕⊕⊝⊝	⊕⊕⊝⊝	NOUN
aiua-10305	105	1	[	[	X
aiua-10305	105	2	assessed	assess	VERB
aiua-10305	105	3	using	use	VERB
aiua-10305	105	4	different	different	ADJ
aiua-10305	105	5	sexual	sexual	ADJ
aiua-10305	105	6	function	function	NOUN
aiua-10305	105	7	scales	scale	NOUN
aiua-10305	105	8	]	]	PUNCT
aiua-10305	105	9	groups	group	NOUN
aiua-10305	105	10	was	be	AUX
aiua-10305	105	11	on	on	ADP
aiua-10305	105	12	average	average	ADJ
aiua-10305	105	13	0.43	0.43	NUM
aiua-10305	105	14	sds	sds	NOUN
aiua-10305	105	15	(	(	PUNCT
aiua-10305	105	16	95	95	NUM
aiua-10305	105	17	%	%	NOUN
aiua-10305	105	18	ci	ci	NOUN
aiua-10305	105	19	:	:	PUNCT
aiua-10305	105	20	-0.18	-0.18	NUM
aiua-10305	105	21	to	to	PART
aiua-10305	105	22	1.05	1.05	NUM
aiua-10305	105	23	)	)	PUNCT
aiua-10305	105	24	(	(	PUNCT
aiua-10305	105	25	5	5	X
aiua-10305	105	26	)	)	PUNCT
aiua-10305	105	27	low	low	ADV
aiua-10305	105	28	higher	high	ADJ
aiua-10305	105	29	than	than	ADP
aiua-10305	105	30	in	in	ADP
aiua-10305	105	31	the	the	DET
aiua-10305	105	32	placebo	placebo	NOUN
aiua-10305	105	33	groups	group	NOUN
aiua-10305	105	34	.	.	PUNCT
aiua-10305	106	1	reasons	reason	NOUN
aiua-10305	106	2	for	for	ADP
aiua-10305	106	3	downgrading	downgrade	VERB
aiua-10305	106	4	:	:	PUNCT
aiua-10305	106	5	–	–	PUNCT
aiua-10305	106	6	inconsistency	inconsistency	NOUN
aiua-10305	106	7	(	(	PUNCT
aiua-10305	106	8	considerable	considerable	ADJ
aiua-10305	106	9	heterogeneity	heterogeneity	NOUN
aiua-10305	106	10	)	)	PUNCT
aiua-10305	106	11	–	–	PUNCT
aiua-10305	106	12	indirectness	indirectness	ADJ
aiua-10305	106	13	(	(	PUNCT
aiua-10305	106	14	subjectiveness	subjectiveness	NOUN
aiua-10305	106	15	)	)	PUNCT
aiua-10305	106	16	of	of	ADP
aiua-10305	106	17	evidences	evidence	NOUN
aiua-10305	106	18	sexual	sexual	ADJ
aiua-10305	106	19	(	(	PUNCT
aiua-10305	106	20	dys)function	dys)function	PROPN
aiua-10305	106	21	,	,	PUNCT
aiua-10305	106	22	sd	sd	ADP
aiua-10305	106	23	units	unit	NOUN
aiua-10305	106	24	the	the	DET
aiua-10305	106	25	score	score	NOUN
aiua-10305	106	26	of	of	ADP
aiua-10305	106	27	the	the	DET
aiua-10305	106	28	msf-4	msf-4	ADJ
aiua-10305	106	29	test	test	NOUN
aiua-10305	106	30	in	in	ADP
aiua-10305	106	31	the	the	DET
aiua-10305	106	32	826	826	NUM
aiua-10305	106	33	⊕⊕⊝⊝	⊕⊕⊝⊝	NOUN
aiua-10305	106	34	[	[	X
aiua-10305	106	35	assessed	assess	VERB
aiua-10305	106	36	using	use	VERB
aiua-10305	106	37	the	the	DET
aiua-10305	106	38	male	male	ADJ
aiua-10305	106	39	sexual	sexual	ADJ
aiua-10305	106	40	function	function	NOUN
aiua-10305	106	41	4	4	NUM
aiua-10305	106	42	-	-	PUNCT
aiua-10305	106	43	items	item	NOUN
aiua-10305	106	44	test	test	NOUN
aiua-10305	106	45	]	]	PUNCT
aiua-10305	106	46	tamsulosin	tamsulosin	NOUN
aiua-10305	106	47	groups	group	NOUN
aiua-10305	106	48	was	be	AUX
aiua-10305	106	49	on	on	ADP
aiua-10305	106	50	average	average	ADJ
aiua-10305	106	51	(	(	PUNCT
aiua-10305	106	52	3	3	NUM
aiua-10305	106	53	)	)	PUNCT
aiua-10305	106	54	low	low	ADJ
aiua-10305	106	55	0.31	0.31	NUM
aiua-10305	106	56	sds	sds	NOUN
aiua-10305	106	57	(	(	PUNCT
aiua-10305	106	58	95	95	NUM
aiua-10305	106	59	%	%	NOUN
aiua-10305	106	60	ci	ci	NOUN
aiua-10305	106	61	:	:	PUNCT
aiua-10305	106	62	-0.82	-0.82	PUNCT
aiua-10305	106	63	to	to	ADP
aiua-10305	106	64	0.19	0.19	NUM
aiua-10305	106	65	)	)	PUNCT
aiua-10305	106	66	reasons	reason	NOUN
aiua-10305	106	67	for	for	ADP
aiua-10305	106	68	downgrading	downgrading	NOUN
aiua-10305	106	69	:	:	PUNCT
aiua-10305	106	70	lower	low	ADJ
aiua-10305	106	71	than	than	ADP
aiua-10305	106	72	in	in	ADP
aiua-10305	106	73	the	the	DET
aiua-10305	106	74	serenoa	serenoa	ADJ
aiua-10305	106	75	repens	repen	NOUN
aiua-10305	106	76	groups	group	NOUN
aiua-10305	106	77	.	.	PUNCT
aiua-10305	107	1	–	–	PUNCT
aiua-10305	107	2	inconsistency	inconsistency	NOUN
aiua-10305	107	3	(	(	PUNCT
aiua-10305	107	4	considerable	considerable	ADJ
aiua-10305	107	5	heterogeneity	heterogeneity	NOUN
aiua-10305	107	6	)	)	PUNCT
aiua-10305	107	7	–	–	PUNCT
aiua-10305	107	8	indirectness	indirectness	ADJ
aiua-10305	107	9	(	(	PUNCT
aiua-10305	107	10	subjectiveness	subjectiveness	NOUN
aiua-10305	107	11	)	)	PUNCT
aiua-10305	107	12	of	of	ADP
aiua-10305	107	13	evidence	evidence	NOUN
aiua-10305	107	14	sd	sd	ADP
aiua-10305	107	15	:	:	PUNCT
aiua-10305	107	16	standard	standard	ADJ
aiua-10305	107	17	deviation	deviation	NOUN
aiua-10305	107	18	;	;	PUNCT
aiua-10305	107	19	ci	ci	NOUN
aiua-10305	107	20	:	:	PUNCT
aiua-10305	107	21	confidence	confidence	NOUN
aiua-10305	107	22	interval	interval	NOUN
aiua-10305	107	23	;	;	PUNCT
aiua-10305	107	24	msf-4	msf-4	NUM
aiua-10305	107	25	:	:	PUNCT
aiua-10305	107	26	male	male	ADJ
aiua-10305	107	27	sexual	sexual	ADJ
aiua-10305	107	28	function	function	NOUN
aiua-10305	107	29	4	4	NUM
aiua-10305	107	30	-	-	PUNCT
aiua-10305	107	31	items	item	NOUN
aiua-10305	107	32	test	test	NOUN
aiua-10305	107	33	.	.	PUNCT
aiua-10305	108	1	grade	grade	NOUN
aiua-10305	108	2	working	working	NOUN
aiua-10305	108	3	group	group	NOUN
aiua-10305	108	4	grades	grade	NOUN
aiua-10305	108	5	of	of	ADP
aiua-10305	108	6	evidence	evidence	NOUN
aiua-10305	108	7	.	.	PUNCT
aiua-10305	109	1	high	high	ADJ
aiua-10305	109	2	quality	quality	NOUN
aiua-10305	109	3	:	:	PUNCT
aiua-10305	109	4	further	further	ADJ
aiua-10305	109	5	research	research	NOUN
aiua-10305	109	6	is	be	AUX
aiua-10305	109	7	very	very	ADV
aiua-10305	109	8	unlikely	unlikely	ADJ
aiua-10305	109	9	to	to	PART
aiua-10305	109	10	change	change	VERB
aiua-10305	109	11	our	our	PRON
aiua-10305	109	12	confidence	confidence	NOUN
aiua-10305	109	13	in	in	ADP
aiua-10305	109	14	the	the	DET
aiua-10305	109	15	estimate	estimate	NOUN
aiua-10305	109	16	of	of	ADP
aiua-10305	109	17	effect	effect	NOUN
aiua-10305	109	18	.	.	PUNCT
aiua-10305	110	1	moderate	moderate	ADJ
aiua-10305	110	2	quality	quality	NOUN
aiua-10305	110	3	:	:	PUNCT
aiua-10305	110	4	further	further	ADJ
aiua-10305	110	5	research	research	NOUN
aiua-10305	110	6	is	be	AUX
aiua-10305	110	7	likely	likely	ADJ
aiua-10305	110	8	to	to	PART
aiua-10305	110	9	have	have	VERB
aiua-10305	110	10	an	an	DET
aiua-10305	110	11	important	important	ADJ
aiua-10305	110	12	impact	impact	NOUN
aiua-10305	110	13	on	on	ADP
aiua-10305	110	14	our	our	PRON
aiua-10305	110	15	confidence	confidence	NOUN
aiua-10305	110	16	in	in	ADP
aiua-10305	110	17	the	the	DET
aiua-10305	110	18	estimate	estimate	NOUN
aiua-10305	110	19	of	of	ADP
aiua-10305	110	20	effect	effect	NOUN
aiua-10305	110	21	and	and	CCONJ
aiua-10305	110	22	may	may	AUX
aiua-10305	110	23	change	change	VERB
aiua-10305	110	24	the	the	DET
aiua-10305	110	25	estimate	estimate	NOUN
aiua-10305	110	26	.	.	PUNCT
aiua-10305	111	1	low	low	ADJ
aiua-10305	111	2	quality	quality	NOUN
aiua-10305	111	3	:	:	PUNCT
aiua-10305	111	4	further	further	ADJ
aiua-10305	111	5	research	research	NOUN
aiua-10305	111	6	is	be	AUX
aiua-10305	111	7	very	very	ADV
aiua-10305	111	8	likely	likely	ADJ
aiua-10305	111	9	to	to	PART
aiua-10305	111	10	have	have	VERB
aiua-10305	111	11	an	an	DET
aiua-10305	111	12	important	important	ADJ
aiua-10305	111	13	impact	impact	NOUN
aiua-10305	111	14	on	on	ADP
aiua-10305	111	15	our	our	PRON
aiua-10305	111	16	confidence	confidence	NOUN
aiua-10305	111	17	in	in	ADP
aiua-10305	111	18	the	the	DET
aiua-10305	111	19	estimate	estimate	NOUN
aiua-10305	111	20	of	of	ADP
aiua-10305	111	21	effect	effect	NOUN
aiua-10305	111	22	and	and	CCONJ
aiua-10305	111	23	is	be	AUX
aiua-10305	111	24	likely	likely	ADJ
aiua-10305	111	25	to	to	PART
aiua-10305	111	26	change	change	VERB
aiua-10305	111	27	the	the	DET
aiua-10305	111	28	estimate	estimate	NOUN
aiua-10305	111	29	.	.	PUNCT
aiua-10305	112	1	very	very	ADV
aiua-10305	112	2	low	low	ADJ
aiua-10305	112	3	quality	quality	NOUN
aiua-10305	112	4	:	:	PUNCT
aiua-10305	112	5	we	we	PRON
aiua-10305	112	6	are	be	AUX
aiua-10305	112	7	very	very	ADV
aiua-10305	112	8	uncertain	uncertain	ADJ
aiua-10305	112	9	about	about	ADP
aiua-10305	112	10	the	the	DET
aiua-10305	112	11	estimate	estimate	NOUN
aiua-10305	112	12	.	.	PUNCT
aiua-10305	113	1	479archivio	479archivio	PROPN
aiua-10305	113	2	italiano	italiano	NOUN
aiua-10305	113	3	di	di	X
aiua-10305	113	4	urologia	urologia	PROPN
aiua-10305	113	5	e	e	PROPN
aiua-10305	113	6	andrologia	andrologia	NOUN
aiua-10305	113	7	2021	2021	NUM
aiua-10305	113	8	;	;	PUNCT
aiua-10305	113	9	93	93	NUM
aiua-10305	113	10	,	,	PUNCT
aiua-10305	113	11	4	4	NUM
aiua-10305	113	12	serenoa	serenoa	ADJ
aiua-10305	113	13	repens	repen	NOUN
aiua-10305	113	14	and	and	CCONJ
aiua-10305	113	15	sexual	sexual	ADJ
aiua-10305	113	16	function	function	NOUN
aiua-10305	113	17	and	and	CCONJ
aiua-10305	113	18	toxicity	toxicity	NOUN
aiua-10305	113	19	of	of	ADP
aiua-10305	113	20	lipidosterolic	lipidosterolic	ADJ
aiua-10305	113	21	extract	extract	NOUN
aiua-10305	113	22	of	of	ADP
aiua-10305	113	23	american	american	ADJ
aiua-10305	113	24	dwarf	dwarf	PROPN
aiua-10305	113	25	palm	palm	PROPN
aiua-10305	113	26	serenoa	serenoa	PROPN
aiua-10305	113	27	repens	repen	NOUN
aiua-10305	113	28	in	in	ADP
aiua-10305	113	29	wistar	wistar	PROPN
aiua-10305	113	30	rats	rat	NOUN
aiua-10305	113	31	:	:	PUNCT
aiua-10305	113	32	well	well	ADV
aiua-10305	113	33	-	-	PUNCT
aiua-10305	113	34	known	know	VERB
aiua-10305	113	35	extract	extract	NOUN
aiua-10305	113	36	,	,	PUNCT
aiua-10305	113	37	new	new	ADJ
aiua-10305	113	38	insight	insight	NOUN
aiua-10305	113	39	.	.	PUNCT
aiua-10305	114	1	eur	eur	PROPN
aiua-10305	114	2	rev	rev	PROPN
aiua-10305	114	3	med	med	PROPN
aiua-10305	114	4	pharmacol	pharmacol	PROPN
aiua-10305	114	5	sci	sci	PROPN
aiua-10305	114	6	.	.	PROPN
aiua-10305	114	7	2011	2011	NUM
aiua-10305	114	8	;	;	PUNCT
aiua-10305	114	9	15:1311	15:1311	NUM
aiua-10305	114	10	-	-	SYM
aiua-10305	114	11	1317	1317	NUM
aiua-10305	114	12	.	.	PUNCT
aiua-10305	115	1	3	3	X
aiua-10305	115	2	.	.	X
aiua-10305	115	3	bayne	bayne	PROPN
aiua-10305	115	4	cw	cw	PROPN
aiua-10305	115	5	,	,	PUNCT
aiua-10305	115	6	donnelly	donnelly	PROPN
aiua-10305	115	7	f	f	PROPN
aiua-10305	115	8	,	,	PUNCT
aiua-10305	115	9	ross	ross	PROPN
aiua-10305	115	10	m	m	PROPN
aiua-10305	115	11	,	,	PUNCT
aiua-10305	115	12	et	et	PROPN
aiua-10305	115	13	al	al	PROPN
aiua-10305	115	14	.	.	PROPN
aiua-10305	116	1	serenoa	serenoa	PROPN
aiua-10305	116	2	repens	repen	NOUN
aiua-10305	116	3	(	(	PUNCT
aiua-10305	116	4	permixon	permixon	ADJ
aiua-10305	116	5	®	®	NOUN
aiua-10305	116	6	):	):	PUNCT
aiua-10305	116	7	a	a	DET
aiua-10305	116	8	5areductase	5areductase	NUM
aiua-10305	116	9	types	type	NOUN
aiua-10305	116	10	i	i	PRON
aiua-10305	116	11	and	and	CCONJ
aiua-10305	116	12	ii	ii	NOUN
aiua-10305	116	13	inhibitor	inhibitor	NOUN
aiua-10305	116	14	—	—	PUNCT
aiua-10305	116	15	new	new	ADJ
aiua-10305	116	16	evidence	evidence	NOUN
aiua-10305	116	17	in	in	ADP
aiua-10305	116	18	a	a	DET
aiua-10305	116	19	coculture	coculture	NOUN
aiua-10305	116	20	model	model	NOUN
aiua-10305	116	21	of	of	ADP
aiua-10305	116	22	bph	bph	NOUN
aiua-10305	116	23	.	.	PUNCT
aiua-10305	116	24	prostate	prostate	NOUN
aiua-10305	116	25	.	.	PUNCT
aiua-10305	117	1	1999	1999	NUM
aiua-10305	117	2	;	;	PUNCT
aiua-10305	117	3	40:232	40:232	NUM
aiua-10305	117	4	-	-	PUNCT
aiua-10305	117	5	241	241	NUM
aiua-10305	117	6	.	.	PUNCT
aiua-10305	118	1	4	4	NUM
aiua-10305	118	2	.	.	X
aiua-10305	118	3	habib	habib	PROPN
aiua-10305	118	4	fk	fk	PROPN
aiua-10305	118	5	.	.	PUNCT
aiua-10305	119	1	serenoa	serenoa	PROPN
aiua-10305	119	2	repens	repen	NOUN
aiua-10305	119	3	:	:	PUNCT
aiua-10305	119	4	the	the	DET
aiua-10305	119	5	scientific	scientific	ADJ
aiua-10305	119	6	basis	basis	NOUN
aiua-10305	119	7	for	for	ADP
aiua-10305	119	8	the	the	DET
aiua-10305	119	9	treatment	treatment	NOUN
aiua-10305	119	10	of	of	ADP
aiua-10305	119	11	benign	benign	ADJ
aiua-10305	119	12	prostatic	prostatic	ADJ
aiua-10305	119	13	hyperplasia	hyperplasia	NOUN
aiua-10305	119	14	.	.	PUNCT
aiua-10305	120	1	eur	eur	PROPN
aiua-10305	120	2	urol	urol	PROPN
aiua-10305	120	3	suppl	suppl	PROPN
aiua-10305	120	4	.	.	PUNCT
aiua-10305	120	5	2009	2009	NUM
aiua-10305	120	6	;	;	PUNCT
aiua-10305	120	7	8:887	8:887	NUM
aiua-10305	120	8	-	-	SYM
aiua-10305	120	9	893	893	NUM
aiua-10305	120	10	.	.	PUNCT
aiua-10305	121	1	5	5	X
aiua-10305	121	2	.	.	X
aiua-10305	121	3	mcnicholas	mcnicholas	PROPN
aiua-10305	121	4	ta	ta	PROPN
aiua-10305	121	5	,	,	PUNCT
aiua-10305	121	6	kirby	kirby	PROPN
aiua-10305	121	7	rs	rs	NOUN
aiua-10305	121	8	,	,	PUNCT
aiua-10305	121	9	lepor	lepor	ADJ
aiua-10305	121	10	h.	h.	NOUN
aiua-10305	121	11	evaluation	evaluation	NOUN
aiua-10305	121	12	and	and	CCONJ
aiua-10305	121	13	nonsurgical	nonsurgical	ADJ
aiua-10305	121	14	management	management	NOUN
aiua-10305	121	15	of	of	ADP
aiua-10305	121	16	benign	benign	ADJ
aiua-10305	121	17	prostatic	prostatic	ADJ
aiua-10305	121	18	hyperplasia	hyperplasia	NOUN
aiua-10305	121	19	.	.	PUNCT
aiua-10305	122	1	in	in	ADP
aiua-10305	122	2	:	:	PUNCT
aiua-10305	122	3	wein	wein	PROPN
aiua-10305	122	4	aj	aj	PROPN
aiua-10305	122	5	,	,	PUNCT
aiua-10305	122	6	kavoussi	kavoussi	PROPN
aiua-10305	122	7	lr	lr	PROPN
aiua-10305	122	8	,	,	PUNCT
aiua-10305	122	9	novick	novick	PROPN
aiua-10305	122	10	ac	ac	PROPN
aiua-10305	122	11	,	,	PUNCT
aiua-10305	122	12	partin	partin	PROPN
aiua-10305	122	13	aw	aw	INTJ
aiua-10305	122	14	,	,	PUNCT
aiua-10305	122	15	peters	peters	PROPN
aiua-10305	122	16	ca	can	AUX
aiua-10305	122	17	,	,	PUNCT
aiua-10305	122	18	editors	editor	NOUN
aiua-10305	122	19	.	.	PUNCT
aiua-10305	123	1	campbell	campbell	PROPN
aiua-10305	123	2	-	-	PUNCT
aiua-10305	123	3	walsh	walsh	PROPN
aiua-10305	123	4	urology	urology	NOUN
aiua-10305	123	5	.	.	PUNCT
aiua-10305	124	1	6	6	NUM
aiua-10305	124	2	.	.	X
aiua-10305	124	3	paubert	paubert	NOUN
aiua-10305	124	4	-	-	PUNCT
aiua-10305	124	5	braquet	braquet	NOUN
aiua-10305	124	6	m	m	PROPN
aiua-10305	124	7	,	,	PUNCT
aiua-10305	124	8	mencia	mencia	PROPN
aiua-10305	124	9	huerta	huerta	PROPN
aiua-10305	124	10	jmm	jmm	PROPN
aiua-10305	124	11	,	,	PUNCT
aiua-10305	124	12	cousse	cousse	NOUN
aiua-10305	124	13	h	h	NOUN
aiua-10305	124	14	,	,	PUNCT
aiua-10305	124	15	et	et	PROPN
aiua-10305	124	16	al	al	PROPN
aiua-10305	124	17	.	.	PROPN
aiua-10305	124	18	effect	effect	NOUN
aiua-10305	124	19	of	of	ADP
aiua-10305	124	20	the	the	DET
aiua-10305	124	21	lipidic	lipidic	ADJ
aiua-10305	124	22	lipidosterolic	lipidosterolic	ADJ
aiua-10305	124	23	extract	extract	NOUN
aiua-10305	124	24	of	of	ADP
aiua-10305	124	25	serenoa	serenoa	ADJ
aiua-10305	124	26	repens	repen	NOUN
aiua-10305	124	27	(	(	PUNCT
aiua-10305	124	28	permixon	permixon	ADJ
aiua-10305	124	29	®	®	NOUN
aiua-10305	124	30	)	)	PUNCT
aiua-10305	124	31	on	on	ADP
aiua-10305	124	32	the	the	DET
aiua-10305	124	33	ionophore	ionophore	ADJ
aiua-10305	124	34	a23187	a23187	NOUN
aiua-10305	124	35	-	-	PUNCT
aiua-10305	124	36	stimulated	stimulate	VERB
aiua-10305	124	37	production	production	NOUN
aiua-10305	124	38	of	of	ADP
aiua-10305	124	39	leukotriene	leukotriene	NOUN
aiua-10305	124	40	b4	b4	NOUN
aiua-10305	124	41	(	(	PUNCT
aiua-10305	124	42	ltb4	ltb4	PROPN
aiua-10305	124	43	)	)	PUNCT
aiua-10305	124	44	from	from	ADP
aiua-10305	124	45	human	human	ADJ
aiua-10305	124	46	polymorphonuclear	polymorphonuclear	NOUN
aiua-10305	124	47	neutrophils	neutrophil	NOUN
aiua-10305	124	48	.	.	PUNCT
aiua-10305	125	1	prostaglandins	prostaglandin	NOUN
aiua-10305	125	2	leukot	leukot	VERB
aiua-10305	125	3	essent	essent	ADJ
aiua-10305	125	4	fatty	fatty	NOUN
aiua-10305	125	5	acids	acid	NOUN
aiua-10305	125	6	.	.	PUNCT
aiua-10305	126	1	1997	1997	NUM
aiua-10305	126	2	;	;	PUNCT
aiua-10305	126	3	57:299	57:299	NUM
aiua-10305	126	4	-	-	SYM
aiua-10305	126	5	304	304	NUM
aiua-10305	126	6	.	.	PUNCT
aiua-10305	127	1	7	7	NUM
aiua-10305	127	2	.	.	X
aiua-10305	127	3	colado	colado	PROPN
aiua-10305	127	4	-	-	PUNCT
aiua-10305	127	5	velázquez	velázquez	NOUN
aiua-10305	127	6	j	j	PROPN
aiua-10305	127	7	,	,	PUNCT
aiua-10305	127	8	mailloux	mailloux	NOUN
aiua-10305	127	9	-	-	PUNCT
aiua-10305	127	10	salinas	salinas	PROPN
aiua-10305	127	11	p	p	PROPN
aiua-10305	127	12	,	,	PUNCT
aiua-10305	127	13	medina	medina	PROPN
aiua-10305	127	14	-	-	PUNCT
aiua-10305	127	15	contreras	contreras	PROPN
aiua-10305	127	16	jml	jml	PROPN
aiua-10305	127	17	,	,	PUNCT
aiua-10305	127	18	et	et	PROPN
aiua-10305	127	19	al	al	PROPN
aiua-10305	127	20	.	.	PROPN
aiua-10305	127	21	effect	effect	NOUN
aiua-10305	127	22	of	of	ADP
aiua-10305	127	23	serenoa	serenoa	ADJ
aiua-10305	127	24	repens	repen	NOUN
aiua-10305	127	25	on	on	ADP
aiua-10305	127	26	oxidative	oxidative	ADJ
aiua-10305	127	27	stress	stress	NOUN
aiua-10305	127	28	,	,	PUNCT
aiua-10305	127	29	inflammatory	inflammatory	ADJ
aiua-10305	127	30	and	and	CCONJ
aiua-10305	127	31	growth	growth	NOUN
aiua-10305	127	32	factors	factor	NOUN
aiua-10305	127	33	in	in	ADP
aiua-10305	127	34	obese	obese	ADJ
aiua-10305	127	35	wistar	wistar	PROPN
aiua-10305	127	36	rats	rat	NOUN
aiua-10305	127	37	with	with	ADP
aiua-10305	127	38	benign	benign	ADJ
aiua-10305	127	39	prostatic	prostatic	ADJ
aiua-10305	127	40	hyperplasia	hyperplasia	NOUN
aiua-10305	127	41	.	.	PUNCT
aiua-10305	128	1	phytother	phytother	PROPN
aiua-10305	128	2	res	re	NOUN
aiua-10305	128	3	.	.	PUNCT
aiua-10305	129	1	2015;29:1525	2015;29:1525	NUM
aiua-10305	129	2	-	-	SYM
aiua-10305	129	3	1531	1531	NUM
aiua-10305	129	4	.	.	PUNCT
aiua-10305	130	1	8	8	NUM
aiua-10305	130	2	.	.	PUNCT
aiua-10305	130	3	latil	latil	PROPN
aiua-10305	130	4	a	a	PROPN
aiua-10305	130	5	,	,	PUNCT
aiua-10305	130	6	pétrissans	pétrissans	PROPN
aiua-10305	130	7	mt	mt	PROPN
aiua-10305	130	8	,	,	PUNCT
aiua-10305	130	9	rouquet	rouquet	VERB
aiua-10305	130	10	j	j	PROPN
aiua-10305	130	11	,	,	PUNCT
aiua-10305	130	12	et	et	PROPN
aiua-10305	130	13	al	al	PROPN
aiua-10305	130	14	.	.	PUNCT
aiua-10305	131	1	effects	effect	NOUN
aiua-10305	131	2	of	of	ADP
aiua-10305	131	3	hexanic	hexanic	ADJ
aiua-10305	131	4	extract	extract	NOUN
aiua-10305	131	5	of	of	ADP
aiua-10305	131	6	serenoa	serenoa	ADJ
aiua-10305	131	7	repens	repen	NOUN
aiua-10305	131	8	(	(	PUNCT
aiua-10305	131	9	permixon	permixon	ADJ
aiua-10305	131	10	®	®	NOUN
aiua-10305	131	11	160	160	NUM
aiua-10305	131	12	mg	mg	NOUN
aiua-10305	131	13	)	)	PUNCT
aiua-10305	131	14	on	on	ADP
aiua-10305	131	15	inflammation	inflammation	ADJ
aiua-10305	131	16	biomarkers	biomarker	NOUN
aiua-10305	131	17	in	in	ADP
aiua-10305	131	18	the	the	DET
aiua-10305	131	19	treatment	treatment	NOUN
aiua-10305	131	20	of	of	ADP
aiua-10305	131	21	lower	low	ADJ
aiua-10305	131	22	urinary	urinary	ADJ
aiua-10305	131	23	tract	tract	NOUN
aiua-10305	131	24	symptoms	symptom	NOUN
aiua-10305	131	25	related	relate	VERB
aiua-10305	131	26	to	to	ADP
aiua-10305	131	27	benign	benign	ADJ
aiua-10305	131	28	prostatic	prostatic	ADJ
aiua-10305	131	29	hyperplasia	hyperplasia	NOUN
aiua-10305	131	30	.	.	PUNCT
aiua-10305	132	1	prostate	prostate	NOUN
aiua-10305	132	2	.	.	PUNCT
aiua-10305	133	1	2015	2015	NUM
aiua-10305	133	2	;	;	PUNCT
aiua-10305	133	3	75:1857	75:1857	NOUN
aiua-10305	133	4	-	-	SYM
aiua-10305	133	5	1867	1867	NUM
aiua-10305	133	6	.	.	PUNCT
aiua-10305	134	1	9	9	X
aiua-10305	134	2	.	.	X
aiua-10305	134	3	vela	vela	NOUN
aiua-10305	134	4	navarrete	navarrete	PROPN
aiua-10305	134	5	r	r	PROPN
aiua-10305	134	6	,	,	PUNCT
aiua-10305	134	7	garcia	garcia	PROPN
aiua-10305	134	8	cardoso	cardoso	PROPN
aiua-10305	134	9	jg	jg	PROPN
aiua-10305	134	10	,	,	PUNCT
aiua-10305	134	11	barat	barat	PROPN
aiua-10305	134	12	a	a	PROPN
aiua-10305	134	13	,	,	PUNCT
aiua-10305	134	14	et	et	PROPN
aiua-10305	134	15	al	al	PROPN
aiua-10305	134	16	.	.	PROPN
aiua-10305	134	17	bph	bph	PROPN
aiua-10305	134	18	and	and	CCONJ
aiua-10305	134	19	inflammation	inflammation	NOUN
aiua-10305	134	20	:	:	PUNCT
aiua-10305	134	21	pharmacological	pharmacological	ADJ
aiua-10305	134	22	effects	effect	NOUN
aiua-10305	134	23	of	of	ADP
aiua-10305	134	24	permixon	permixon	ADJ
aiua-10305	134	25	on	on	ADP
aiua-10305	134	26	histological	histological	ADJ
aiua-10305	134	27	and	and	CCONJ
aiua-10305	134	28	molecular	molecular	ADJ
aiua-10305	134	29	inflammatory	inflammatory	ADJ
aiua-10305	134	30	markers	marker	NOUN
aiua-10305	134	31	.	.	PUNCT
aiua-10305	135	1	results	result	NOUN
aiua-10305	135	2	of	of	ADP
aiua-10305	135	3	a	a	DET
aiua-10305	135	4	double	double	ADJ
aiua-10305	135	5	blind	blind	ADJ
aiua-10305	135	6	pilot	pilot	NOUN
aiua-10305	135	7	clinical	clinical	ADJ
aiua-10305	135	8	assay	assay	NOUN
aiua-10305	135	9	.	.	PUNCT
aiua-10305	136	1	eur	eur	PROPN
aiua-10305	136	2	urol	urol	PROPN
aiua-10305	136	3	.	.	PUNCT
aiua-10305	136	4	2003	2003	NUM
aiua-10305	136	5	;	;	PUNCT
aiua-10305	136	6	44:549	44:549	NUM
aiua-10305	136	7	-	-	SYM
aiua-10305	136	8	555	555	NUM
aiua-10305	136	9	.	.	PUNCT
aiua-10305	137	1	10	10	NUM
aiua-10305	137	2	.	.	PUNCT
aiua-10305	138	1	morgia	morgia	NOUN
aiua-10305	138	2	g	g	PROPN
aiua-10305	138	3	,	,	PUNCT
aiua-10305	138	4	cimino	cimino	PROPN
aiua-10305	138	5	s	s	PROPN
aiua-10305	138	6	,	,	PUNCT
aiua-10305	138	7	favilla	favilla	NOUN
aiua-10305	138	8	v	v	NOUN
aiua-10305	138	9	,	,	PUNCT
aiua-10305	138	10	et	et	PROPN
aiua-10305	138	11	al	al	PROPN
aiua-10305	138	12	.	.	PUNCT
aiua-10305	138	13	effects	effect	NOUN
aiua-10305	138	14	of	of	ADP
aiua-10305	138	15	serenoa	serenoa	ADJ
aiua-10305	138	16	repens	repen	NOUN
aiua-10305	138	17	,	,	PUNCT
aiua-10305	138	18	selenium	selenium	NOUN
aiua-10305	138	19	and	and	CCONJ
aiua-10305	138	20	lycopene	lycopene	NOUN
aiua-10305	138	21	(	(	PUNCT
aiua-10305	138	22	profluss	profluss	NOUN
aiua-10305	138	23	®	®	NOUN
aiua-10305	138	24	)	)	PUNCT
aiua-10305	138	25	on	on	ADP
aiua-10305	138	26	chronic	chronic	ADJ
aiua-10305	138	27	inflammation	inflammation	NOUN
aiua-10305	138	28	associated	associate	VERB
aiua-10305	138	29	with	with	ADP
aiua-10305	138	30	benign	benign	ADJ
aiua-10305	138	31	prostatic	prostatic	ADJ
aiua-10305	138	32	hyperplasia	hyperplasia	NOUN
aiua-10305	138	33	:	:	PUNCT
aiua-10305	138	34	results	result	NOUN
aiua-10305	138	35	of	of	ADP
aiua-10305	138	36	flog	flog	NOUN
aiua-10305	138	37	(	(	PUNCT
aiua-10305	138	38	flogosis	flogosis	NOUN
aiua-10305	138	39	and	and	CCONJ
aiua-10305	138	40	profluss	profluss	NOUN
aiua-10305	138	41	in	in	ADP
aiua-10305	138	42	prostatic	prostatic	ADJ
aiua-10305	138	43	and	and	CCONJ
aiua-10305	138	44	genital	genital	ADJ
aiua-10305	138	45	disease	disease	NOUN
aiua-10305	138	46	)	)	PUNCT
aiua-10305	138	47	,	,	PUNCT
aiua-10305	138	48	a	a	DET
aiua-10305	138	49	multicentre	multicentre	ADJ
aiua-10305	138	50	italian	italian	ADJ
aiua-10305	138	51	study	study	NOUN
aiua-10305	138	52	.	.	PUNCT
aiua-10305	139	1	int	int	PROPN
aiua-10305	139	2	braz	braz	PROPN
aiua-10305	139	3	j	j	PROPN
aiua-10305	139	4	urol	urol	PROPN
aiua-10305	139	5	.	.	PUNCT
aiua-10305	140	1	2013	2013	NUM
aiua-10305	140	2	;	;	PUNCT
aiua-10305	140	3	39:214	39:214	NUM
aiua-10305	140	4	-	-	SYM
aiua-10305	140	5	221	221	NUM
aiua-10305	140	6	.	.	PUNCT
aiua-10305	141	1	11	11	NUM
aiua-10305	141	2	.	.	X
aiua-10305	142	1	park	park	PROPN
aiua-10305	142	2	ej	ej	PROPN
aiua-10305	142	3	,	,	PUNCT
aiua-10305	142	4	kim	kim	PROPN
aiua-10305	142	5	sa	sa	PROPN
aiua-10305	142	6	,	,	PUNCT
aiua-10305	142	7	choi	choi	PROPN
aiua-10305	142	8	ym	ym	PROPN
aiua-10305	142	9	,	,	PUNCT
aiua-10305	142	10	et	et	PROPN
aiua-10305	142	11	al	al	PROPN
aiua-10305	142	12	.	.	PROPN
aiua-10305	142	13	capric	capric	PROPN
aiua-10305	142	14	acid	acid	PROPN
aiua-10305	142	15	inhibits	inhibit	VERB
aiua-10305	142	16	no	no	DET
aiua-10305	142	17	production	production	NOUN
aiua-10305	142	18	and	and	CCONJ
aiua-10305	142	19	stat3	stat3	NOUN
aiua-10305	142	20	activation	activation	NOUN
aiua-10305	142	21	during	during	ADP
aiua-10305	142	22	lps	lps	PROPN
aiua-10305	142	23	-	-	PUNCT
aiua-10305	142	24	induced	induce	VERB
aiua-10305	142	25	osteoclastogenesis	osteoclastogenesis	NOUN
aiua-10305	142	26	.	.	PUNCT
aiua-10305	143	1	plos	plos	PROPN
aiua-10305	143	2	one	one	NUM
aiua-10305	143	3	.	.	PUNCT
aiua-10305	143	4	2011	2011	NUM
aiua-10305	143	5	;	;	PUNCT
aiua-10305	143	6	6	6	NUM
aiua-10305	143	7	:	:	SYM
aiua-10305	143	8	e27739	e27739	NOUN
aiua-10305	143	9	.	.	NOUN
aiua-10305	143	10	12	12	NUM
aiua-10305	143	11	.	.	PUNCT
aiua-10305	144	1	kim	kim	PROPN
aiua-10305	144	2	hj	hj	PROPN
aiua-10305	144	3	,	,	PUNCT
aiua-10305	144	4	yoon	yoon	PROPN
aiua-10305	144	5	hj	hj	PROPN
aiua-10305	144	6	,	,	PUNCT
aiua-10305	144	7	kim	kim	PROPN
aiua-10305	144	8	sy	sy	PROPN
aiua-10305	144	9	,	,	PUNCT
aiua-10305	144	10	et	et	PROPN
aiua-10305	144	11	al	al	PROPN
aiua-10305	144	12	.	.	PUNCT
aiua-10305	145	1	a	a	DET
aiua-10305	145	2	medium	medium	ADJ
aiua-10305	145	3	-	-	PUNCT
aiua-10305	145	4	chain	chain	NOUN
aiua-10305	145	5	fatty	fatty	NOUN
aiua-10305	145	6	acid	acid	NOUN
aiua-10305	145	7	,	,	PUNCT
aiua-10305	145	8	capric	capric	NOUN
aiua-10305	145	9	acid	acid	NOUN
aiua-10305	145	10	,	,	PUNCT
aiua-10305	145	11	inhibits	inhibit	VERB
aiua-10305	145	12	rankl	rankl	VERB
aiua-10305	145	13	-	-	PUNCT
aiua-10305	145	14	induced	induce	VERB
aiua-10305	145	15	osteoclast	osteoclast	ADJ
aiua-10305	145	16	differentiation	differentiation	NOUN
aiua-10305	145	17	via	via	ADP
aiua-10305	145	18	the	the	DET
aiua-10305	145	19	suppression	suppression	NOUN
aiua-10305	145	20	of	of	ADP
aiua-10305	145	21	nf	nf	NOUN
aiua-10305	145	22	-	-	PUNCT
aiua-10305	145	23	kb	kb	NOUN
aiua-10305	145	24	signaling	signaling	NOUN
aiua-10305	145	25	and	and	CCONJ
aiua-10305	145	26	blocks	block	VERB
aiua-10305	145	27	cytoskeletal	cytoskeletal	ADJ
aiua-10305	145	28	organization	organization	NOUN
aiua-10305	145	29	and	and	CCONJ
aiua-10305	145	30	survival	survival	NOUN
aiua-10305	145	31	in	in	ADP
aiua-10305	145	32	mature	mature	ADJ
aiua-10305	145	33	osteoclasts	osteoclast	NOUN
aiua-10305	145	34	.	.	PUNCT
aiua-10305	146	1	mol	mol	ADP
aiua-10305	146	2	cells	cell	NOUN
aiua-10305	146	3	.	.	PUNCT
aiua-10305	147	1	2014	2014	NUM
aiua-10305	147	2	;	;	PUNCT
aiua-10305	147	3	37:598	37:598	NUM
aiua-10305	147	4	-	-	SYM
aiua-10305	147	5	604	604	NUM
aiua-10305	147	6	.	.	PUNCT
aiua-10305	148	1	13	13	NUM
aiua-10305	148	2	.	.	PUNCT
aiua-10305	149	1	henry	henry	PROPN
aiua-10305	149	2	ge	ge	PROPN
aiua-10305	149	3	,	,	PUNCT
aiua-10305	149	4	momin	momin	PROPN
aiua-10305	149	5	ra	ra	PROPN
aiua-10305	149	6	,	,	PUNCT
aiua-10305	149	7	nair	nair	PROPN
aiua-10305	149	8	mg	mg	PROPN
aiua-10305	149	9	,	,	PUNCT
aiua-10305	149	10	et	et	PROPN
aiua-10305	149	11	al	al	PROPN
aiua-10305	149	12	.	.	PROPN
aiua-10305	149	13	antioxidant	antioxidant	PROPN
aiua-10305	149	14	and	and	CCONJ
aiua-10305	149	15	cyclooxygenase	cyclooxygenase	NOUN
aiua-10305	149	16	activities	activity	NOUN
aiua-10305	149	17	of	of	ADP
aiua-10305	149	18	fatty	fatty	NOUN
aiua-10305	149	19	acids	acid	NOUN
aiua-10305	149	20	found	find	VERB
aiua-10305	149	21	in	in	ADP
aiua-10305	149	22	food	food	NOUN
aiua-10305	149	23	.	.	PUNCT
aiua-10305	150	1	j	j	PROPN
aiua-10305	150	2	agric	agric	PROPN
aiua-10305	150	3	food	food	PROPN
aiua-10305	150	4	chem	chem	NOUN
aiua-10305	150	5	.	.	PUNCT
aiua-10305	151	1	2002	2002	NUM
aiua-10305	151	2	;	;	PUNCT
aiua-10305	151	3	50:2231	50:2231	NUM
aiua-10305	151	4	-	-	SYM
aiua-10305	151	5	2234	2234	NUM
aiua-10305	151	6	.	.	PUNCT
aiua-10305	152	1	14	14	NUM
aiua-10305	152	2	.	.	PUNCT
aiua-10305	153	1	hoshimoto	hoshimoto	PROPN
aiua-10305	153	2	a	a	PROPN
aiua-10305	153	3	,	,	PUNCT
aiua-10305	153	4	suzuki	suzuki	PROPN
aiua-10305	153	5	y	y	PROPN
aiua-10305	153	6	,	,	PUNCT
aiua-10305	153	7	katsuno	katsuno	PROPN
aiua-10305	153	8	t	t	PROPN
aiua-10305	153	9	,	,	PUNCT
aiua-10305	153	10	et	et	PROPN
aiua-10305	153	11	al	al	PROPN
aiua-10305	153	12	.	.	PROPN
aiua-10305	153	13	caprylic	caprylic	PROPN
aiua-10305	153	14	acid	acid	PROPN
aiua-10305	153	15	and	and	CCONJ
aiua-10305	153	16	medium	medium	ADJ
aiua-10305	153	17	-	-	PUNCT
aiua-10305	153	18	chain	chain	NOUN
aiua-10305	153	19	triglycerides	triglyceride	NOUN
aiua-10305	153	20	inhibit	inhibit	VERB
aiua-10305	153	21	il-8	il-8	VERB
aiua-10305	153	22	gene	gene	NOUN
aiua-10305	153	23	transcription	transcription	NOUN
aiua-10305	153	24	in	in	ADP
aiua-10305	153	25	caco-2	caco-2	NUM
aiua-10305	153	26	cells	cell	NOUN
aiua-10305	153	27	:	:	PUNCT
aiua-10305	153	28	comparison	comparison	NOUN
aiua-10305	153	29	with	with	ADP
aiua-10305	153	30	the	the	DET
aiua-10305	153	31	potent	potent	ADJ
aiua-10305	153	32	histone	histone	NOUN
aiua-10305	153	33	deacetylase	deacetylase	PROPN
aiua-10305	153	34	inhibitor	inhibitor	PROPN
aiua-10305	153	35	trichostatin	trichostatin	PROPN
aiua-10305	153	36	a.	a.	PROPN
aiua-10305	153	37	br	br	PROPN
aiua-10305	153	38	j	j	PROPN
aiua-10305	153	39	pharmacol	pharmacol	PROPN
aiua-10305	153	40	.	.	PUNCT
aiua-10305	154	1	2002	2002	NUM
aiua-10305	154	2	;	;	PUNCT
aiua-10305	154	3	136:280	136:280	NUM
aiua-10305	154	4	-	-	SYM
aiua-10305	154	5	286	286	NUM
aiua-10305	154	6	.	.	PUNCT
aiua-10305	155	1	15	15	NUM
aiua-10305	155	2	.	.	PUNCT
aiua-10305	156	1	srivastava	srivastava	PROPN
aiua-10305	156	2	a	a	PROPN
aiua-10305	156	3	,	,	PUNCT
aiua-10305	156	4	rao	rao	PROPN
aiua-10305	156	5	ljm	ljm	PROPN
aiua-10305	156	6	,	,	PUNCT
aiua-10305	156	7	shivanandappa	shivanandappa	ADJ
aiua-10305	156	8	t.	t.	PROPN
aiua-10305	156	9	14	14	NUM
aiua-10305	156	10	-	-	PUNCT
aiua-10305	156	11	aminotetradecanoic	aminotetradecanoic	ADJ
aiua-10305	156	12	acid	acid	NOUN
aiua-10305	156	13	exhibits	exhibit	VERB
aiua-10305	156	14	antioxidant	antioxidant	ADJ
aiua-10305	156	15	activity	activity	NOUN
aiua-10305	156	16	and	and	CCONJ
aiua-10305	156	17	ameliorates	ameliorate	NOUN
aiua-10305	156	18	xenobiotics	xenobiotic	NOUN
aiua-10305	156	19	-	-	PUNCT
aiua-10305	156	20	induced	induce	VERB
aiua-10305	156	21	cytotoxicity	cytotoxicity	NOUN
aiua-10305	156	22	.	.	PUNCT
aiua-10305	157	1	mol	mol	ADP
aiua-10305	157	2	cell	cell	NOUN
aiua-10305	157	3	biochem	biochem	PROPN
aiua-10305	157	4	.	.	PUNCT
aiua-10305	158	1	2012	2012	NUM
aiua-10305	158	2	;	;	PUNCT
aiua-10305	158	3	364:1	364:1	NUM
aiua-10305	158	4	-	-	PUNCT
aiua-10305	158	5	9	9	NUM
aiua-10305	158	6	.	.	NOUN
aiua-10305	158	7	16	16	NUM
aiua-10305	158	8	.	.	PUNCT
aiua-10305	159	1	oh	oh	INTJ
aiua-10305	159	2	yt	yt	PROPN
aiua-10305	159	3	,	,	PUNCT
aiua-10305	159	4	lee	lee	PROPN
aiua-10305	159	5	jy	jy	PROPN
aiua-10305	159	6	,	,	PUNCT
aiua-10305	159	7	lee	lee	PROPN
aiua-10305	159	8	j	j	PROPN
aiua-10305	159	9	,	,	PUNCT
aiua-10305	159	10	et	et	PROPN
aiua-10305	159	11	al	al	PROPN
aiua-10305	159	12	.	.	PROPN
aiua-10305	159	13	oleic	oleic	PROPN
aiua-10305	159	14	acid	acid	PROPN
aiua-10305	159	15	reduces	reduce	VERB
aiua-10305	159	16	lipopolysaccharideinduced	lipopolysaccharideinduced	ADJ
aiua-10305	159	17	expression	expression	NOUN
aiua-10305	159	18	of	of	ADP
aiua-10305	159	19	inos	ino	NOUN
aiua-10305	159	20	and	and	CCONJ
aiua-10305	159	21	cox-2	cox-2	ADV
aiua-10305	159	22	in	in	ADP
aiua-10305	159	23	bv2	bv2	NOUN
aiua-10305	159	24	murine	murine	ADJ
aiua-10305	159	25	microglial	microglial	ADJ
aiua-10305	159	26	cells	cell	NOUN
aiua-10305	159	27	:	:	PUNCT
aiua-10305	159	28	possible	possible	ADJ
aiua-10305	159	29	involvement	involvement	NOUN
aiua-10305	159	30	of	of	ADP
aiua-10305	159	31	reactive	reactive	ADJ
aiua-10305	159	32	oxygen	oxygen	NOUN
aiua-10305	159	33	species	specie	NOUN
aiua-10305	159	34	,	,	PUNCT
aiua-10305	159	35	p38	p38	NOUN
aiua-10305	159	36	mapk	mapk	NOUN
aiua-10305	159	37	,	,	PUNCT
aiua-10305	159	38	and	and	CCONJ
aiua-10305	159	39	ikk	ikk	PROPN
aiua-10305	159	40	/	/	SYM
aiua-10305	159	41	nf	nf	NOUN
aiua-10305	159	42	-	-	PUNCT
aiua-10305	159	43	kappab	kappab	NOUN
aiua-10305	159	44	signaling	signal	VERB
aiua-10305	159	45	pathways	pathway	NOUN
aiua-10305	159	46	.	.	PUNCT
aiua-10305	160	1	neurosci	neurosci	PROPN
aiua-10305	160	2	lett	lett	PROPN
aiua-10305	160	3	.	.	PUNCT
aiua-10305	161	1	2009	2009	NUM
aiua-10305	161	2	;	;	PUNCT
aiua-10305	161	3	464:93	464:93	NUM
aiua-10305	161	4	-	-	SYM
aiua-10305	161	5	97	97	NUM
aiua-10305	161	6	.	.	PUNCT
aiua-10305	161	7	17	17	NUM
aiua-10305	161	8	.	.	PUNCT
aiua-10305	162	1	ambrozova	ambrozova	PROPN
aiua-10305	162	2	g	g	NOUN
aiua-10305	162	3	,	,	PUNCT
aiua-10305	162	4	pekarova	pekarova	PROPN
aiua-10305	162	5	m	m	PRON
aiua-10305	162	6	,	,	PUNCT
aiua-10305	162	7	lojek	lojek	NOUN
aiua-10305	162	8	a.	a.	NOUN
aiua-10305	162	9	effect	effect	NOUN
aiua-10305	162	10	of	of	ADP
aiua-10305	162	11	polyunsaturated	polyunsaturated	ADJ
aiua-10305	162	12	fatty	fatty	NOUN
aiua-10305	162	13	acids	acid	NOUN
aiua-10305	162	14	on	on	ADP
aiua-10305	162	15	the	the	DET
aiua-10305	162	16	reactive	reactive	ADJ
aiua-10305	162	17	oxygen	oxygen	NOUN
aiua-10305	162	18	and	and	CCONJ
aiua-10305	162	19	nitrogen	nitrogen	NOUN
aiua-10305	162	20	species	specie	NOUN
aiua-10305	162	21	production	production	NOUN
aiua-10305	162	22	by	by	ADP
aiua-10305	162	23	raw	raw	ADJ
aiua-10305	162	24	264.7	264.7	NUM
aiua-10305	162	25	macrophages	macrophage	NOUN
aiua-10305	162	26	.	.	PUNCT
aiua-10305	163	1	eur	eur	PROPN
aiua-10305	163	2	j	j	PROPN
aiua-10305	163	3	nutr	nutr	PROPN
aiua-10305	163	4	.	.	PROPN
aiua-10305	163	5	2010	2010	NUM
aiua-10305	163	6	;	;	PUNCT
aiua-10305	163	7	49:133	49:133	NUM
aiua-10305	163	8	-	-	SYM
aiua-10305	163	9	139	139	NUM
aiua-10305	163	10	.	.	PUNCT
aiua-10305	164	1	18	18	NUM
aiua-10305	164	2	.	.	PUNCT
aiua-10305	165	1	ren	ren	PROPN
aiua-10305	165	2	j	j	PROPN
aiua-10305	165	3	,	,	PUNCT
aiua-10305	165	4	chung	chung	PROPN
aiua-10305	165	5	sh	sh	PROPN
aiua-10305	165	6	.	.	PUNCT
aiua-10305	165	7	anti	anti	ADJ
aiua-10305	165	8	-	-	ADJ
aiua-10305	165	9	inflammatory	inflammatory	ADJ
aiua-10305	165	10	effect	effect	NOUN
aiua-10305	165	11	of	of	ADP
aiua-10305	165	12	a	a	DET
aiua-10305	165	13	-	-	PUNCT
aiua-10305	165	14	linolenic	linolenic	NOUN
aiua-10305	165	15	acid	acid	NOUN
aiua-10305	165	16	and	and	CCONJ
aiua-10305	165	17	its	its	PRON
aiua-10305	165	18	mode	mode	NOUN
aiua-10305	165	19	of	of	ADP
aiua-10305	165	20	action	action	NOUN
aiua-10305	165	21	through	through	ADP
aiua-10305	165	22	the	the	DET
aiua-10305	165	23	inhibition	inhibition	NOUN
aiua-10305	165	24	of	of	ADP
aiua-10305	165	25	nitric	nitric	ADJ
aiua-10305	165	26	oxide	oxide	NOUN
aiua-10305	165	27	production	production	NOUN
aiua-10305	165	28	and	and	CCONJ
aiua-10305	165	29	inducible	inducible	ADJ
aiua-10305	165	30	nitric	nitric	ADJ
aiua-10305	165	31	oxide	oxide	NOUN
aiua-10305	165	32	synthase	synthase	NOUN
aiua-10305	165	33	gene	gene	NOUN
aiua-10305	165	34	expression	expression	NOUN
aiua-10305	165	35	via	via	ADP
aiua-10305	165	36	nf	nf	PROPN
aiua-10305	165	37	-	-	PUNCT
aiua-10305	165	38	kb	kb	PROPN
aiua-10305	165	39	and	and	CCONJ
aiua-10305	165	40	mitogen	mitogen	NOUN
aiua-10305	165	41	-	-	PUNCT
aiua-10305	165	42	activated	activate	VERB
aiua-10305	165	43	protein	protein	NOUN
aiua-10305	165	44	kinase	kinase	NOUN
aiua-10305	165	45	pathways	pathway	NOUN
aiua-10305	165	46	.	.	PUNCT
aiua-10305	166	1	j	j	PROPN
aiua-10305	166	2	agric	agric	PROPN
aiua-10305	166	3	food	food	PROPN
aiua-10305	166	4	chem	chem	NOUN
aiua-10305	166	5	.	.	PUNCT
aiua-10305	167	1	2007	2007	NUM
aiua-10305	167	2	;	;	PUNCT
aiua-10305	167	3	55:5073	55:5073	X
aiua-10305	167	4	-	-	SYM
aiua-10305	167	5	5080	5080	NUM
aiua-10305	167	6	.	.	PUNCT
aiua-10305	168	1	19	19	NUM
aiua-10305	168	2	.	.	X
aiua-10305	168	3	olennikov	olennikov	PROPN
aiua-10305	168	4	dn	dn	PROPN
aiua-10305	168	5	,	,	PUNCT
aiua-10305	168	6	zilfikarov	zilfikarov	NOUN
aiua-10305	168	7	in	in	ADP
aiua-10305	168	8	,	,	PUNCT
aiua-10305	168	9	khodakova	khodakova	PROPN
aiua-10305	168	10	se	se	X
aiua-10305	168	11	.	.	PUNCT
aiua-10305	169	1	phenolic	phenolic	ADJ
aiua-10305	169	2	compounds	compound	NOUN
aiua-10305	169	3	from	from	ADP
aiua-10305	169	4	serenoa	serenoa	ADJ
aiua-10305	169	5	repens	repen	NOUN
aiua-10305	169	6	fruit	fruit	NOUN
aiua-10305	169	7	.	.	PUNCT
aiua-10305	170	1	chem	chem	NOUN
aiua-10305	170	2	nat	nat	PROPN
aiua-10305	170	3	compd	compd	PROPN
aiua-10305	170	4	.	.	PUNCT
aiua-10305	171	1	2013	2013	NUM
aiua-10305	171	2	;	;	PUNCT
aiua-10305	171	3	49:526529	49:526529	NUM
aiua-10305	171	4	.	.	PROPN
aiua-10305	172	1	20	20	NUM
aiua-10305	172	2	.	.	PUNCT
aiua-10305	173	1	cristoni	cristoni	PROPN
aiua-10305	173	2	a	a	DET
aiua-10305	173	3	,	,	PUNCT
aiua-10305	173	4	di	di	X
aiua-10305	173	5	pierro	pierro	PROPN
aiua-10305	173	6	f	f	PROPN
aiua-10305	173	7	,	,	PUNCT
aiua-10305	173	8	bombardelli	bombardelli	PROPN
aiua-10305	173	9	e.	e.	PROPN
aiua-10305	173	10	botanical	botanical	PROPN
aiua-10305	173	11	derivatives	derivative	NOUN
aiua-10305	173	12	for	for	ADP
aiua-10305	173	13	the	the	DET
aiua-10305	173	14	prostate	prostate	NOUN
aiua-10305	173	15	.	.	PUNCT
aiua-10305	174	1	fitoterapia	fitoterapia	PROPN
aiua-10305	174	2	.	.	PROPN
aiua-10305	174	3	2000	2000	NUM
aiua-10305	174	4	;	;	PUNCT
aiua-10305	174	5	71	71	NUM
aiua-10305	174	6	:	:	PUNCT
aiua-10305	174	7	s21	s21	NOUN
aiua-10305	174	8	-	-	PUNCT
aiua-10305	174	9	s28	s28	NOUN
aiua-10305	174	10	.	.	PUNCT
aiua-10305	175	1	21	21	NUM
aiua-10305	175	2	.	.	PUNCT
aiua-10305	176	1	nickel	nickel	PROPN
aiua-10305	176	2	jc	jc	PROPN
aiua-10305	176	3	.	.	PROPN
aiua-10305	177	1	shoskes	shoske	NOUN
aiua-10305	177	2	d	d	PROPN
aiua-10305	177	3	,	,	PUNCT
aiua-10305	177	4	roehrborn	roehrborn	ADJ
aiua-10305	177	5	cg	cg	NOUN
aiua-10305	177	6	,	,	PUNCT
aiua-10305	177	7	et	et	PROPN
aiua-10305	177	8	al	al	PROPN
aiua-10305	177	9	.	.	PUNCT
aiua-10305	178	1	nutraceuticals	nutraceutical	NOUN
aiua-10305	178	2	in	in	ADP
aiua-10305	178	3	prostate	prostate	NOUN
aiua-10305	178	4	disease	disease	NOUN
aiua-10305	178	5	:	:	PUNCT
aiua-10305	178	6	the	the	DET
aiua-10305	178	7	urologist	urologist	NOUN
aiua-10305	178	8	’s	’s	PART
aiua-10305	178	9	role	role	NOUN
aiua-10305	178	10	.	.	PUNCT
aiua-10305	179	1	rev	rev	PROPN
aiua-10305	179	2	urol	urol	PROPN
aiua-10305	179	3	.	.	PROPN
aiua-10305	179	4	2008	2008	NUM
aiua-10305	179	5	;	;	PUNCT
aiua-10305	179	6	10:192	10:192	NUM
aiua-10305	179	7	-	-	SYM
aiua-10305	179	8	206	206	NUM
aiua-10305	179	9	.	.	PUNCT
aiua-10305	180	1	22	22	NUM
aiua-10305	180	2	.	.	PUNCT
aiua-10305	181	1	požgain	požgain	PROPN
aiua-10305	181	2	i	i	PRON
aiua-10305	181	3	,	,	PUNCT
aiua-10305	181	4	požgain	požgain	VERB
aiua-10305	181	5	z	z	PROPN
aiua-10305	181	6	,	,	PUNCT
aiua-10305	181	7	degmecic	degmecic	PROPN
aiua-10305	181	8	d.	d.	PROPN
aiua-10305	181	9	placebo	placebo	PROPN
aiua-10305	181	10	and	and	CCONJ
aiua-10305	181	11	nocebo	nocebo	NOUN
aiua-10305	181	12	effect	effect	NOUN
aiua-10305	181	13	:	:	PUNCT
aiua-10305	181	14	a	a	DET
aiua-10305	181	15	mini	mini	NOUN
aiua-10305	181	16	-	-	NOUN
aiua-10305	181	17	review	review	NOUN
aiua-10305	181	18	.	.	PUNCT
aiua-10305	182	1	psychiatr	psychiatr	ADJ
aiua-10305	182	2	danub	danub	NOUN
aiua-10305	182	3	.	.	PUNCT
aiua-10305	183	1	2014	2014	NUM
aiua-10305	183	2	;	;	PUNCT
aiua-10305	183	3	26:0	26:0	NUM
aiua-10305	183	4	-	-	SYM
aiua-10305	183	5	107	107	NUM
aiua-10305	183	6	.	.	PUNCT
aiua-10305	184	1	23	23	NUM
aiua-10305	184	2	.	.	PUNCT
aiua-10305	185	1	moher	moher	PROPN
aiua-10305	185	2	d	d	PROPN
aiua-10305	185	3	,	,	PUNCT
aiua-10305	185	4	liberati	liberati	PROPN
aiua-10305	185	5	a	a	PRON
aiua-10305	185	6	,	,	PUNCT
aiua-10305	185	7	tetzlaff	tetzlaff	PROPN
aiua-10305	185	8	j	j	PROPN
aiua-10305	185	9	,	,	PUNCT
aiua-10305	185	10	altman	altman	PROPN
aiua-10305	185	11	dg	dg	PROPN
aiua-10305	185	12	,	,	PUNCT
aiua-10305	185	13	the	the	DET
aiua-10305	185	14	prisma	prisma	PROPN
aiua-10305	185	15	group	group	NOUN
aiua-10305	185	16	.	.	PUNCT
aiua-10305	186	1	preferred	preferred	ADJ
aiua-10305	186	2	reporting	reporting	NOUN
aiua-10305	186	3	items	item	NOUN
aiua-10305	186	4	for	for	ADP
aiua-10305	186	5	systematic	systematic	ADJ
aiua-10305	186	6	reviews	review	NOUN
aiua-10305	186	7	and	and	CCONJ
aiua-10305	186	8	metaanalyses	metaanalyse	NOUN
aiua-10305	186	9	:	:	PUNCT
aiua-10305	186	10	the	the	DET
aiua-10305	186	11	prisma	prisma	PROPN
aiua-10305	186	12	statement	statement	NOUN
aiua-10305	186	13	.	.	PUNCT
aiua-10305	187	1	plos	plos	PROPN
aiua-10305	187	2	med	med	PROPN
aiua-10305	187	3	.	.	PUNCT
aiua-10305	188	1	2009	2009	NUM
aiua-10305	188	2	:	:	PUNCT
aiua-10305	188	3	6	6	NUM
aiua-10305	188	4	:	:	SYM
aiua-10305	188	5	e1000097	e1000097	PROPN
aiua-10305	188	6	.	.	PROPN
aiua-10305	188	7	24	24	NUM
aiua-10305	188	8	.	.	PUNCT
aiua-10305	188	9	o'leary	o'leary	PROPN
aiua-10305	188	10	mp	mp	PROPN
aiua-10305	188	11	,	,	PUNCT
aiua-10305	188	12	fowler	fowler	PROPN
aiua-10305	188	13	fj	fj	PROPN
aiua-10305	188	14	,	,	PUNCT
aiua-10305	188	15	lenderking	lenderking	NOUN
aiua-10305	188	16	wr	wr	PROPN
aiua-10305	188	17	,	,	PUNCT
aiua-10305	188	18	et	et	PROPN
aiua-10305	188	19	al	al	PROPN
aiua-10305	188	20	.	.	PUNCT
aiua-10305	189	1	a	a	DET
aiua-10305	189	2	brief	brief	ADJ
aiua-10305	189	3	male	male	ADJ
aiua-10305	189	4	sexual	sexual	ADJ
aiua-10305	189	5	function	function	NOUN
aiua-10305	189	6	inventory	inventory	NOUN
aiua-10305	189	7	for	for	ADP
aiua-10305	189	8	urology	urology	NOUN
aiua-10305	189	9	.	.	PUNCT
aiua-10305	190	1	urology	urology	NOUN
aiua-10305	190	2	.	.	PUNCT
aiua-10305	191	1	1995	1995	NUM
aiua-10305	191	2	;	;	PUNCT
aiua-10305	191	3	46:697	46:697	NUM
aiua-10305	191	4	-	-	SYM
aiua-10305	191	5	706	706	NUM
aiua-10305	191	6	.	.	NUM
aiua-10305	191	7	25	25	NUM
aiua-10305	191	8	.	.	PUNCT
aiua-10305	192	1	rosen	rosen	PROPN
aiua-10305	192	2	rc	rc	PROPN
aiua-10305	192	3	,	,	PUNCT
aiua-10305	192	4	riley	riley	PROPN
aiua-10305	192	5	a	a	PRON
aiua-10305	192	6	,	,	PUNCT
aiua-10305	192	7	wagner	wagner	PROPN
aiua-10305	192	8	g	g	PROPN
aiua-10305	192	9	,	,	PUNCT
aiua-10305	192	10	et	et	PROPN
aiua-10305	192	11	al	al	PROPN
aiua-10305	192	12	.	.	PUNCT
aiua-10305	193	1	the	the	DET
aiua-10305	193	2	international	international	ADJ
aiua-10305	193	3	index	index	NOUN
aiua-10305	193	4	of	of	ADP
aiua-10305	193	5	erectile	erectile	NOUN
aiua-10305	193	6	function	function	NOUN
aiua-10305	193	7	(	(	PUNCT
aiua-10305	193	8	iief	iief	ADJ
aiua-10305	193	9	):	):	PUNCT
aiua-10305	193	10	a	a	DET
aiua-10305	193	11	multidimensional	multidimensional	ADJ
aiua-10305	193	12	scale	scale	NOUN
aiua-10305	193	13	for	for	ADP
aiua-10305	193	14	assessment	assessment	NOUN
aiua-10305	193	15	of	of	ADP
aiua-10305	193	16	erectile	erectile	ADJ
aiua-10305	193	17	dysfunction	dysfunction	NOUN
aiua-10305	193	18	.	.	PUNCT
aiua-10305	194	1	urology	urology	NOUN
aiua-10305	194	2	.	.	PUNCT
aiua-10305	195	1	1997	1997	NUM
aiua-10305	195	2	;	;	PUNCT
aiua-10305	195	3	49:822	49:822	NUM
aiua-10305	195	4	-	-	SYM
aiua-10305	195	5	830	830	NUM
aiua-10305	195	6	.	.	PUNCT
aiua-10305	196	1	26	26	NUM
aiua-10305	196	2	.	.	PUNCT
aiua-10305	196	3	rosen	rosen	PROPN
aiua-10305	196	4	rc	rc	PROPN
aiua-10305	196	5	,	,	PUNCT
aiua-10305	196	6	cappelleri	cappelleri	PROPN
aiua-10305	196	7	jc	jc	PROPN
aiua-10305	196	8	,	,	PUNCT
aiua-10305	196	9	smith	smith	PROPN
aiua-10305	196	10	md	md	PROPN
aiua-10305	196	11	,	,	PUNCT
aiua-10305	196	12	et	et	PROPN
aiua-10305	196	13	al	al	PROPN
aiua-10305	196	14	.	.	PUNCT
aiua-10305	196	15	development	development	NOUN
aiua-10305	196	16	and	and	CCONJ
aiua-10305	196	17	evaluation	evaluation	NOUN
aiua-10305	196	18	of	of	ADP
aiua-10305	196	19	an	an	DET
aiua-10305	196	20	abridged	abridge	VERB
aiua-10305	196	21	,	,	PUNCT
aiua-10305	196	22	5	5	NUM
aiua-10305	196	23	-	-	PUNCT
aiua-10305	196	24	item	item	NOUN
aiua-10305	196	25	version	version	NOUN
aiua-10305	196	26	of	of	ADP
aiua-10305	196	27	the	the	DET
aiua-10305	196	28	international	international	ADJ
aiua-10305	196	29	index	index	NOUN
aiua-10305	196	30	of	of	ADP
aiua-10305	196	31	erectile	erectile	NOUN
aiua-10305	196	32	function	function	NOUN
aiua-10305	196	33	(	(	PUNCT
aiua-10305	196	34	iief-5	iief-5	NOUN
aiua-10305	196	35	)	)	PUNCT
aiua-10305	196	36	as	as	ADP
aiua-10305	196	37	a	a	DET
aiua-10305	196	38	diagnostic	diagnostic	ADJ
aiua-10305	196	39	tool	tool	NOUN
aiua-10305	196	40	for	for	ADP
aiua-10305	196	41	erectile	erectile	ADJ
aiua-10305	196	42	dysfunction	dysfunction	NOUN
aiua-10305	196	43	.	.	PUNCT
aiua-10305	197	1	int	int	NOUN
aiua-10305	197	2	j	j	PROPN
aiua-10305	197	3	impot	impot	NOUN
aiua-10305	197	4	res	re	NOUN
aiua-10305	197	5	.	.	PUNCT
aiua-10305	197	6	1999	1999	NUM
aiua-10305	197	7	;	;	PUNCT
aiua-10305	197	8	11:319	11:319	NUM
aiua-10305	197	9	-	-	SYM
aiua-10305	197	10	326	326	NUM
aiua-10305	197	11	.	.	PUNCT
aiua-10305	198	1	27	27	NUM
aiua-10305	198	2	.	.	PUNCT
aiua-10305	199	1	marquis	marquis	PROPN
aiua-10305	199	2	p	p	PROPN
aiua-10305	199	3	,	,	PUNCT
aiua-10305	199	4	marrel	marrel	NOUN
aiua-10305	199	5	,	,	PUNCT
aiua-10305	199	6	a.	a.	NOUN
aiua-10305	199	7	reproducibility	reproducibility	NOUN
aiua-10305	199	8	and	and	CCONJ
aiua-10305	199	9	clinical	clinical	ADJ
aiua-10305	199	10	and	and	CCONJ
aiua-10305	199	11	concurrent	concurrent	ADJ
aiua-10305	199	12	validity	validity	NOUN
aiua-10305	199	13	of	of	ADP
aiua-10305	199	14	the	the	DET
aiua-10305	199	15	msf-4	msf-4	ADJ
aiua-10305	199	16	:	:	PUNCT
aiua-10305	199	17	a	a	DET
aiua-10305	199	18	four	four	NUM
aiua-10305	199	19	-	-	PUNCT
aiua-10305	199	20	item	item	NOUN
aiua-10305	199	21	male	male	ADJ
aiua-10305	199	22	sexual	sexual	ADJ
aiua-10305	199	23	function	function	NOUN
aiua-10305	199	24	questionnaire	questionnaire	NOUN
aiua-10305	199	25	for	for	ADP
aiua-10305	199	26	patients	patient	NOUN
aiua-10305	199	27	with	with	ADP
aiua-10305	199	28	benign	benign	ADJ
aiua-10305	199	29	prostatic	prostatic	ADJ
aiua-10305	199	30	hyperplasia	hyperplasia	NOUN
aiua-10305	199	31	.	.	PUNCT
aiua-10305	200	1	value	value	NOUN
aiua-10305	200	2	health	health	NOUN
aiua-10305	200	3	.	.	PUNCT
aiua-10305	201	1	2001	2001	NUM
aiua-10305	201	2	;	;	PUNCT
aiua-10305	201	3	4:335	4:335	NUM
aiua-10305	201	4	-	-	SYM
aiua-10305	201	5	343	343	NUM
aiua-10305	201	6	.	.	PUNCT
aiua-10305	202	1	28	28	NUM
aiua-10305	202	2	.	.	PUNCT
aiua-10305	203	1	avins	avin	NOUN
aiua-10305	203	2	al	al	PROPN
aiua-10305	203	3	,	,	PUNCT
aiua-10305	203	4	bent	bent	NOUN
aiua-10305	203	5	s	s	NOUN
aiua-10305	203	6	,	,	PUNCT
aiua-10305	203	7	staccone	staccone	NOUN
aiua-10305	203	8	s	s	PART
aiua-10305	203	9	,	,	PUNCT
aiua-10305	203	10	et	et	PROPN
aiua-10305	203	11	al	al	PROPN
aiua-10305	203	12	.	.	PUNCT
aiua-10305	204	1	a	a	DET
aiua-10305	204	2	detailed	detailed	ADJ
aiua-10305	204	3	safety	safety	NOUN
aiua-10305	204	4	assessment	assessment	NOUN
aiua-10305	204	5	of	of	ADP
aiua-10305	204	6	a	a	DET
aiua-10305	204	7	saw	saw	NOUN
aiua-10305	204	8	palmetto	palmetto	NOUN
aiua-10305	204	9	extract	extract	NOUN
aiua-10305	204	10	.	.	PUNCT
aiua-10305	205	1	complement	complement	VERB
aiua-10305	205	2	ther	ther	NOUN
aiua-10305	205	3	med	med	PROPN
aiua-10305	205	4	.	.	PROPN
aiua-10305	205	5	2008	2008	NUM
aiua-10305	205	6	;	;	PUNCT
aiua-10305	205	7	16:147154	16:147154	NUM
aiua-10305	205	8	.	.	X
aiua-10305	206	1	29	29	NUM
aiua-10305	206	2	.	.	PUNCT
aiua-10305	206	3	gerber	gerber	PROPN
aiua-10305	206	4	gs	gs	PROPN
aiua-10305	206	5	,	,	PUNCT
aiua-10305	206	6	kuznetsov	kuznetsov	PROPN
aiua-10305	206	7	d	d	PROPN
aiua-10305	206	8	,	,	PUNCT
aiua-10305	206	9	johnson	johnson	PROPN
aiua-10305	206	10	bc	bc	PROPN
aiua-10305	206	11	,	,	PUNCT
aiua-10305	206	12	et	et	PROPN
aiua-10305	206	13	al	al	PROPN
aiua-10305	206	14	.	.	PROPN
aiua-10305	206	15	randomized	randomize	VERB
aiua-10305	206	16	,	,	PUNCT
aiua-10305	206	17	double	double	ADJ
aiua-10305	206	18	-	-	PUNCT
aiua-10305	206	19	blind	blind	ADJ
aiua-10305	206	20	,	,	PUNCT
aiua-10305	206	21	placebo	placebo	NOUN
aiua-10305	206	22	-	-	PUNCT
aiua-10305	206	23	controlled	control	VERB
aiua-10305	206	24	trial	trial	NOUN
aiua-10305	206	25	of	of	ADP
aiua-10305	206	26	saw	see	VERB
aiua-10305	206	27	palmetto	palmetto	NOUN
aiua-10305	206	28	in	in	ADP
aiua-10305	206	29	men	man	NOUN
aiua-10305	206	30	with	with	ADP
aiua-10305	206	31	lower	low	ADJ
aiua-10305	206	32	urinary	urinary	ADJ
aiua-10305	206	33	tract	tract	NOUN
aiua-10305	206	34	symptoms	symptom	NOUN
aiua-10305	206	35	.	.	PUNCT
aiua-10305	207	1	urology	urology	NOUN
aiua-10305	207	2	.	.	PUNCT
aiua-10305	208	1	2001	2001	NUM
aiua-10305	208	2	;	;	PUNCT
aiua-10305	208	3	58:960	58:960	NUM
aiua-10305	208	4	-	-	SYM
aiua-10305	208	5	963	963	NUM
aiua-10305	208	6	.	.	NUM
aiua-10305	209	1	30	30	NUM
aiua-10305	209	2	.	.	PUNCT
aiua-10305	210	1	willetts	willetts	PROPN
aiua-10305	210	2	ke	ke	PROPN
aiua-10305	210	3	,	,	PUNCT
aiua-10305	210	4	clements	clements	PROPN
aiua-10305	210	5	ms	ms	PROPN
aiua-10305	210	6	,	,	PUNCT
aiua-10305	210	7	champion	champion	NOUN
aiua-10305	210	8	s	s	PROPN
aiua-10305	210	9	,	,	PUNCT
aiua-10305	210	10	et	et	PROPN
aiua-10305	210	11	al	al	PROPN
aiua-10305	210	12	.	.	PROPN
aiua-10305	211	1	serenoa	serenoa	PROPN
aiua-10305	211	2	repens	repen	NOUN
aiua-10305	211	3	extract	extract	VERB
aiua-10305	211	4	for	for	ADP
aiua-10305	211	5	benign	benign	ADJ
aiua-10305	211	6	prostate	prostate	NOUN
aiua-10305	211	7	hyperplasia	hyperplasia	NOUN
aiua-10305	211	8	:	:	PUNCT
aiua-10305	211	9	a	a	DET
aiua-10305	211	10	randomized	randomized	ADJ
aiua-10305	211	11	controlled	control	VERB
aiua-10305	211	12	trial	trial	NOUN
aiua-10305	211	13	.	.	PUNCT
aiua-10305	212	1	bju	bju	NOUN
aiua-10305	212	2	int	int	PROPN
aiua-10305	212	3	.	.	PUNCT
aiua-10305	213	1	2003	2003	NUM
aiua-10305	213	2	;	;	PUNCT
aiua-10305	213	3	92:267	92:267	NUM
aiua-10305	213	4	-	-	SYM
aiua-10305	213	5	70	70	NUM
aiua-10305	213	6	.	.	PUNCT
aiua-10305	214	1	31	31	NUM
aiua-10305	214	2	.	.	PUNCT
aiua-10305	215	1	ye	ye	PRON
aiua-10305	215	2	z	z	PROPN
aiua-10305	215	3	,	,	PUNCT
aiua-10305	215	4	huang	huang	PROPN
aiua-10305	215	5	j	j	PROPN
aiua-10305	215	6	,	,	PUNCT
aiua-10305	215	7	zhou	zhou	PROPN
aiua-10305	215	8	l	l	PROPN
aiua-10305	215	9	,	,	PUNCT
aiua-10305	215	10	et	et	PROPN
aiua-10305	215	11	al	al	PROPN
aiua-10305	215	12	.	.	PROPN
aiua-10305	215	13	efficacy	efficacy	NOUN
aiua-10305	215	14	and	and	CCONJ
aiua-10305	215	15	safety	safety	NOUN
aiua-10305	215	16	of	of	ADP
aiua-10305	215	17	serenoa	serenoa	ADJ
aiua-10305	215	18	repens	repen	NOUN
aiua-10305	215	19	extract	extract	NOUN
aiua-10305	215	20	among	among	ADP
aiua-10305	215	21	patients	patient	NOUN
aiua-10305	215	22	with	with	ADP
aiua-10305	215	23	benign	benign	ADJ
aiua-10305	215	24	prostatic	prostatic	ADJ
aiua-10305	215	25	hyperplasia	hyperplasia	NOUN
aiua-10305	215	26	in	in	ADP
aiua-10305	215	27	china	china	PROPN
aiua-10305	215	28	:	:	PUNCT
aiua-10305	215	29	a	a	DET
aiua-10305	215	30	multicenter	multicenter	NOUN
aiua-10305	215	31	,	,	PUNCT
aiua-10305	215	32	randomized	randomize	VERB
aiua-10305	215	33	,	,	PUNCT
aiua-10305	215	34	double	double	ADJ
aiua-10305	215	35	-	-	PUNCT
aiua-10305	215	36	blind	blind	ADJ
aiua-10305	215	37	,	,	PUNCT
aiua-10305	215	38	placebo	placebo	NOUN
aiua-10305	215	39	-	-	PUNCT
aiua-10305	215	40	controlled	control	VERB
aiua-10305	215	41	trial	trial	NOUN
aiua-10305	215	42	.	.	PUNCT
aiua-10305	216	1	urology	urology	NOUN
aiua-10305	216	2	.	.	PUNCT
aiua-10305	217	1	2019	2019	NUM
aiua-10305	217	2	;	;	PUNCT
aiua-10305	217	3	129:172	129:172	NUM
aiua-10305	217	4	-	-	SYM
aiua-10305	217	5	179	179	NUM
aiua-10305	217	6	.	.	PUNCT
aiua-10305	218	1	32	32	NUM
aiua-10305	218	2	.	.	PUNCT
aiua-10305	219	1	zhang	zhang	PROPN
aiua-10305	219	2	k	k	PROPN
aiua-10305	219	3	,	,	PUNCT
aiua-10305	219	4	guo	guo	PROPN
aiua-10305	219	5	rq	rq	PROPN
aiua-10305	219	6	,	,	PUNCT
aiua-10305	219	7	chen	chen	PROPN
aiua-10305	219	8	sw	sw	PROPN
aiua-10305	219	9	,	,	PUNCT
aiua-10305	219	10	et	et	PROPN
aiua-10305	219	11	al	al	PROPN
aiua-10305	219	12	.	.	PUNCT
aiua-10305	220	1	the	the	DET
aiua-10305	220	2	efficacy	efficacy	NOUN
aiua-10305	220	3	and	and	CCONJ
aiua-10305	220	4	safety	safety	NOUN
aiua-10305	220	5	of	of	ADP
aiua-10305	220	6	serenoa	serenoa	ADJ
aiua-10305	220	7	repens	repen	NOUN
aiua-10305	220	8	extract	extract	NOUN
aiua-10305	220	9	for	for	ADP
aiua-10305	220	10	the	the	DET
aiua-10305	220	11	treatment	treatment	NOUN
aiua-10305	220	12	of	of	ADP
aiua-10305	220	13	patients	patient	NOUN
aiua-10305	220	14	with	with	ADP
aiua-10305	220	15	chronic	chronic	ADJ
aiua-10305	220	16	prostatitis	prostatitis	NOUN
aiua-10305	220	17	/	/	SYM
aiua-10305	220	18	chronic	chronic	ADJ
aiua-10305	220	19	pelvic	pelvic	ADJ
aiua-10305	220	20	pain	pain	NOUN
aiua-10305	220	21	syndrome	syndrome	NOUN
aiua-10305	220	22	:	:	PUNCT
aiua-10305	220	23	a	a	DET
aiua-10305	220	24	multicenter	multicenter	NOUN
aiua-10305	220	25	,	,	PUNCT
aiua-10305	220	26	randomized	randomize	VERB
aiua-10305	220	27	,	,	PUNCT
aiua-10305	220	28	double	double	ADJ
aiua-10305	220	29	-	-	PUNCT
aiua-10305	220	30	blind	blind	ADJ
aiua-10305	220	31	,	,	PUNCT
aiua-10305	220	32	placebo	placebo	NOUN
aiua-10305	220	33	-	-	PUNCT
aiua-10305	220	34	controlled	control	VERB
aiua-10305	220	35	trial	trial	NOUN
aiua-10305	220	36	.	.	PUNCT
aiua-10305	221	1	world	world	PROPN
aiua-10305	221	2	j	j	PROPN
aiua-10305	221	3	urol	urol	PROPN
aiua-10305	221	4	.	.	PUNCT
aiua-10305	221	5	2021	2021	NUM
aiua-10305	221	6	;	;	PUNCT
aiua-10305	221	7	1	1	NUM
aiua-10305	221	8	-	-	SYM
aiua-10305	221	9	7	7	NUM
aiua-10305	221	10	.	.	NOUN
aiua-10305	221	11	33	33	NUM
aiua-10305	221	12	.	.	PUNCT
aiua-10305	222	1	debruyne	debruyne	PROPN
aiua-10305	222	2	f	f	PROPN
aiua-10305	222	3	,	,	PUNCT
aiua-10305	222	4	koch	koch	PROPN
aiua-10305	222	5	g	g	PROPN
aiua-10305	222	6	,	,	PUNCT
aiua-10305	222	7	boyle	boyle	PROPN
aiua-10305	222	8	p	p	X
aiua-10305	222	9	,	,	PUNCT
aiua-10305	222	10	et	et	PROPN
aiua-10305	222	11	al	al	PROPN
aiua-10305	222	12	.	.	PROPN
aiua-10305	222	13	comparison	comparison	NOUN
aiua-10305	222	14	of	of	ADP
aiua-10305	222	15	a	a	DET
aiua-10305	222	16	phytotherapeutic	phytotherapeutic	ADJ
aiua-10305	222	17	agent	agent	NOUN
aiua-10305	222	18	(	(	PUNCT
aiua-10305	222	19	permixon	permixon	ADJ
aiua-10305	222	20	)	)	PUNCT
aiua-10305	222	21	with	with	ADP
aiua-10305	222	22	an	an	DET
aiua-10305	222	23	a	a	DET
aiua-10305	222	24	-	-	PUNCT
aiua-10305	222	25	blocker	blocker	NOUN
aiua-10305	222	26	(	(	PUNCT
aiua-10305	222	27	tamsulosin	tamsulosin	NOUN
aiua-10305	222	28	)	)	PUNCT
aiua-10305	222	29	in	in	ADP
aiua-10305	222	30	the	the	DET
aiua-10305	222	31	treatment	treatment	NOUN
aiua-10305	222	32	of	of	ADP
aiua-10305	222	33	benign	benign	ADJ
aiua-10305	222	34	prostatic	prostatic	ADJ
aiua-10305	222	35	hyperplasia	hyperplasia	NOUN
aiua-10305	222	36	:	:	PUNCT
aiua-10305	222	37	a	a	DET
aiua-10305	222	38	1	1	NUM
aiua-10305	222	39	-	-	PUNCT
aiua-10305	222	40	year	year	NOUN
aiua-10305	222	41	randomized	randomize	VERB
aiua-10305	222	42	international	international	ADJ
aiua-10305	222	43	study	study	NOUN
aiua-10305	222	44	.	.	PUNCT
aiua-10305	223	1	eur	eur	PROPN
aiua-10305	223	2	urol	urol	PROPN
aiua-10305	223	3	.	.	PUNCT
aiua-10305	224	1	2002	2002	NUM
aiua-10305	224	2	;	;	PUNCT
aiua-10305	224	3	41:497	41:497	NUM
aiua-10305	224	4	-	-	SYM
aiua-10305	224	5	506	506	NUM
aiua-10305	224	6	.	.	PUNCT
aiua-10305	225	1	34	34	NUM
aiua-10305	225	2	.	.	PUNCT
aiua-10305	226	1	debruyne	debruyne	PROPN
aiua-10305	226	2	f	f	PROPN
aiua-10305	226	3	,	,	PUNCT
aiua-10305	226	4	boyle	boyle	PROPN
aiua-10305	226	5	p	p	PROPN
aiua-10305	226	6	,	,	PUNCT
aiua-10305	226	7	calais	calais	PROPN
aiua-10305	226	8	da	da	PROPN
aiua-10305	226	9	silva	silva	PROPN
aiua-10305	226	10	f	f	PROPN
aiua-10305	226	11	,	,	PUNCT
aiua-10305	226	12	et	et	PROPN
aiua-10305	226	13	al	al	PROPN
aiua-10305	226	14	.	.	PUNCT
aiua-10305	226	15	evaluation	evaluation	NOUN
aiua-10305	226	16	of	of	ADP
aiua-10305	226	17	the	the	DET
aiua-10305	226	18	clinical	clinical	ADJ
aiua-10305	226	19	benefit	benefit	NOUN
aiua-10305	226	20	of	of	ADP
aiua-10305	226	21	permixon	permixon	ADJ
aiua-10305	226	22	and	and	CCONJ
aiua-10305	226	23	tamsulosin	tamsulosin	VERB
aiua-10305	226	24	in	in	ADP
aiua-10305	226	25	severe	severe	ADJ
aiua-10305	226	26	bph	bph	NOUN
aiua-10305	226	27	patients	patient	NOUN
aiua-10305	226	28	permal	permal	ADJ
aiua-10305	226	29	study	study	NOUN
aiua-10305	226	30	subset	subset	VERB
aiua-10305	226	31	analysis	analysis	NOUN
aiua-10305	226	32	eur	eur	NOUN
aiua-10305	226	33	urol	urol	NOUN
aiua-10305	226	34	.	.	PUNCT
aiua-10305	227	1	2004	2004	NUM
aiua-10305	227	2	;	;	PUNCT
aiua-10305	227	3	45:773	45:773	NUM
aiua-10305	227	4	-	-	PUNCT
aiua-10305	227	5	780	780	NUM
aiua-10305	227	6	.	.	PUNCT
aiua-10305	228	1	35	35	NUM
aiua-10305	228	2	.	.	PUNCT
aiua-10305	229	1	hizli	hizli	PROPN
aiua-10305	229	2	f	f	PROPN
aiua-10305	229	3	,	,	PUNCT
aiua-10305	229	4	uygur	uygur	PROPN
aiua-10305	229	5	mc	mc	PROPN
aiua-10305	229	6	.	.	PUNCT
aiua-10305	230	1	a	a	DET
aiua-10305	230	2	prospective	prospective	ADJ
aiua-10305	230	3	study	study	NOUN
aiua-10305	230	4	of	of	ADP
aiua-10305	230	5	the	the	DET
aiua-10305	230	6	efficacy	efficacy	NOUN
aiua-10305	230	7	of	of	ADP
aiua-10305	230	8	serenoa	serenoa	PROPN
aiua-10305	230	9	repens	repen	NOUN
aiua-10305	230	10	,	,	PUNCT
aiua-10305	230	11	tamsulosin	tamsulosin	NOUN
aiua-10305	230	12	,	,	PUNCT
aiua-10305	230	13	and	and	CCONJ
aiua-10305	230	14	serenoa	serenoa	ADJ
aiua-10305	230	15	repens	repen	NOUN
aiua-10305	230	16	plus	plus	CCONJ
aiua-10305	230	17	tamsulosin	tamsulosin	NOUN
aiua-10305	230	18	treatment	treatment	NOUN
aiua-10305	230	19	for	for	ADP
aiua-10305	230	20	patients	patient	NOUN
aiua-10305	230	21	with	with	ADP
aiua-10305	230	22	benign	benign	ADJ
aiua-10305	230	23	prostate	prostate	NOUN
aiua-10305	230	24	hyperplasia	hyperplasia	NOUN
aiua-10305	230	25	.	.	PUNCT
aiua-10305	231	1	int	int	PROPN
aiua-10305	231	2	urol	urol	ADJ
aiua-10305	231	3	nephrol	nephrol	NOUN
aiua-10305	231	4	.	.	PUNCT
aiua-10305	232	1	2007	2007	NUM
aiua-10305	232	2	;	;	PUNCT
aiua-10305	232	3	39:879	39:879	NUM
aiua-10305	232	4	-	-	SYM
aiua-10305	232	5	886	886	NUM
aiua-10305	232	6	.	.	PUNCT
aiua-10305	233	1	archivio	archivio	NOUN
aiua-10305	233	2	italiano	italiano	X
aiua-10305	233	3	di	di	X
aiua-10305	233	4	urologia	urologia	PROPN
aiua-10305	233	5	e	e	PROPN
aiua-10305	233	6	andrologia	andrologia	NOUN
aiua-10305	233	7	2021	2021	NUM
aiua-10305	233	8	;	;	PUNCT
aiua-10305	233	9	93	93	NUM
aiua-10305	233	10	,	,	PUNCT
aiua-10305	233	11	4	4	NUM
aiua-10305	233	12	g.	g.	NOUN
aiua-10305	233	13	paulis	paulis	PROPN
aiua-10305	233	14	,	,	PUNCT
aiua-10305	233	15	a.	a.	NOUN
aiua-10305	233	16	paulis	paulis	PROPN
aiua-10305	233	17	,	,	PUNCT
aiua-10305	233	18	g.	g.	PROPN
aiua-10305	233	19	perletti	perletti	PROPN
aiua-10305	233	20	480	480	NUM
aiua-10305	233	21	36	36	NUM
aiua-10305	233	22	.	.	PUNCT
aiua-10305	234	1	latil	latil	PROPN
aiua-10305	234	2	a	a	PROPN
aiua-10305	234	3	,	,	PUNCT
aiua-10305	234	4	pétrissans	pétrissans	PROPN
aiua-10305	234	5	mt	mt	PROPN
aiua-10305	234	6	,	,	PUNCT
aiua-10305	234	7	rouquet	rouquet	VERB
aiua-10305	234	8	j	j	PROPN
aiua-10305	234	9	,	,	PUNCT
aiua-10305	234	10	et	et	PROPN
aiua-10305	234	11	al	al	PROPN
aiua-10305	234	12	.	.	PUNCT
aiua-10305	235	1	effects	effect	NOUN
aiua-10305	235	2	of	of	ADP
aiua-10305	235	3	hexanic	hexanic	ADJ
aiua-10305	235	4	extract	extract	NOUN
aiua-10305	235	5	of	of	ADP
aiua-10305	235	6	serenoa	serenoa	ADJ
aiua-10305	235	7	repens	repen	NOUN
aiua-10305	235	8	(	(	PUNCT
aiua-10305	235	9	permixon	permixon	ADJ
aiua-10305	235	10	®	®	NOUN
aiua-10305	235	11	160	160	NUM
aiua-10305	235	12	mg	mg	NOUN
aiua-10305	235	13	)	)	PUNCT
aiua-10305	235	14	on	on	ADP
aiua-10305	235	15	inflammation	inflammation	ADJ
aiua-10305	235	16	biomarkers	biomarker	NOUN
aiua-10305	235	17	in	in	ADP
aiua-10305	235	18	the	the	DET
aiua-10305	235	19	treatment	treatment	NOUN
aiua-10305	235	20	of	of	ADP
aiua-10305	235	21	lower	low	ADJ
aiua-10305	235	22	urinary	urinary	ADJ
aiua-10305	235	23	tract	tract	NOUN
aiua-10305	235	24	symptoms	symptom	NOUN
aiua-10305	235	25	related	relate	VERB
aiua-10305	235	26	to	to	ADP
aiua-10305	235	27	benign	benign	ADJ
aiua-10305	235	28	prostatic	prostatic	ADJ
aiua-10305	235	29	hyperplasia	hyperplasia	NOUN
aiua-10305	235	30	.	.	PUNCT
aiua-10305	236	1	prostate	prostate	NOUN
aiua-10305	236	2	.	.	PUNCT
aiua-10305	237	1	2015	2015	NUM
aiua-10305	237	2	;	;	PUNCT
aiua-10305	237	3	75:1857	75:1857	NOUN
aiua-10305	237	4	-	-	SYM
aiua-10305	237	5	1867	1867	NUM
aiua-10305	237	6	.	.	PUNCT
aiua-10305	238	1	37	37	NUM
aiua-10305	238	2	.	.	PUNCT
aiua-10305	238	3	carraro	carraro	PROPN
aiua-10305	238	4	jc	jc	PROPN
aiua-10305	238	5	,	,	PUNCT
aiua-10305	238	6	raynaud	raynaud	PROPN
aiua-10305	238	7	jp	jp	PROPN
aiua-10305	238	8	,	,	PUNCT
aiua-10305	238	9	koch	koch	PROPN
aiua-10305	238	10	g	g	PROPN
aiua-10305	238	11	,	,	PUNCT
aiua-10305	238	12	et	et	PROPN
aiua-10305	238	13	al	al	PROPN
aiua-10305	238	14	.	.	PROPN
aiua-10305	238	15	comparison	comparison	NOUN
aiua-10305	238	16	of	of	ADP
aiua-10305	238	17	phytotherapy	phytotherapy	NOUN
aiua-10305	238	18	(	(	PUNCT
aiua-10305	238	19	permixon	permixon	ADJ
aiua-10305	238	20	®	®	NOUN
aiua-10305	238	21	)	)	PUNCT
aiua-10305	238	22	with	with	ADP
aiua-10305	238	23	finasteride	finasteride	NOUN
aiua-10305	238	24	in	in	ADP
aiua-10305	238	25	the	the	DET
aiua-10305	238	26	treatment	treatment	NOUN
aiua-10305	238	27	of	of	ADP
aiua-10305	238	28	benign	benign	ADJ
aiua-10305	238	29	prostate	prostate	NOUN
aiua-10305	238	30	hyperplasia	hyperplasia	NOUN
aiua-10305	238	31	:	:	PUNCT
aiua-10305	238	32	a	a	DET
aiua-10305	238	33	randomized	randomized	ADJ
aiua-10305	238	34	international	international	ADJ
aiua-10305	238	35	study	study	NOUN
aiua-10305	238	36	of	of	ADP
aiua-10305	238	37	1,098	1,098	NUM
aiua-10305	238	38	patients	patient	NOUN
aiua-10305	238	39	.	.	PUNCT
aiua-10305	239	1	prostate	prostate	NOUN
aiua-10305	239	2	.	.	PUNCT
aiua-10305	239	3	1996	1996	NUM
aiua-10305	239	4	;	;	PUNCT
aiua-10305	239	5	29:231	29:231	NUM
aiua-10305	239	6	-	-	SYM
aiua-10305	239	7	240	240	NUM
aiua-10305	239	8	.	.	PUNCT
aiua-10305	239	9	38	38	NUM
aiua-10305	239	10	.	.	PUNCT
aiua-10305	240	1	marks	mark	NOUN
aiua-10305	240	2	ls	ls	PROPN
aiua-10305	240	3	,	,	PUNCT
aiua-10305	240	4	partin	partin	PROPN
aiua-10305	240	5	aw	aw	PROPN
aiua-10305	240	6	,	,	PUNCT
aiua-10305	240	7	epstein	epstein	PROPN
aiua-10305	240	8	ji	ji	PROPN
aiua-10305	240	9	,	,	PUNCT
aiua-10305	240	10	et	et	PROPN
aiua-10305	240	11	al	al	PROPN
aiua-10305	240	12	.	.	PUNCT
aiua-10305	241	1	effects	effect	NOUN
aiua-10305	241	2	of	of	ADP
aiua-10305	241	3	a	a	DET
aiua-10305	241	4	saw	saw	NOUN
aiua-10305	241	5	palmetto	palmetto	NOUN
aiua-10305	241	6	herbal	herbal	ADJ
aiua-10305	241	7	blend	blend	NOUN
aiua-10305	241	8	in	in	ADP
aiua-10305	241	9	men	man	NOUN
aiua-10305	241	10	with	with	ADP
aiua-10305	241	11	symptomatic	symptomatic	ADJ
aiua-10305	241	12	benign	benign	ADJ
aiua-10305	241	13	prostatic	prostatic	ADJ
aiua-10305	241	14	hyperplasia	hyperplasia	NOUN
aiua-10305	241	15	.	.	PUNCT
aiua-10305	242	1	j	j	PROPN
aiua-10305	242	2	urol	urol	PROPN
aiua-10305	242	3	.	.	PROPN
aiua-10305	242	4	2000	2000	NUM
aiua-10305	242	5	;	;	PUNCT
aiua-10305	242	6	163:1451	163:1451	NUM
aiua-10305	242	7	-	-	SYM
aiua-10305	242	8	1456	1456	NUM
aiua-10305	242	9	.	.	PUNCT
aiua-10305	243	1	39	39	NUM
aiua-10305	243	2	.	.	PUNCT
aiua-10305	244	1	pytel	pytel	PROPN
aiua-10305	244	2	ya	ya	PROPN
aiua-10305	244	3	,	,	PUNCT
aiua-10305	244	4	vinarov	vinarov	X
aiua-10305	244	5	a	a	PRON
aiua-10305	244	6	,	,	PUNCT
aiua-10305	244	7	lopatkin	lopatkin	ADJ
aiua-10305	244	8	n.	n.	NOUN
aiua-10305	244	9	et	et	PROPN
aiua-10305	244	10	al	al	PROPN
aiua-10305	244	11	.	.	PUNCT
aiua-10305	245	1	long	long	ADJ
aiua-10305	245	2	-	-	PUNCT
aiua-10305	245	3	term	term	NOUN
aiua-10305	245	4	clinical	clinical	ADJ
aiua-10305	245	5	and	and	CCONJ
aiua-10305	245	6	biologic	biologic	NOUN
aiua-10305	245	7	effects	effect	NOUN
aiua-10305	245	8	of	of	ADP
aiua-10305	245	9	the	the	DET
aiua-10305	245	10	lipidosterolic	lipidosterolic	ADJ
aiua-10305	245	11	extract	extract	NOUN
aiua-10305	245	12	of	of	ADP
aiua-10305	245	13	serenoa	serenoa	ADJ
aiua-10305	245	14	repens	repen	NOUN
aiua-10305	245	15	in	in	ADP
aiua-10305	245	16	patients	patient	NOUN
aiua-10305	245	17	with	with	ADP
aiua-10305	245	18	symptomatic	symptomatic	ADJ
aiua-10305	245	19	benign	benign	ADJ
aiua-10305	245	20	prostatic	prostatic	ADJ
aiua-10305	245	21	hyperplasia	hyperplasia	NOUN
aiua-10305	245	22	.	.	PUNCT
aiua-10305	246	1	adv	adv	INTJ
aiua-10305	246	2	ther	ther	ADV
aiua-10305	246	3	.	.	PUNCT
aiua-10305	247	1	2002	2002	NUM
aiua-10305	247	2	;	;	PUNCT
aiua-10305	247	3	19:297	19:297	NUM
aiua-10305	247	4	-	-	SYM
aiua-10305	247	5	306	306	NUM
aiua-10305	247	6	.	.	PUNCT
aiua-10305	248	1	40	40	NUM
aiua-10305	248	2	.	.	PUNCT
aiua-10305	248	3	vela	vela	NOUN
aiua-10305	248	4	-	-	PUNCT
aiua-10305	248	5	navarrete	navarrete	NOUN
aiua-10305	248	6	r	r	NOUN
aiua-10305	248	7	,	,	PUNCT
aiua-10305	248	8	alcaraz	alcaraz	NOUN
aiua-10305	248	9	a	a	PRON
aiua-10305	248	10	,	,	PUNCT
aiua-10305	248	11	rodríguez	rodríguez	NOUN
aiua-10305	248	12	-	-	PUNCT
aiua-10305	248	13	antolín	antolín	NOUN
aiua-10305	248	14	a	a	NOUN
aiua-10305	248	15	,	,	PUNCT
aiua-10305	248	16	et	et	PROPN
aiua-10305	248	17	al	al	PROPN
aiua-10305	248	18	.	.	PROPN
aiua-10305	248	19	efficacy	efficacy	NOUN
aiua-10305	248	20	and	and	CCONJ
aiua-10305	248	21	safety	safety	NOUN
aiua-10305	248	22	of	of	ADP
aiua-10305	248	23	a	a	DET
aiua-10305	248	24	hexanic	hexanic	ADJ
aiua-10305	248	25	extract	extract	NOUN
aiua-10305	248	26	of	of	ADP
aiua-10305	248	27	serenoa	serenoa	ADJ
aiua-10305	248	28	repens	repen	NOUN
aiua-10305	248	29	(	(	PUNCT
aiua-10305	248	30	permixon	permixon	ADJ
aiua-10305	248	31	®	®	NOUN
aiua-10305	248	32	)	)	PUNCT
aiua-10305	248	33	for	for	ADP
aiua-10305	248	34	the	the	DET
aiua-10305	248	35	treatment	treatment	NOUN
aiua-10305	248	36	of	of	ADP
aiua-10305	248	37	lower	low	ADJ
aiua-10305	248	38	urinary	urinary	ADJ
aiua-10305	248	39	tract	tract	NOUN
aiua-10305	248	40	symptoms	symptom	NOUN
aiua-10305	248	41	associated	associate	VERB
aiua-10305	248	42	with	with	ADP
aiua-10305	248	43	benign	benign	ADJ
aiua-10305	248	44	prostatic	prostatic	ADJ
aiua-10305	248	45	hyperplasia	hyperplasia	NOUN
aiua-10305	248	46	(	(	PUNCT
aiua-10305	248	47	luts	luts	PROPN
aiua-10305	248	48	/	/	SYM
aiua-10305	248	49	bph	bph	NOUN
aiua-10305	248	50	):	):	PUNCT
aiua-10305	248	51	systematic	systematic	ADJ
aiua-10305	248	52	review	review	NOUN
aiua-10305	248	53	and	and	CCONJ
aiua-10305	248	54	meta	meta	NOUN
aiua-10305	248	55	-	-	PUNCT
aiua-10305	248	56	analysis	analysis	NOUN
aiua-10305	248	57	of	of	ADP
aiua-10305	248	58	randomised	randomised	ADJ
aiua-10305	248	59	controlled	control	VERB
aiua-10305	248	60	trials	trial	NOUN
aiua-10305	248	61	and	and	CCONJ
aiua-10305	248	62	observational	observational	ADJ
aiua-10305	248	63	studies	study	NOUN
aiua-10305	248	64	.	.	PUNCT
aiua-10305	249	1	bju	bju	NOUN
aiua-10305	249	2	int	int	PROPN
aiua-10305	249	3	.	.	PUNCT
aiua-10305	250	1	2018	2018	NUM
aiua-10305	250	2	;	;	PUNCT
aiua-10305	250	3	122:1049	122:1049	NUM
aiua-10305	250	4	-	-	SYM
aiua-10305	250	5	1065	1065	NUM
aiua-10305	250	6	.	.	PUNCT
aiua-10305	251	1	41	41	NUM
aiua-10305	251	2	.	.	PUNCT
aiua-10305	252	1	novara	novara	PROPN
aiua-10305	252	2	g	g	PROPN
aiua-10305	252	3	,	,	PUNCT
aiua-10305	252	4	giannarini	giannarini	VERB
aiua-10305	252	5	g	g	NOUN
aiua-10305	252	6	,	,	PUNCT
aiua-10305	252	7	alcaraz	alcaraz	NOUN
aiua-10305	252	8	a	a	PRON
aiua-10305	252	9	,	,	PUNCT
aiua-10305	252	10	et	et	PROPN
aiua-10305	252	11	al	al	PROPN
aiua-10305	252	12	.	.	PROPN
aiua-10305	252	13	efficacy	efficacy	NOUN
aiua-10305	252	14	and	and	CCONJ
aiua-10305	252	15	safety	safety	NOUN
aiua-10305	252	16	of	of	ADP
aiua-10305	252	17	hexanic	hexanic	ADJ
aiua-10305	252	18	lipidosterolic	lipidosterolic	ADJ
aiua-10305	252	19	extract	extract	NOUN
aiua-10305	252	20	of	of	ADP
aiua-10305	252	21	serenoa	serenoa	ADJ
aiua-10305	252	22	repens	repen	NOUN
aiua-10305	252	23	(	(	PUNCT
aiua-10305	252	24	permixon	permixon	ADJ
aiua-10305	252	25	)	)	PUNCT
aiua-10305	252	26	in	in	ADP
aiua-10305	252	27	the	the	DET
aiua-10305	252	28	treatment	treatment	NOUN
aiua-10305	252	29	of	of	ADP
aiua-10305	252	30	lower	low	ADJ
aiua-10305	252	31	urinary	urinary	ADJ
aiua-10305	252	32	tract	tract	NOUN
aiua-10305	252	33	symptoms	symptom	NOUN
aiua-10305	252	34	due	due	ADJ
aiua-10305	252	35	to	to	ADP
aiua-10305	252	36	benign	benign	ADJ
aiua-10305	252	37	prostatic	prostatic	ADJ
aiua-10305	252	38	hyperplasia	hyperplasia	NOUN
aiua-10305	252	39	:	:	PUNCT
aiua-10305	252	40	systematic	systematic	ADJ
aiua-10305	252	41	review	review	NOUN
aiua-10305	252	42	and	and	CCONJ
aiua-10305	252	43	meta	meta	NOUN
aiua-10305	252	44	-	-	PUNCT
aiua-10305	252	45	analysis	analysis	NOUN
aiua-10305	252	46	of	of	ADP
aiua-10305	252	47	randomized	randomized	ADJ
aiua-10305	252	48	controlled	control	VERB
aiua-10305	252	49	trials	trial	NOUN
aiua-10305	252	50	.	.	PUNCT
aiua-10305	253	1	euro	euro	PROPN
aiua-10305	253	2	urol	urol	ADJ
aiua-10305	253	3	focus	focus	NOUN
aiua-10305	253	4	.	.	PUNCT
aiua-10305	254	1	2016	2016	NUM
aiua-10305	254	2	;	;	PUNCT
aiua-10305	254	3	2:553	2:553	NUM
aiua-10305	254	4	-	-	SYM
aiua-10305	254	5	561	561	NUM
aiua-10305	254	6	.	.	PUNCT
aiua-10305	255	1	42	42	NUM
aiua-10305	255	2	.	.	PUNCT
aiua-10305	256	1	cai	cai	PROPN
aiua-10305	256	2	t	t	PROPN
aiua-10305	256	3	,	,	PUNCT
aiua-10305	256	4	cui	cui	VERB
aiua-10305	256	5	y	y	PROPN
aiua-10305	256	6	,	,	PUNCT
aiua-10305	256	7	yu	yu	PROPN
aiua-10305	256	8	s	s	PROPN
aiua-10305	256	9	,	,	PUNCT
aiua-10305	256	10	et	et	PROPN
aiua-10305	256	11	al	al	PROPN
aiua-10305	256	12	.	.	PROPN
aiua-10305	256	13	comparison	comparison	NOUN
aiua-10305	256	14	of	of	ADP
aiua-10305	256	15	serenoa	serenoa	PROPN
aiua-10305	256	16	repens	repen	NOUN
aiua-10305	256	17	with	with	ADP
aiua-10305	256	18	tamsulosin	tamsulosin	NOUN
aiua-10305	256	19	in	in	ADP
aiua-10305	256	20	the	the	DET
aiua-10305	256	21	treatment	treatment	NOUN
aiua-10305	256	22	of	of	ADP
aiua-10305	256	23	benign	benign	ADJ
aiua-10305	256	24	prostatic	prostatic	ADJ
aiua-10305	256	25	hyperplasia	hyperplasia	NOUN
aiua-10305	256	26	:	:	PUNCT
aiua-10305	256	27	a	a	DET
aiua-10305	256	28	systematic	systematic	ADJ
aiua-10305	256	29	review	review	NOUN
aiua-10305	256	30	and	and	CCONJ
aiua-10305	256	31	meta	meta	ADJ
aiua-10305	256	32	-	-	PUNCT
aiua-10305	256	33	analysis	analysis	NOUN
aiua-10305	256	34	.	.	PUNCT
aiua-10305	256	35	am	be	AUX
aiua-10305	256	36	j	j	PROPN
aiua-10305	256	37	mens	mens	PROPN
aiua-10305	256	38	health	health	NOUN
aiua-10305	256	39	.	.	PUNCT
aiua-10305	257	1	2020	2020	NUM
aiua-10305	257	2	;	;	PUNCT
aiua-10305	257	3	14	14	NUM
aiua-10305	257	4	:	:	SYM
aiua-10305	257	5	1557988320905407	1557988320905407	NUM
aiua-10305	257	6	.	.	PUNCT
aiua-10305	258	1	43	43	NUM
aiua-10305	258	2	.	.	PUNCT
aiua-10305	259	1	colloca	colloca	PROPN
aiua-10305	259	2	l	l	PROPN
aiua-10305	259	3	,	,	PUNCT
aiua-10305	259	4	barsky	barsky	PROPN
aiua-10305	259	5	aj	aj	PROPN
aiua-10305	259	6	.	.	PROPN
aiua-10305	259	7	placebo	placebo	PROPN
aiua-10305	259	8	and	and	CCONJ
aiua-10305	259	9	nocebo	nocebo	NOUN
aiua-10305	259	10	effects	effect	NOUN
aiua-10305	259	11	.	.	PUNCT
aiua-10305	260	1	n	n	PROPN
aiua-10305	260	2	engl	engl	PROPN
aiua-10305	260	3	j	j	PROPN
aiua-10305	260	4	med	med	PROPN
aiua-10305	260	5	.	.	PUNCT
aiua-10305	260	6	2020	2020	NUM
aiua-10305	260	7	;	;	PUNCT
aiua-10305	260	8	382:554	382:554	NUM
aiua-10305	260	9	-	-	SYM
aiua-10305	260	10	561	561	NUM
aiua-10305	260	11	.	.	PUNCT
aiua-10305	261	1	44	44	NUM
aiua-10305	261	2	.	.	PUNCT
aiua-10305	262	1	mondaini	mondaini	PROPN
aiua-10305	262	2	n	n	PROPN
aiua-10305	262	3	,	,	PUNCT
aiua-10305	262	4	gontero	gontero	NOUN
aiua-10305	262	5	p	p	NOUN
aiua-10305	262	6	,	,	PUNCT
aiua-10305	262	7	giubilei	giubilei	VERB
aiua-10305	262	8	g	g	NOUN
aiua-10305	262	9	,	,	PUNCT
aiua-10305	262	10	et	et	PROPN
aiua-10305	262	11	al	al	PROPN
aiua-10305	262	12	.	.	PUNCT
aiua-10305	263	1	finasteride	finasteride	ADJ
aiua-10305	263	2	5	5	NUM
aiua-10305	263	3	mg	mg	NOUN
aiua-10305	263	4	and	and	CCONJ
aiua-10305	263	5	sexual	sexual	ADJ
aiua-10305	263	6	side	side	NOUN
aiua-10305	263	7	effects	effect	NOUN
aiua-10305	263	8	:	:	PUNCT
aiua-10305	263	9	how	how	SCONJ
aiua-10305	263	10	many	many	ADJ
aiua-10305	263	11	of	of	ADP
aiua-10305	263	12	these	these	PRON
aiua-10305	263	13	are	be	AUX
aiua-10305	263	14	related	relate	VERB
aiua-10305	263	15	to	to	ADP
aiua-10305	263	16	a	a	DET
aiua-10305	263	17	nocebo	nocebo	NOUN
aiua-10305	263	18	phenomenon	phenomenon	NOUN
aiua-10305	263	19	?	?	PUNCT
aiua-10305	263	20	.	.	PUNCT
aiua-10305	264	1	j	j	PROPN
aiua-10305	264	2	sex	sex	PROPN
aiua-10305	264	3	med	me	VERB
aiua-10305	264	4	,	,	PUNCT
aiua-10305	264	5	2007	2007	NUM
aiua-10305	264	6	;	;	PUNCT
aiua-10305	264	7	4:1708	4:1708	NUM
aiua-10305	264	8	-	-	SYM
aiua-10305	264	9	1712	1712	NUM
aiua-10305	264	10	.	.	PUNCT
aiua-10305	265	1	correspondence	correspondence	NOUN
aiua-10305	265	2	gianni	gianni	PROPN
aiua-10305	265	3	paulis	paulis	PROPN
aiua-10305	265	4	,	,	PUNCT
aiua-10305	265	5	md	md	PROPN
aiua-10305	265	6	(	(	PUNCT
aiua-10305	265	7	corresponding	correspond	VERB
aiua-10305	265	8	author	author	NOUN
aiua-10305	265	9	)	)	PUNCT
aiua-10305	265	10	paulisg@libero.it	paulisg@libero.it	PROPN
aiua-10305	265	11	department	department	PROPN
aiua-10305	265	12	of	of	ADP
aiua-10305	265	13	uro	uro	PROPN
aiua-10305	265	14	-	-	PUNCT
aiua-10305	265	15	andrology	andrology	PROPN
aiua-10305	265	16	,	,	PUNCT
aiua-10305	265	17	castelfidardo	castelfidardo	PROPN
aiua-10305	265	18	medical	medical	ADJ
aiua-10305	265	19	team	team	PROPN
aiua-10305	265	20	,	,	PUNCT
aiua-10305	265	21	rome	rome	PROPN
aiua-10305	265	22	(	(	PUNCT
aiua-10305	265	23	italy	italy	PROPN
aiua-10305	265	24	)	)	PUNCT
aiua-10305	265	25	andrea	andrea	PROPN
aiua-10305	265	26	paulis	paulis	PROPN
aiua-10305	265	27	,	,	PUNCT
aiua-10305	265	28	clinical	clinical	ADJ
aiua-10305	265	29	psychologist	psychologist	NOUN
aiua-10305	265	30	andrea.fx.94@gmail.com	andrea.fx.94@gmail.com	PUNCT
aiua-10305	265	31	neurosystem	neurosystem	NOUN
aiua-10305	265	32	center	center	NOUN
aiua-10305	265	33	for	for	ADP
aiua-10305	265	34	applied	applied	ADJ
aiua-10305	265	35	psychology	psychology	NOUN
aiua-10305	265	36	and	and	CCONJ
aiua-10305	265	37	neuroscience	neuroscience	NOUN
aiua-10305	265	38	,	,	PUNCT
aiua-10305	265	39	janet	janet	PROPN
aiua-10305	265	40	clinical	clinical	ADJ
aiua-10305	265	41	centre	centre	NOUN
aiua-10305	265	42	,	,	PUNCT
aiua-10305	265	43	rome	rome	PROPN
aiua-10305	265	44	(	(	PUNCT
aiua-10305	265	45	italy	italy	PROPN
aiua-10305	265	46	)	)	PUNCT
aiua-10305	265	47	gianpaolo	gianpaolo	PROPN
aiua-10305	265	48	perletti	perletti	PROPN
aiua-10305	265	49	,	,	PUNCT
aiua-10305	265	50	phd	phd	PROPN
aiua-10305	265	51	gianpaolo.perletti@uninsubria.it	gianpaolo.perletti@uninsubria.it	PROPN
aiua-10305	265	52	department	department	PROPN
aiua-10305	265	53	of	of	ADP
aiua-10305	265	54	biotechnology	biotechnology	NOUN
aiua-10305	265	55	and	and	CCONJ
aiua-10305	265	56	life	life	NOUN
aiua-10305	265	57	sciences	science	NOUN
aiua-10305	265	58	,	,	PUNCT
aiua-10305	265	59	section	section	NOUN
aiua-10305	265	60	of	of	ADP
aiua-10305	265	61	medical	medical	ADJ
aiua-10305	265	62	and	and	CCONJ
aiua-10305	265	63	surgical	surgical	ADJ
aiua-10305	265	64	sciences	science	NOUN
aiua-10305	265	65	,	,	PUNCT
aiua-10305	265	66	university	university	NOUN
aiua-10305	265	67	of	of	ADP
aiua-10305	265	68	insubria	insubria	PROPN
aiua-10305	265	69	,	,	PUNCT
aiua-10305	265	70	varese	varese	PROPN
aiua-10305	265	71	(	(	PUNCT
aiua-10305	265	72	italy	italy	PROPN
aiua-10305	265	73	)	)	PUNCT